Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,29545,0.0795386900684224,0.0018626385686905,0.075887918473789,0.0831894616630558,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.165737520254049,0.00205182362489755,0.16171594594925,0.169759094558848,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,28797,-0.334308269257659,0.0083680515638405,-0.350709650322786,-0.317906888192531,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,29443,-0.12144304593931,0.00294375718690721,-0.127212810025648,-0.115673281852972,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.162144053037359,0.00198499440529063,0.158253464002989,0.166034642071728,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,0.0816218538948321,0.00190115483085461,0.0778955904263571,0.0853481173633072,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,24938,-0.110046128678289,0.00274130663981959,-0.115419089692336,-0.104673167664243,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,29347,-0.116159741759844,0.00275238245297537,-0.121554411367675,-0.110765072152012,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,24951,0.065705853806315,0.00168634576332434,0.0624006161101993,0.0690110915024307,1.11253692925361e-308
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,29435,0.0787902318222688,0.00214083124990516,0.0745942025724547,0.0829862610720829,6.14718465096225e-290
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,0.299771272494347,0.00824294890594473,0.283615092638695,0.315927452349998,2.29931935730451e-283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,24922,-0.197381970313456,0.00560667374047136,-0.20837105084478,-0.186392889782132,5.23809906703485e-265
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,24111,-0.221142492138427,0.0065938146018184,-0.234066368757991,-0.208218615518863,4.67882152745125e-241
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,29454,-0.12350033099281,0.00370446671398776,-0.130761085752226,-0.116239576233394,3.05757066705484e-239
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,24966,0.149644802705402,0.00458622684159452,0.140655798095877,0.158633807314928,1.0106660863311e-228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,29725,0.0747085629515954,0.00242277749474467,0.0699599190618958,0.079457206841295,1.51050129350869e-205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,29694,0.0451016215447814,0.00147498842604898,0.0422106442297254,0.0479925988598374,3.34661664133203e-202
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,29694,-0.28775450827326,0.00946101110144864,-0.306298090032099,-0.269210926514421,4.14946192882711e-200
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0543913581272738,0.00185095552807266,0.0507634852922514,0.0580192309622962,4.22395926178782e-187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,0.0613050607836184,0.0020878680878418,0.0572128393314485,0.0653972822357883,2.89752516940037e-186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C9,Complement component C9,24951,0.106439367487697,0.00362971934679929,0.0993251175679706,0.113553617407424,7.23664558297785e-186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,-0.0591539730366389,0.00202799149895279,-0.0631288363745863,-0.0551791096986914,2.14051758378996e-184
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,24914,0.0744142522636879,0.00255507825701588,0.0694062988799368,0.079422205647439,2.11571418817004e-183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0724829841846027,0.00251355240127575,0.0675564214781022,0.0774095468911031,6.8279723176847e-180
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,29507,0.0385258025933092,0.00135095878379708,0.0358779233770669,0.0411736818095515,1.77840977960196e-176
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,29443,-0.0802147852648994,0.00281292727814385,-0.0857281227300613,-0.0747014477997374,1.84495258721257e-176
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,29725,-0.0655841623001771,0.00230562866665332,-0.0701031944868176,-0.0610651301135366,1.26590958292002e-175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,29478,0.0899404298057572,0.00320801344694673,0.0836527234497416,0.0962281361617728,1.02982866617472e-170
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,-0.106214240967935,0.00378966513887863,-0.113641984640137,-0.0987864972957326,3.40751743061991e-170
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0656774614062069,0.00238170341780832,-0.0703456001051112,-0.0610093227073026,2.69474929054264e-165
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,23787,0.0803748935471789,0.00297044905472095,0.0745528133999258,0.086196973694432,7.79007474442045e-159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.127440059514283,0.00472493810851819,-0.136700938206978,-0.118179180821587,2.70973788513036e-158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,29725,-0.120465725087306,0.00449383413027168,-0.129273639982638,-0.111657810191973,1.95624531001401e-156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,0.0607552980293061,0.00227410746652298,0.0562980473949211,0.0652125486636912,2.1437204229807e-155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,29034,0.0962357314003621,0.00366511273684038,0.089052110436155,0.103419352364569,3.36767011308125e-150
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,29349,-0.161545042624092,0.00617827463649832,-0.173654460911629,-0.149435624336556,5.41047752449451e-149
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,29443,0.0668550834673649,0.00256315142546837,0.0618313066734468,0.0718788602612829,2.75181576865943e-148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,0.05234804840449,0.00201294341890403,0.0484026793034381,0.0562934175055419,1.95586833020899e-147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0451197929948284,0.00177954500855994,0.0416318847780509,0.0486077012116059,2.46827737248976e-140
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,0.0846629644031227,0.00334936017454002,0.0780982184610243,0.0912277103452211,3.24351732117309e-139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,29536,-0.0570263322808934,0.00227593938472353,-0.0614871734749515,-0.0525654910868353,4.06097485023227e-137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,29725,0.0279826283047109,0.0011370643924018,0.0257539820956034,0.0302112745138185,2.11925637046283e-132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,-0.055262454630598,0.00224764231783037,-0.0596678335735455,-0.0508570756876505,3.86092927864719e-132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,29435,0.0757102490418593,0.00308770108617094,0.0696583549129643,0.0817621431707544,1.89347810869534e-131
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,-0.091999818431191,0.00377652173491794,-0.0994018010316301,-0.0845978358307518,9.03045652496576e-130
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,0.0652315789850214,0.00268042024308643,0.059977955308572,0.0704852026614708,1.54791943559354e-129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REN,Renin,29478,-0.126799658023377,0.00521299533721929,-0.137017128884326,-0.116582187162427,2.08071593257621e-129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,28931,-0.13142645596253,0.00544783279464151,-0.142104208240028,-0.120748703685033,2.51048244688494e-127
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,29702,0.0589480165178849,0.00245626269883936,0.0541337416281598,0.0637622914076101,4.52652573793547e-126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,29434,-0.0841251943111682,0.00365426932355717,-0.0912875621853402,-0.0769628264369961,3.05958120454509e-116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,29786,-0.08323245909678,0.00362194596707838,-0.0903314731922537,-0.0761334450013064,7.53569448300534e-116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,24951,0.081112048338018,0.00354563350731953,0.0741626066636717,0.0880614900123643,1.20409883292382e-114
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,28916,-0.102602327738726,0.00453970542598348,-0.111500150373653,-0.0937045051037981,3.96883809477765e-112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,29584,-0.0528714959558369,0.00234719412909459,-0.0574719964488623,-0.0482709954628115,2.03024116453802e-111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,29192,0.0436323293813333,0.00194445806450693,0.0398211915748997,0.0474434671877668,1.40534687139138e-110
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,29400,-0.155526810697799,0.00697398724786035,-0.169195825703605,-0.141857795691993,2.91971487407312e-109
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,29478,-0.0936760055812144,0.00422764568530358,-0.101962191124409,-0.0853898200380193,6.66409076933558e-108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,29820,0.0248667846041448,0.00112515775771021,0.0226614753990328,0.0270720938092568,2.27067501707959e-107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,29434,0.0516310218549227,0.00235210714486219,0.0470208918509928,0.0562411518588526,6.01756371189863e-106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,29786,-0.0426545290879914,0.00194465781060717,-0.0464660583967815,-0.0388429997792014,8.45152598390854e-106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,29480,0.0788474497312381,0.00360160650101346,0.0717883009892517,0.0859065984732244,2.13206749820557e-105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,29581,0.0646637250412446,0.00296091712302608,0.0588603274801135,0.0704671226023757,6.67232045140456e-105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,24922,-0.136813119721567,0.00628115380330971,-0.149124181176054,-0.124502058267079,3.2634460249232e-104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,29674,-0.176514939701678,0.00812068867704241,-0.192431489508681,-0.160598389894675,6.01991446318636e-104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,29820,-0.0773726116149187,0.00358535976950424,-0.084399916763147,-0.0703453064666904,1.68301452061556e-102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,29820,-0.065774218334177,0.00305015563348514,-0.0717525233758079,-0.0597959132925461,2.36267189832523e-102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,24240,-0.0746718504139455,0.00351710723102473,-0.0815653805867539,-0.067778320241137,3.95186339335131e-99
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,29527,0.0565059573299698,0.00267226915620254,0.0512683097838128,0.0617436048761268,1.64204942883703e-98
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,24381,-0.0583326394833008,0.00277194417964489,-0.0637656500754048,-0.0528996288911968,1.91426654639558e-97
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,-0.0463377523255125,0.0022077598740804,-0.0506649616787101,-0.0420105429723149,6.29821154502923e-97
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,29489,-0.116037050409313,0.0055378100090675,-0.126891158027085,-0.105182942791541,8.84692443243763e-97
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,-0.0770155777407939,0.00370079603147411,-0.0842691379624832,-0.0697620175191047,1.70102325440457e-95
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,0.0480438280347753,0.00234111273430478,0.0434552470755379,0.0526324089940126,6.04713823421089e-93
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,-0.0368415237974836,0.00179698851177907,-0.0403636212805706,-0.0333194263143967,1.23764281861632e-92
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,0.0498325672119619,0.00244724076274925,0.0450359753169733,0.0546291591069504,1.52608629232806e-91
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,29434,0.0647326968316547,0.00318155529705658,0.0584968484494238,0.0709685452138856,2.13626557763043e-91
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,-0.0722250219381357,0.00355016560280046,-0.0791833465196246,-0.0652666973566468,2.28719833008382e-91
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,28990,0.041823070087562,0.00206137151473681,0.0377827819186779,0.0458633582564461,6.89965146950405e-91
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,29750,0.0748487588702861,0.0037057044797618,0.067585578089953,0.0821119396506192,4.08594431111655e-90
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,27442,-0.0561573151546617,0.0027969852782379,-0.0616394063000079,-0.0506752240093154,5.03929380604615e-89
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,-0.0648893668281954,0.00324141419925356,-0.0712425386587324,-0.0585361949976585,1.45628595800714e-88
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,-0.0528515834155849,0.00266775326857456,-0.058080379821991,-0.0476227870091787,8.63586235978405e-87
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,0.0365986186344062,0.00185106192042027,0.0329705372703825,0.04022669999843,1.9027728505633e-86
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,29577,-0.0884043920445786,0.00448120177930344,-0.0971875475320134,-0.0796212365571439,4.45738736424714e-86
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASPN,Asporin,24922,0.0373686258097441,0.00189540077117459,0.0336536402982419,0.0410836113212463,7.18660423233621e-86
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0340426855551393,0.00175454980705127,0.0306037679333188,0.0374816031769598,2.4459404938579e-83
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,-0.0842733925447895,0.00434934579773443,-0.092798110308349,-0.07574867478123,4.15988917289385e-83
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,29349,-0.0608667763746677,0.00314419580387635,-0.0670294001502653,-0.05470415259907,5.70398179213815e-83
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,24845,0.0252971860999394,0.0013149589215503,0.0227198666137008,0.027874505586178,7.02239233555481e-82
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,-0.110448809358446,0.00574876689677488,-0.121716392476124,-0.099181226240767,9.40022167286318e-82
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,28774,-0.0680095025365842,0.0035405420393503,-0.0749489649337108,-0.0610700401394577,1.01680688334723e-81
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,29559,-0.0429790468193866,0.00224071680493461,-0.0473708517570584,-0.0385872418817147,1.6735091398949e-81
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,29218,0.0446194183443125,0.00233835022698032,0.040036251899431,0.0492025847891939,1.11398104263624e-80
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,-0.0572013495632627,0.00301399940188823,-0.0631087883909636,-0.0512939107355617,7.84107331590307e-80
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FURIN,Furin,29566,-0.0435089083930395,0.00230086684969561,-0.0480186074184428,-0.0389992093676361,2.78693002556001e-79
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,24892,0.0948749589984255,0.00504960752783684,0.0849777282438653,0.104772189752986,3.26085762100045e-78
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,29786,-0.0337906021292966,0.00180328233355335,-0.0373250355030611,-0.030256168755532,6.76622822733872e-78
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,-0.0423763553843708,0.00226169820726531,-0.0468092838706108,-0.0379434268981308,8.54720781540242e-78
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,29683,-0.0258521972583049,0.0013819076644628,-0.028560736280652,-0.0231436582359578,1.20194131831141e-77
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD248,Endosialin,24938,0.051710197904323,0.00276788992008493,0.0462851336609565,0.0571352621476894,2.33637106783341e-77
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,29443,0.0345797434325069,0.00185356153407391,0.030946762825722,0.0382127240392918,3.16120584048148e-77
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,-0.0677231595911638,0.00363479066893479,-0.074847349302276,-0.0605989698800516,5.0346813591953e-77
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,24938,0.0758221808051335,0.00407165208335463,0.0678417427217585,0.0838026188885086,7.09381321048787e-77
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,29426,-0.107373760166027,0.00578845847396325,-0.118719138774995,-0.096028381557059,2.24197333567473e-76
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,29218,0.0327943120623779,0.00177070307043732,0.0293237340443208,0.0362648900804351,3.85579814302303e-76
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,29468,0.0491243495059012,0.0026552172822768,0.0439201236326387,0.0543285753791637,5.46197471073204e-76
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,29545,-0.0231115003416046,0.00124986668031085,-0.0255612390350139,-0.0206617616481954,6.53164947190199e-76
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,-0.0482190058535535,0.00261200745831058,-0.0533385404718423,-0.0430994712352648,1.13626851147703e-75
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.0392250034822498,0.00212930039921963,0.0350515746997793,0.0433984322647203,2.33565515748218e-75
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,-0.099261905636165,0.00541846131037224,-0.109882089804495,-0.0886417214678354,1.53693033492392e-74
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,24805,-0.0901974031080233,0.00496005323574993,-0.0999191074500931,-0.0804756987659534,2.04653656038619e-73
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.0418496104898547,0.00232125146333403,0.03729995762172,0.0463992633579894,2.82781003791627e-72
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,29786,-0.0374646947982272,0.00208620478257737,-0.0415536561720788,-0.0333757334243755,9.88866084722264e-72
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,-0.104892736752655,0.00586497391343935,-0.116388085622996,-0.093397387882314,4.35162905752898e-71
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,29474,0.0267309388089127,0.00149584494577741,0.023799082715189,0.0296627949026364,4.78448293505465e-71
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,-0.028718610129719,0.00160894428776792,-0.0318721409337441,-0.0255650793256939,6.8974511840117e-71
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POSTN,Periostin,24938,0.0465995865753557,0.00260943259387783,0.0414850986913552,0.0517140744593562,6.91476272798091e-71
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,29694,0.0458885717428375,0.00257122961737128,0.0408489616927898,0.0509281817928852,7.17091027491271e-71
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,29820,-0.0540337326395082,0.00302887188037197,-0.0599703215250373,-0.0480971437539791,8.14282951815507e-71
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,0.0761896981382834,0.00427815229842591,0.0678045196333687,0.0845748766431982,1.40014753178612e-70
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,29786,-0.0421006694733554,0.00236509579552245,-0.0467362572325794,-0.0374650817141314,1.61685364789074e-70
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,-0.0991649255286447,0.00559225224974247,-0.11012573993814,-0.0882041111191495,5.45658016886567e-70
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFM,Afamin,24966,-0.0233538271626978,0.00134292755928306,-0.0259859651788926,-0.020721689146503,2.44265043952309e-67
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,29434,0.0520308065993817,0.00299745934300869,0.0461557862870847,0.0579058269116788,3.69157457902526e-67
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,-0.0702436518120282,0.00406737417100988,-0.0782157051872076,-0.0622715984368489,1.7128185812158e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,-0.119921151702109,0.00695160577092937,-0.13354629901313,-0.106296004391087,2.39462508693283e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,-0.0441457654945253,0.00258761089689328,-0.0492174828524362,-0.0390740481366145,6.96632157796669e-65
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,0.0714009861267206,0.00419889584247945,0.0631711502754608,0.0796308219779803,1.79445597521099e-64
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,29697,-0.0310310805568237,0.00182785521566328,-0.0346136767795237,-0.0274484843341237,2.45693098202013e-64
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,24329,-0.0440600347526156,0.00259397231075916,-0.0491442204817035,-0.0389758490235276,2.47064017728159e-64
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,-0.0363947878989413,0.00216042493717722,-0.0406292207758086,-0.0321603550220739,2.21051548766665e-63
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,29511,0.0427200374111111,0.00255105892623872,0.0377199619156832,0.047720112906539,1.18003033760731e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,-0.0411475980328889,0.00246828067232311,-0.0459854281506422,-0.0363097679151356,4.12724097566092e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,0.0303555588164144,0.00182716418434721,0.0267743170150939,0.033936800617735,1.19463250421095e-61
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0273519852689204,0.0016700659856763,0.0240786559369948,0.0306253146008459,5.0667288247515e-60
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.0662924571750123,0.00406109317401206,-0.074252199796076,-0.0583327145539487,1.22865189120111e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,28797,-0.0857854173977187,0.00526534194697918,-0.0961054876137979,-0.0754653471816395,2.06034814464147e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,24381,0.0253926459177872,0.00156577823248594,0.0223237205821147,0.0284615712534596,7.74414971477081e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MME,Neprilysin,29349,-0.0894774782814642,0.00552786446622719,-0.10031209263527,-0.0786428639276589,1.12608331210741e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,-0.0628854487080446,0.00388409826825337,-0.0704982813138212,-0.055272616102268,1.20097382958982e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,29434,-0.0843622681308186,0.00522846523874885,-0.0946100599987663,-0.0741144762628708,2.57069985897414e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,0.0273716332296824,0.00169684996498381,0.0240458072983141,0.0306974591610506,2.73567777108837e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,-0.163503755104838,0.0101413722054638,-0.183380844627547,-0.143626665582129,3.17865350232012e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,-0.0383591840395453,0.00238686749324169,-0.043037444326299,-0.0336809237527916,7.16234974521569e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,29383,-0.0329760329608963,0.00205745007341157,-0.0370086351047829,-0.0289434308170096,1.43888806597135e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELE,E-selectin,29820,-0.0554845812979192,0.00346573376806136,-0.0622774194833194,-0.0486917431125189,1.9059492962799e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,29693,-0.0624856503459915,0.00391255400158506,-0.0701542561890982,-0.0548170445028848,3.54943710290522e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,24381,-0.0315068396460327,0.00198320787809677,-0.0353939270871024,-0.0276197522049631,1.50452113101943e-56
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,29349,-0.060954245467559,0.00386611251383179,-0.0685318259946693,-0.0533766649404487,8.99827604883209e-56
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAST,Gastrin,24845,-0.140993019575931,0.00898625416801518,-0.15860607774524,-0.123379961406621,3.26949573259291e-55
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FST,Follistatin,29536,0.0545415184667963,0.00348052756715788,0.0477196844351669,0.0613633524984258,4.01750955133639e-55
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.0731443944704583,0.00467293070767661,-0.0823033386575044,-0.0639854502834121,5.30799808179934e-55
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,-0.0856805428582672,0.00547829925249918,-0.0964180093931656,-0.0749430763233688,6.48257956263543e-55
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,-0.060453799180442,0.0038695577485741,-0.0680381323676472,-0.0528694659932368,8.4743874789562e-55
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.0286282745552399,0.00183254634579295,0.0250364837174857,0.0322200653929941,8.5601908786614e-55
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,24922,-0.0303935988867178,0.00195618034262234,-0.0342277123582576,-0.026559485415178,3.48993594385982e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,24195,-0.0867830300051006,0.0055893626635082,-0.0977381808255767,-0.0758278791846245,4.19315964149881e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,-0.0324597356333276,0.00209805622608855,-0.0365719258364611,-0.028347545430194,8.82067633244454e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,-0.0361089087769255,0.00233833361280382,-0.040692042658021,-0.0315257748958301,1.38239207998476e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,29426,-0.0493356019003206,0.00319492952689224,-0.0555976637730294,-0.0430735400276118,1.39020098189296e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,29433,-0.0317016341307419,0.00205505329818642,-0.0357295385951873,-0.0276737296662965,1.76835820425136e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,0.0463668645544223,0.00301313205849199,0.0404611257197781,0.0522726033890666,3.15666067350848e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,24805,-0.117753350963046,0.00765727286692143,-0.132761605782212,-0.10274509614388,4.04777839692462e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,29725,0.0360387639689696,0.00234768211877651,0.0314373070161677,0.0406402209217716,5.5916833163675e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,29632,-0.0511485013465489,0.00333339686292182,-0.0576819591978757,-0.0446150434952222,6.18761493044331e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,28477,-0.0424873148789911,0.00276954492602903,-0.047915622934008,-0.0370590068239742,6.63785347560049e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,24966,0.0290501950954598,0.00189786788943314,0.0253303740321708,0.0327700161587487,1.19604624862423e-52
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,0.0251240760594441,0.00165484190139924,0.0218805859327016,0.0283675661861867,7.31219191037531e-52
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,0.0442233094229261,0.00291456742437803,0.0385107572711451,0.049935861574707,8.34602309019776e-52
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,0.0438024908354441,0.0029137744407931,0.0380914929314896,0.0495134887393985,6.91833235376414e-51
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,0.0329564498440785,0.0021934516747281,0.0286572845616114,0.0372556151265456,7.74323223810519e-51
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,-0.0328794798723303,0.00219079913602944,-0.037173446178948,-0.0285855135657126,1.00467187448117e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,29820,-0.060880742459489,0.00406628483947274,-0.0688506607448556,-0.0529108241741225,1.70638518701774e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,-0.0484370157220353,0.00326204912040947,-0.0548306319980379,-0.0420433994460327,1.07985619117578e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.0437503328084765,0.00294650464896058,-0.0495254819204393,-0.0379751836965138,1.08151848461171e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,29566,0.0410263838243159,0.00276316366692426,0.0356105830371444,0.0464421846114875,1.08932433495958e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,29820,0.0279007499288529,0.00187960520504904,0.0242167237269568,0.031584776130749,1.14613980561174e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,29725,0.0471198232196758,0.00317874581133797,0.0408894814294534,0.0533501650098982,1.55506694602654e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,24905,0.0352301479456267,0.00237841775356688,0.0305684491486356,0.0398918467426178,1.97766556589853e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,-0.0958009696929593,0.00647906378652822,-0.108499934714555,-0.0831020046713639,2.70166657634914e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,29443,0.0295863022610255,0.0020040820170589,0.02565830150759,0.0335143030144609,3.80402986024404e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,0.0307602632934338,0.00208433515009823,0.0266749663992413,0.0348455601876263,4.09756881247409e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,24229,-0.0455445574122344,0.00308603313984408,-0.0515931823663288,-0.03949593245814,4.44762296913263e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,29443,-0.0569488435011034,0.00386305273190213,-0.0645204268556316,-0.0493772601465752,5.18797915954765e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,29786,0.00903359267525637,0.000612972530780855,0.00783216651492589,0.0102350188355868,5.52324771480317e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,29478,0.0315098380317762,0.00214225589583906,0.0273110164759317,0.0357086595876208,8.44465746041296e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,29349,-0.0361760821168514,0.0024595648901024,-0.0409968293014521,-0.0313553349322507,8.50820499256236e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,0.0354418754098004,0.00240978818760443,0.0307186905620957,0.0401650602575051,8.60641141277869e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0400027038430971,0.00272241804617317,0.0346667644725977,0.0453386432135965,1.05859229081819e-48
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,-0.0331486644435514,0.00226017525618501,-0.037578607945674,-0.0287187209414288,1.56417362706427e-48
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,24381,0.05245307693682,0.00358339194215304,0.0454296287302,0.05947652514344,2.58495357006083e-48
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,-0.0300499254279287,0.00205643780335322,-0.034080543522501,-0.0260193073333564,3.4440515091644e-48
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,-0.0549196063295614,0.00378930755156402,-0.0623466491306269,-0.047492563528496,1.9596126544499e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,-0.0724983368281967,0.00500527904238333,-0.082308683751268,-0.0626879899051254,2.36994138918514e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,-0.0511846212053407,0.00353498680884729,-0.0581131953506814,-0.04425604706,2.37856023550217e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,24867,-0.0442517361834305,0.00305715229575715,-0.0502437546831145,-0.0382597176837465,2.72276102399473e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0392888493264594,0.00273150092234885,0.0339351075186556,0.0446425911342631,9.44957234625834e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,-0.0908262077976778,0.00632812729100724,-0.103229337288052,-0.0784230783073036,1.48015178499465e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,-0.0567685330042478,0.00395922354487528,-0.0645286111522034,-0.0490084548562923,1.95402686287293e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,24914,-0.0277394607163629,0.00194822084931115,-0.0315579735810127,-0.023920947851713,8.01564902539219e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,-0.0380380594466098,0.00268251956506265,-0.0432957977941326,-0.032780321099087,1.72615064772568e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,29497,-0.0485259685696708,0.00342799926611287,-0.055244847131252,-0.0418070900080896,2.42276239041125e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,0.031651898268295,0.00224025170597477,0.0272610049245845,0.0360427916120056,3.8198384179928e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,29443,0.0278585078822518,0.00197467593627655,0.0239881430471498,0.0317288727173538,4.76337337262763e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,29500,-0.0511198973895846,0.00363108618009095,-0.0582368263025629,-0.0440029684766063,7.20744388406134e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.06273940486304,0.00452034457491492,-0.0715992802298732,-0.0538795294962067,1.16067861867283e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,29489,0.0262762194537108,0.00189600666332453,0.0225600463935947,0.0299923925138269,1.54351732632561e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,29786,-0.0313058767979345,0.00226022837430028,-0.035735924411563,-0.0268758291843059,1.71782633308925e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,0.0499440739964307,0.00361357799872609,0.0428614611189276,0.0570266868739338,2.59283049841966e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,29434,-0.0455217443901727,0.00329695186967102,-0.0519837700547278,-0.0390597187256175,3.14571737098242e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,29478,-0.0602772879459518,0.00437903172287424,-0.0688601901227853,-0.0516943857691183,5.6248404749571e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,29478,0.0487495113312869,0.00355022951260302,0.0417910614865849,0.0557079611759888,8.92408401376358e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,29214,0.0319027572512275,0.00232343500302473,0.0273488246452991,0.036456689857156,9.01137105281808e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,29443,0.024411591121178,0.00177962931902052,0.0209235176558978,0.0278996645864583,1.08361727295959e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0387555383885167,0.00282772983788204,-0.0442978888707655,-0.0332131879062679,1.27260720723354e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,-0.0412806690366751,0.00302396757856317,-0.047207645490659,-0.0353536925826913,2.68778589046142e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,0.0223848269113917,0.00164926035816418,0.0191522766093899,0.0256173772133935,7.77319349279836e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,24240,-0.0600545185392858,0.00442972230693405,-0.0687367742608765,-0.051372262817695,1.02024626927219e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,24381,0.026586042680043,0.00197453362997256,0.0227159567652968,0.0304561285947892,3.55375844194834e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0304545584661776,0.00226218821078003,0.0260206695730487,0.0348884473593064,3.62552545421686e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,24922,-0.0756089828381408,0.00563926390017562,-0.0866619400824851,-0.0645560255937966,7.56418679401869e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,0.0221334672395273,0.00165142908975954,0.0188966662235986,0.025370268255456,7.68375744531638e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,-0.0457876003676335,0.00341965404383966,-0.0524901222935592,-0.0390850784417077,9.69991479177422e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEP,Leptin,29478,-0.0618833897324854,0.0046327729318459,-0.0709636246789034,-0.0528031547860675,1.40129991174209e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,24381,0.01976337114398,0.00148018755617229,0.0168622035338823,0.0226645387540777,1.60228763414846e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,0.0275385446567762,0.00206980495181502,0.0234817269512187,0.0315953623623336,2.97964127389549e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,-0.0562247249149269,0.00424099908135071,-0.0645370831143743,-0.0479123667154795,5.32399687057652e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,0.0285812104247277,0.00215595839014276,0.0243555319800479,0.0328068888694075,5.55631335447767e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,29435,-0.0307261870030115,0.00232518094060883,-0.0352835416466049,-0.0261688323594182,9.39062914950302e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,0.0365832630843375,0.00277284493316882,0.0311484870153266,0.0420180391533484,1.24111844805645e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,-0.0618058104156242,0.00469279350235184,-0.0710036856802338,-0.0526079351510146,1.68277808342104e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,-0.0430302476165058,0.00326661583888373,-0.0494328146607179,-0.0366276805722937,1.71942696897054e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,29701,-0.0215720308906069,0.00164597405088181,-0.0247981400303352,-0.0183459217508785,3.9110935690414e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,24922,-0.0239399014326791,0.00182624124659269,-0.0275193342760008,-0.0203604685893574,3.9496985352848e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,0.0298531704164411,0.00228092130457165,0.0253825646594807,0.0343237761734016,5.17266151687905e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,28916,0.0211713197852623,0.00161846882847181,0.0179991208814575,0.024343518689067,5.45207096145199e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,24707,-0.022901631729792,0.00175267720624521,-0.0263368790540326,-0.0194663844055514,6.87332565673657e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,29081,-0.0325519629293977,0.00249596724137717,-0.0374440587224969,-0.0276598671362984,9.09081328857121e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,-0.0260563525713116,0.002002886442714,-0.0299820099990311,-0.0221306951435922,1.38100264018101e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,-0.0320907835743047,0.00246785431760867,-0.0369277780368177,-0.0272537891117917,1.50075624612794e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,-0.0512047924742242,0.00393718328998849,-0.0589216717226016,-0.0434879132258467,1.52388892487351e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,29293,-0.0635346310432571,0.00490154422268811,-0.0731416577197258,-0.0539276043667884,2.55650818536777e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,-0.0284623745142669,0.00220200643149495,-0.032778307119997,-0.0241464419085368,4.29255545403589e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,-0.0647610164813537,0.00501181118127168,-0.0745841663966461,-0.0549378665660612,4.32227573966877e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,24229,0.0268859743422431,0.00209363406769839,0.0227824515695543,0.030989497114932,1.26933772658889e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,29443,0.0252238365177483,0.00196947733500032,0.0213636609411477,0.029084012094349,1.8773833225692e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,-0.108797221426414,0.00851062697902997,-0.125478050305313,-0.0921163925475152,2.6701476294717e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,29639,-0.0509112232963915,0.00398481891743118,-0.0587214683745566,-0.0431009782182264,2.79027634317165e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,24805,-0.0861819883209294,0.00675438761853721,-0.0994205880532623,-0.0729433885885965,3.6170874416432e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,-0.0579826308636376,0.00455490108417378,-0.0669102369886182,-0.049055024738657,5.27281141781727e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,29594,-0.0469707265693928,0.00369260486261567,-0.0542082321001195,-0.0397332210386661,5.70778331245834e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,-0.0926967990872652,0.00729448608472056,-0.106993991813318,-0.0783996063612129,6.6975828463908e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,29433,-0.0262461949666226,0.0020712197801748,-0.0303057857357652,-0.02218660419748,1.0563781869553e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,-0.0314446774243243,0.00249248803435022,-0.0363299539716507,-0.0265594008769979,2.15274533083721e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,29443,-0.0280102586238871,0.00222170165955039,-0.0323647938766058,-0.0236557233711683,2.38194462711039e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,29545,-0.0286314275191176,0.00227773225801817,-0.0330957827448332,-0.024167072293402,3.81407114970601e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,-0.0264769635144387,0.00210669843660911,-0.0306060924501926,-0.0223478345786849,3.92033458967904e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,29725,-0.0330608769702688,0.00263100739778387,-0.0382176514699252,-0.0279041024706124,4.02006716628323e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,29786,-0.0471327098110864,0.00375639255218474,-0.0544952392133685,-0.0397701804088043,5.07208295190465e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,29683,-0.0297150625751921,0.00237109049449198,-0.0343623999443964,-0.0250677252059878,6.13492295817982e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OCLN,Occludin,24867,-0.0380719419951299,0.00303715116702865,-0.0440247582825061,-0.0321191257077537,6.1389123957983e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,29169,-0.0265638378071465,0.00212116366158832,-0.0307213185838596,-0.0224063570304334,6.89288640639208e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,-0.0588829186462211,0.00471528207898882,-0.0681248715210392,-0.049640965771403,1.12414187854324e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,29725,-0.110103912556701,0.00882305555343403,-0.127397101441432,-0.0928107236719706,1.19258889632984e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,29531,0.0241650504691106,0.00193848496809332,0.0203656199316477,0.0279644810065735,1.40758409211313e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.0185046414935418,0.00148885498900021,0.0155864857151014,0.0214227972719822,2.32226102031416e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASN,Vasorin,29065,0.0236015000355396,0.00190033400017527,0.019876845395196,0.0273261546758831,2.51362640361726e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,29478,-0.0580896927143464,0.00469361123143233,-0.0672891707279538,-0.0488902147007391,4.29154131408108e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,29820,0.0256537395339022,0.00207623595320334,0.0215843170656237,0.0297231620021808,5.51512883892586e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,29530,-0.0241636489542954,0.00195618110524585,-0.0279977639205773,-0.0203295339880136,5.76517523203837e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,-0.0447432344532076,0.00362209687354637,-0.0518425443253585,-0.0376439245810567,5.95880765711356e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0243777768956899,0.00197547661356846,0.0205058427330958,0.0282497110582841,6.69725635463728e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,29725,-0.0391131520661959,0.00317780306934628,-0.0453416460821146,-0.0328846580502772,9.94003189458651e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,-0.0313423619170814,0.00254677744451714,-0.036334045708335,-0.0263506781258278,1.01332150556625e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,29192,-0.0314297935512715,0.00255667183998328,-0.0364408703576388,-0.0264187167449043,1.19983864708424e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,29725,-0.0224895374487677,0.00183284858332869,-0.026081920672092,-0.0188971542254435,1.58614220864457e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,0.0244852682824799,0.00199836288469685,0.020568477028474,0.0284020595364857,1.97086150879267e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,0.0223525739286671,0.00182821600816619,0.0187692705526614,0.0259358773046728,2.81574785909974e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,-0.0333291585898827,0.00273310029645186,-0.0386860351709283,-0.027972282008837,4.01600617075441e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,-0.0688480387954896,0.00566057983891648,-0.0799427752797659,-0.0577533023112133,5.94885675254708e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,29566,-0.0348591887108595,0.00287122006179152,-0.0404867800319709,-0.0292315973897482,7.7201020033192e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,24623,0.0351231903655969,0.0028934863833113,0.0294519570543068,0.0407944236768871,8.22812090909207e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,29604,-0.0499130361608605,0.00411608081633264,-0.0579805545608725,-0.0418455177608485,9.2111019823103e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,24828,-0.0257639543073668,0.00212784598759883,-0.0299345324430605,-0.0215933761716731,1.19215408633958e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,29478,0.0296776124350864,0.00246136216141447,0.024853342598714,0.0345018822714587,2.12527906805229e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,29349,-0.0646430815833219,0.00536229223310398,-0.0751531743602057,-0.0541329888064381,2.18616077260622e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,29434,-0.0388410166934472,0.00322455090023587,-0.0451611364579095,-0.0325208969289849,2.45699235692703e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.03235089986451,0.00268720455525457,-0.037617820792809,-0.0270839789362111,2.65825205378968e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,-0.045688104402556,0.00380089643162724,-0.0531378614085454,-0.0382383473965666,3.33980045054561e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,-0.0494603271335163,0.00411439780643057,-0.0575245468341202,-0.0413961074329124,3.39814684665956e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,-0.0289974946366656,0.00241515386181437,-0.0337311962058217,-0.0242637930675094,3.91816448902262e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,29820,-0.0502710130067084,0.00419377530166537,-0.0584908125979725,-0.0420512134154443,4.94871089504675e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,29725,-0.0457799437241123,0.00382664681965635,-0.0532801714906388,-0.0382797159575859,6.57180271808092e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,29820,-0.0465233307196777,0.00389118008820387,-0.0541500436925573,-0.0388966177467981,7.17418595681329e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,-0.0192556135517679,0.00161044904268311,-0.0224120936754268,-0.016099133428109,7.36989277463182e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,29487,-0.02605752182508,0.00218000068518464,-0.0303303231680419,-0.0217847204821181,7.46105457097165e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,0.0314177501723308,0.00263056174838734,0.0262618491454916,0.0365736511991699,8.36721425458776e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,24240,-0.0444287443310296,0.00373412406606292,-0.0517476275005129,-0.0371098611615463,1.49314481486702e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,0.0199439856375223,0.00167709836036384,0.0166568728512092,0.0232310984238354,1.54619567320887e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,-0.0249744378617388,0.00210538184210672,-0.0291009862722679,-0.0208478894512096,2.20724681233767e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,0.0277558641027491,0.00236388229860382,0.0231226547974856,0.0323890734080126,9.1778612751801e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,-0.0178644346483726,0.00152161129967903,-0.0208467927957435,-0.0148820765010017,9.29960727425422e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0294139378106766,0.00252064908443449,-0.0343544100161682,-0.024473465605185,2.14790791467459e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,24229,-0.0369955864514453,0.00317808345351004,-0.0432246300203249,-0.0307665428825656,3.09430621535539e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREH,Trehalase,24938,-0.0600390780286476,0.00517514827445475,-0.0701823686465789,-0.0498957874107163,4.87034732780314e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,29433,0.142022976176766,0.0122451080242327,0.11802256444927,0.166023387904262,4.90853543949614e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,29581,-0.0324459214467492,0.00280262115872195,-0.0379390589178442,-0.0269527839756542,6.28593523117768e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,-0.0691422102926353,0.00597335351121364,-0.0808499831746141,-0.0574344374106566,6.61520827570137e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,29218,-0.0289403074067247,0.00250207784079323,-0.0338443799746795,-0.02403623483877,7.11246084968624e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,29301,-0.060186108523847,0.00520969744665225,-0.0703971155192854,-0.0499751015284085,8.3428844380164e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,0.0170937562968797,0.00148224582349478,0.0141885544828299,0.0199989581109295,1.05829328009429e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,29694,0.0238882183132106,0.00207411130304752,0.0198229601592375,0.0279534764671838,1.25368712096084e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.02197554295277,0.00190966851140822,-0.0257184932351301,-0.0182325926704099,1.40583490923512e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,29443,-0.0296526744939933,0.00258113073197119,-0.0347116907286568,-0.0245936582593297,1.75561207436836e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELL,L-selectin,24966,0.0184383709150896,0.00160639568662731,0.0152898353693001,0.0215869064608791,2.02667209631386e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,29434,0.0209893415312728,0.00183217422753005,0.0173982800453139,0.0245804030172317,2.54527143376824e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,24653,-0.0216194429441322,0.00188779457091252,-0.0253195203031207,-0.0179193655851436,2.73452167807227e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,-0.0335761379347668,0.00294180816177398,-0.0393420819318438,-0.0278101939376898,4.14514791117064e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,24938,-0.029362694238879,0.00257460369763758,-0.0344089174862486,-0.0243164709915093,4.70111487435015e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,24867,-0.0416282585176512,0.00366160043648097,-0.0488049953731539,-0.0344515216621485,7.08330447914326e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,29786,-0.0271601989083975,0.00239168675489836,-0.0318479049479982,-0.0224724928687967,7.96824389827427e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,29694,-0.047555546627581,0.00419218009172742,-0.0557722196073668,-0.0393388736477953,9.16140588725427e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,24240,0.0507915823293435,0.0044800156956932,0.0420107515657848,0.0595724130929021,1.0181843707099e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,29265,-0.01797720271015,0.00158846648502043,-0.02109059702079,-0.0148638083995099,1.24129484969284e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,28916,-0.0418571059728762,0.00370011841182409,-0.0491093380600514,-0.034604873885701,1.31547771352413e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.0513571072309037,0.0045413892156956,0.0424559843681403,0.0602582300936671,1.36886360054781e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,0.0490989304680857,0.00434992550289984,0.040573076482402,0.0576247844537694,1.74429305706721e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,-0.0676270895236167,0.00599576313424525,-0.0793787852667374,-0.055875393780496,1.91291222604217e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,0.0455717647062778,0.00404815347564025,0.0376373838940229,0.0535061455185326,2.44129497132246e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,29443,0.0621477987784476,0.00553294829965884,0.0513032201111163,0.0729923774457789,3.24515109829579e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,-0.0215124261709964,0.0019154745817929,-0.0252667563513105,-0.0177580959906823,3.29882859498459e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,0.0406115518873881,0.00363321398599628,0.0334904524748354,0.0477326512999408,5.98661194574977e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0198145756803393,0.00177855875584921,0.0163286005188748,0.0233005508418037,9.06423609318543e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,29694,-0.0284389540299744,0.00255481673595885,-0.0334463948324538,-0.0234315132274951,1.00475722586751e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,24951,-0.0187926558401278,0.00168980828451375,-0.0221046800777747,-0.0154806316024808,1.15586084788392e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,29683,-0.0442636378127366,0.00398152739760674,-0.0520674315120458,-0.0364598441134274,1.17816467495563e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGRN,Agrin,29581,-0.026365907681452,0.0023745801289551,-0.031020084734204,-0.0217117306287,1.37561152150906e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0174476857472338,0.00157350627510637,0.0143636134480253,0.0205317580464422,1.62600328518027e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.0200731224654677,0.00181524424913463,0.0165152437371638,0.0236310011937716,2.33303889462227e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,29443,0.0346622946633332,0.00315185175206163,0.0284846652292924,0.040839924097374,4.45918120961671e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,-0.0290327385294755,0.0026431972311707,-0.0342134051025701,-0.023852071956381,5.16810298594991e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,24194,-0.020916125099855,0.00190748444136735,-0.024654794604935,-0.017177455594775,6.5295279509904e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,29351,-0.0241425628946329,0.00220405196833249,-0.0284625047525646,-0.0198226210367012,7.22219017239325e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.0159347262570267,0.00145468099860033,0.01308355149977,0.0187859010142833,7.38220111250487e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,24610,0.0819818784504021,0.00748560266439019,0.0673100972281973,0.0966536596726068,7.5426932963557e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,-0.0502805326992008,0.00459958444957125,-0.0592957182203604,-0.0412653471780412,9.2021569413387e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,-0.0317623471294136,0.0029080765918632,-0.0374621772494655,-0.0260625170093618,1.02087407551189e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,-0.0575832996279734,0.0052712733884476,-0.0679149954693307,-0.0472516037866161,1.02371532881849e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,28753,0.0348035583493808,0.00319087931274813,0.0285494348963945,0.0410576818023672,1.20644672615468e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,29732,0.0267779894516937,0.00247233023410729,0.0219322221928434,0.031623756710544,2.75824914115903e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,29544,-0.0228613684677102,0.0021137387629494,-0.0270042964430911,-0.0187184404923294,3.26569065112554e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PXN,Paxillin,28774,-0.0384207949184915,0.00355665987330851,-0.0453918482701762,-0.0314497415668069,3.7771609035767e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,28764,-0.0442622227794255,0.00410230041168927,-0.0523027315863365,-0.0362217139725146,4.34362171571849e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,29434,-0.0298952729084447,0.00277174506154752,-0.0353278932290778,-0.0244626525878116,4.51823715632087e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,0.0326232948432834,0.0030250112499178,0.0266942727934445,0.0385523168931223,4.57730815094673e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0180613766766077,0.00167622203354934,0.014775981490851,0.0213467718623644,5.07158605929024e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,-0.0333160143812171,0.00309302320308781,-0.0393783398592692,-0.027253688903165,5.41228647255909e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,0.0131073456167677,0.00121831456679389,0.0107194490658517,0.0154952421676837,6.06069952772237e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,0.0110344607214124,0.00102595870555072,0.00902358165853297,0.0130453397842918,6.41513629464037e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,28931,-0.0327002779682135,0.00304698347672462,-0.0386723655825938,-0.0267281903538332,8.08930467952364e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,24919,-0.0416289961219429,0.00388128643592547,-0.0492363175363568,-0.0340216747075289,8.83484788155258e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,-0.0205731172983582,0.00191934932202019,-0.0243350419695177,-0.0168111926271986,9.30838646141166e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,-0.0359987213117649,0.00336363815335541,-0.0425914520923415,-0.0294059905311883,1.11379333537298e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,-0.0470338441360195,0.00440136521681227,-0.0556605199609716,-0.0384071683110675,1.32177603830226e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,29581,-0.0306202944367955,0.0028671265912543,-0.0362398625556539,-0.0250007263179371,1.41512550971497e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,29736,-0.036868652770016,0.00346521613381601,-0.0436604763922954,-0.0300768291477367,2.17412015115756e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0376547859275712,0.00354315279227785,-0.0445993654004358,-0.0307102064547066,2.47755453345038e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,-0.0436547862790046,0.00410986935278027,-0.051710130210454,-0.0355994423475553,2.63040323130992e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,29694,0.0169381715826587,0.00159815030628971,0.0138057969823308,0.0200705461829865,3.369009903755e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,-0.0458762788369435,0.00432840724630048,-0.0543599570396924,-0.0373926006341945,3.4301810378048e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,29478,-0.0448108597526823,0.00422967788071889,-0.0531010283988913,-0.0365206911064732,3.52660947364448e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,29595,-0.0496535855933017,0.00469441373799416,-0.0588546365197703,-0.0404525346668331,4.23408698017726e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,29319,-0.0575050909954708,0.00544671701782489,-0.0681806563504076,-0.046829525640534,5.20869136405766e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,29725,-0.0208009237737242,0.00197295180774683,-0.024667909316908,-0.0169339382305404,6.07873715877603e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,-0.0274026602437282,0.0026101194161759,-0.0325184942994329,-0.0222868261880234,9.73372379329821e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,0.0276322765751958,0.00263248437456801,0.0224726072010425,0.032791945949349,9.95082569678435e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,-0.0319131603995752,0.00304319410348713,-0.03787782084241,-0.0259484999567404,1.10376801282783e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,24240,-0.0231385335886384,0.00221246633840119,-0.0274749676119048,-0.0188020995653721,1.52240792243618e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,24381,-0.0196969169772614,0.00188707234182403,-0.0233955787672365,-0.0159982551872863,1.88521966317152e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,0.0324002418927815,0.00312007385305839,0.026284897140787,0.0385155866447759,3.22566716805353e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,-0.0356492405819318,0.00344729366459503,-0.042405936164538,-0.0288925449993255,5.05593361987332e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,-0.0357471448365655,0.00346576233096184,-0.0425400390052507,-0.0289542506678803,6.69200623675875e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,24951,0.0186509124638131,0.00181529600298913,0.0150929322979544,0.0222088926296718,1.03059149485777e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,29604,-0.0422463416401136,0.00412127193339091,-0.0503240346295598,-0.0341686486506675,1.29040833931335e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,28797,-0.0332807433349118,0.00324791051805436,-0.0396466479502984,-0.0269148387195253,1.3480869403966e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,29218,-0.0269630077108334,0.00263700682060974,-0.0321315410792285,-0.0217944743424383,1.68774805138693e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RETN,Resistin,29362,-0.0297398356144701,0.00291351282856365,-0.0354503207584549,-0.0240293504704854,2.01517446984984e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,-0.0685934618952663,0.00672238257227145,-0.0817693317369183,-0.0554175920536142,2.0956385839277e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,-0.0201839097786883,0.00197957661285337,-0.0240638799398809,-0.0163039396174957,2.26650231748992e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.0511283675720746,0.00504286714667665,-0.0610123871795609,-0.0412443479645884,4.1567854321419e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,24966,0.0213391603716202,0.00210589521644049,0.0172116057473968,0.0254667149958435,4.38803102117243e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,24966,-0.015141640759021,0.00149640065098534,-0.0180745860349522,-0.0122086954830897,5.07836977358733e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,-0.0236574679147764,0.00234056085487281,-0.0282449671903271,-0.0190699686392257,5.5933082477431e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,-0.0251938336979975,0.0024931808633621,-0.0300804681901873,-0.0203071992058078,5.73821508472534e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,29434,-0.0378797691222775,0.00374889902305094,-0.0452276112074573,-0.0305319270370976,5.78928760662685e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,0.011785063961339,0.00116697275224948,0.00949779736693003,0.014072330555748,6.21516266676907e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,29372,0.0439763960168353,0.00436108380969297,0.0354286717498371,0.0525241202838336,7.1245000307574e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,29443,-0.016330563552555,0.00162126345520439,-0.0195082399247556,-0.0131528871803544,7.97028663197147e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,29478,-0.0183244352467679,0.00181927381786563,-0.0218902119297845,-0.0147586585637512,7.99768847319482e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNC,Tenascin,29594,0.0331580171995778,0.00329766321548855,0.0266945972972202,0.0396214371019354,9.53398179411556e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,29218,-0.0614467590128234,0.0061110329311843,-0.0734243835579446,-0.0494691344677021,9.54004804165915e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,-0.048390769520929,0.00482474998243381,-0.0578472794864993,-0.0389342595553587,1.25516941487214e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,29566,-0.0226637019831306,0.00226273272846709,-0.0270986581309261,-0.0182287458353351,1.41268911123851e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,-0.019602403686663,0.0019606884256276,-0.0234453530008931,-0.0157594543724329,1.70158314602977e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,-0.0550811487297358,0.00550952368237591,-0.0658798151471926,-0.044282482312279,1.73679330195385e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPTC,Opticin,29349,0.0311055303043592,0.00312323019900724,0.024983999114305,0.0372270614944134,2.49858008003862e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,29443,0.0165327834369794,0.0016616500640563,0.013275949311429,0.0197896175625297,2.75539278061645e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,28797,-0.0431037993473246,0.00434527927051283,-0.0516205467175298,-0.0345870519771195,3.7238764664332e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,0.0170785600997143,0.0017277909244819,0.0136920898877298,0.0204650303116988,5.26641583818007e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,-0.054435839112454,0.00551093213875367,-0.0652372661044112,-0.0436344121204968,5.729019702851e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,-0.032287958193813,0.00327118377122135,-0.0386994783854069,-0.0258764380022192,6.1643037247387e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0250775429516153,0.00254238510544172,-0.0300606177582811,-0.0200944681449496,6.48529162803054e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,-0.0187004648128611,0.00190504069122498,-0.022434344567662,-0.0149665850580601,1.03761927980031e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,29218,-0.0352727119296498,0.0035966443957379,-0.0423221349452961,-0.0282232889140035,1.13736380733652e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,29434,-0.0494869621406179,0.00508216501070497,-0.0594480055615996,-0.0395259187196361,2.25780524115575e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,24938,-0.0170425021051088,0.00175106827893556,-0.0204745959318225,-0.0136104082783951,2.3986541438549e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,-0.0382188485889136,0.00392798761779653,-0.0459177043197948,-0.0305199928580324,2.43432752982107e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.0193657673699392,0.00199470667112877,0.0154561422945269,0.0232753924453516,2.99040099703313e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,0.0126367410314878,0.00130142384383814,0.0100859502975651,0.0151875317654105,2.99540046764924e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,0.030686913911726,0.00316287346129048,0.0244876819275967,0.0368861458958554,3.18301786544689e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,28424,-0.0612904866424133,0.00633506284131673,-0.073707209811394,-0.0488737634734325,4.17368396299863e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,-0.0467867537760103,0.00484511134897786,-0.0562831720200069,-0.0372903355320136,4.98157062240893e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MLN,Promotilin,29434,-0.0593004544065981,0.00614249198789138,-0.0713397387028652,-0.047261170110331,5.09011101687512e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,24966,-0.0133088602720943,0.00137905386450182,-0.0160118058465179,-0.0106059146976708,5.33320759924104e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,-0.0339190162248311,0.003516971246196,-0.0408122798673753,-0.027025752582287,5.60556574588171e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.025132138790956,0.00260747436212877,0.0200214890411836,0.0302427885407284,5.93519729860111e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,-0.0384990962560959,0.00399754306755118,-0.0463342806684962,-0.0306639118436956,6.40289674078886e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,-0.0548074425625941,0.00569402902207084,-0.0659677394458529,-0.0436471456793352,6.7379769312452e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,29820,0.0182376440498638,0.00189808627156286,0.0145173949576006,0.021957893142127,7.92267158346625e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,29218,0.0223945122855522,0.00233366438057305,0.0178205300996291,0.0269684944714754,8.9242891570444e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,29628,0.018390458206829,0.00191919801108766,0.0146288301050972,0.0221520863085608,1.01985479001534e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,24381,-0.0422128041050769,0.00441175158162281,-0.0508598372050576,-0.0335657710050962,1.18674125191153e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,28762,-0.0209880804620271,0.00219525271032904,-0.025290775774272,-0.0166853851497821,1.25997002876644e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,-0.034971603905319,0.00366964700464646,-0.042164112034426,-0.0277790957762119,1.6899234709485e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.0253172306954379,0.00265654712911165,-0.0305240630684967,-0.0201103983223791,1.69089854181978e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,29725,-0.0426432166226858,0.00447698366766275,-0.0514181046113048,-0.0338683286340668,1.77141498872459e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,29566,0.0180045372887138,0.00189965166569023,0.0142812200239609,0.0217278545534666,2.78402836542657e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,-0.0182675624753044,0.00193245183361992,-0.0220551680691994,-0.0144799568814094,3.53250187148902e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.0229461669269096,0.00242846315110413,-0.0277059547030737,-0.0181863791507455,3.67101398434289e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,29478,-0.0278037025028141,0.00294263465085615,-0.0335712664184921,-0.022036138587136,3.68011244264862e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,-0.0328734725944506,0.00347930453669666,-0.039692909486376,-0.0260540357025251,3.69053120088734e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,-0.0265833478457056,0.00281726329570204,-0.0321051839052816,-0.0210615117861296,4.15185038830849e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,24240,-0.0393859356585098,0.0041739645982643,-0.0475669062711078,-0.0312049650459117,4.20592889791504e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,29349,-0.0741088185071321,0.00785567625315425,-0.0895059439633144,-0.0587116930509498,4.23723651535496e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,-0.0682865644557256,0.00723878687838418,-0.0824745867373586,-0.0540985421740926,4.25241826505781e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0291250308934299,0.0030938551807946,-0.0351889870477874,-0.0230610747390725,5.11674375285662e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,29478,0.0221530229433853,0.00235452638807463,0.017538151222759,0.0267678946640116,5.37596565032311e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,24329,0.0199024497456259,0.00212150198083685,0.0157443058631857,0.0240605936280661,7.06783752198181e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,-0.038636199211056,0.00412404326560446,-0.0467193240116408,-0.0305530744104713,7.87272016089736e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,-0.0237003509023329,0.00253059218714322,-0.0286603115891336,-0.0187403902155322,8.2085163784199e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,29411,-0.0391080469296696,0.00417684492915614,-0.0472946629908156,-0.0309214308685236,8.28043703967617e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,0.0182461506513668,0.00195358477228733,0.0144171244976836,0.02207517680505,1.04489507949286e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,-0.0251258701651666,0.00269699138262808,-0.0304119732751176,-0.0198397670552155,1.30468814577091e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,29443,0.0260285875085132,0.00280759739403296,0.0205256966162086,0.0315314784008178,1.97038513427526e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,29353,-0.0315287161353277,0.00340297108653492,-0.0381985394649362,-0.0248588928057193,2.07887235995583e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,-0.055592247439133,0.00600125689747464,-0.0673547109581833,-0.0438297839200828,2.11003205584315e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,29443,0.0201953134373171,0.00218431267210083,0.0159140605999994,0.0244765662746347,2.49200311088015e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,29566,-0.0256023169463809,0.0027697345068706,-0.0310309965798472,-0.0201736373129145,2.53859533430653e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,29349,0.0186751513318524,0.00202711841302557,0.0147019992423223,0.0226483034213826,3.38732429303275e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,29566,-0.0168805553806314,0.00183235952268483,-0.0204719800450936,-0.0132891307161691,3.39175921182707e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,29163,-0.0394220197004422,0.00428680895391596,-0.0478241652501174,-0.0310198741507669,3.95097521956108e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,29349,-0.0443022330425265,0.00481970934126379,-0.0537488633514035,-0.0348556027336495,4.10754254399324e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,24240,0.0270375654314704,0.00295187236975666,0.0212518955867473,0.0328232352761934,5.61726379790399e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,-0.0428211941623222,0.00467710137664723,-0.0519883128605508,-0.0336540754640937,5.75888149216084e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,-0.0520708324037176,0.00569321240323691,-0.063229528714062,-0.0409121360933733,6.34232135776827e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,-0.022680252629079,0.00248052339179374,-0.0275420784769947,-0.0178184267811633,6.43565030623837e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,24793,-0.0281504492428228,0.00307920739639752,-0.0341856957397619,-0.0221152027458836,6.58179918411851e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,29434,-0.0206970076514676,0.00226667762302776,-0.025139695792602,-0.0162543195103332,7.21002002877627e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,29030,-0.0268224879714625,0.00293840994885594,-0.0325817714712201,-0.0210632044717048,7.40162192462213e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,-0.042187331696752,0.00462427513271664,-0.0512509109568766,-0.0331237524366274,7.7532716484505e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,-0.0264308636489287,0.00290769067551505,-0.0321299373729382,-0.0207317899249193,1.05054453131557e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,-0.0528803844956363,0.00583933275529873,-0.0643254766960218,-0.0414352922952508,1.43626699960102e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,29349,0.017596849667114,0.00194757653622078,0.0137795996561212,0.0214140996781067,1.73404422873964e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,-0.0192806187282578,0.00213817777329728,-0.0234714471639205,-0.0150897902925952,2.06681977740456e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,-0.0377141367563973,0.00419630628858366,-0.0459388970820212,-0.0294893764307733,2.68105757004407e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,28774,-0.038130929385671,0.00424492357242917,-0.0464509795876321,-0.0298108791837098,2.79913525742492e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,29786,-0.0476117743061157,0.00530328877315547,-0.0580062203015004,-0.037217328310731,2.92131863379932e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,24240,-0.0373765162895485,0.00416982599330159,-0.0455493752364196,-0.0292036573426774,3.36497931445291e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,29786,-0.0466008510290042,0.00522130113919149,-0.0568346012618196,-0.0363671007961889,4.70070981553666e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0366166681241399,0.00410831327597078,0.0285643741032372,0.0446689621450426,5.25897693616357e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,0.0288162384545235,0.00323629512176512,0.0224731000158639,0.0351593768931832,5.68534427189499e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,24557,-0.0146976036894822,0.00165303406853072,-0.0179375504638024,-0.011457656915162,6.44686323903401e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,29434,-0.0371029574581046,0.00417746725646546,-0.0452907932807769,-0.0289151216354323,6.95156865770213e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,-0.0245783909328842,0.00277064179133717,-0.030008848843905,-0.0191479330218633,7.72601178848957e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,-0.035031079769939,0.00395704061720395,-0.0427868793796587,-0.0272752801602193,9.00815856582716e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,29218,-0.0805849650388679,0.00910296160554062,-0.0984267697857275,-0.0627431602920083,9.02232539717559e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,-0.0390391633903832,0.00441038501387511,-0.0476835180175784,-0.0303948087631879,9.10758234072154e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,29786,-0.0277025212797244,0.00313153666088634,-0.0338403331350616,-0.0215647094243872,9.5356430523238e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,0.0215372422761204,0.0024382669522942,0.0167582390496237,0.026316245502617,1.08658868171849e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,24938,-0.0688428003975692,0.00780295272459098,-0.0841365877377675,-0.0535490130573708,1.18944905125401e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,-0.0228760169468483,0.00259583150355287,-0.0279638466938119,-0.0177881871998847,1.2886714482397e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,-0.055434222780456,0.00630158953850405,-0.0677853382759239,-0.0430831072849881,1.4818390093311e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,-0.0182276537775722,0.00207575472819517,-0.0222961330448347,-0.0141591745103096,1.70313631840204e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,-0.0285291689632674,0.00324959188675121,-0.0348983690612997,-0.022159968865235,1.73407563937439e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,29453,-0.0193041092887681,0.00220192372277497,-0.023619879785407,-0.0149883387921291,1.93284370227792e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,29443,-0.0336261443766823,0.00384023478885051,-0.0411530045628292,-0.0260992841905353,2.12402891195104e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,24966,-0.0184012676247649,0.00210306776385874,-0.022523280441928,-0.0142792548076018,2.27124288439004e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,29135,-0.0207455550698787,0.00237218770349304,-0.0253950429687251,-0.0160960671710324,2.341085862196e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,-0.0263729311444839,0.00301706621432572,-0.0322863809245623,-0.0204594813644055,2.42598257629768e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,29434,-0.0552450021267045,0.00632400492774115,-0.0676400517850772,-0.0428499524683319,2.5460325652462e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,24229,-0.0562617667835227,0.00644641149926715,-0.0688967333220864,-0.0436268002449591,2.7656421633901e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0402405600399396,0.0046147098436267,-0.049285391333448,-0.0311957287464313,2.92434635031157e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,28931,-0.0284703817129302,0.0032758887354875,-0.0348911236344857,-0.0220496397913747,3.78257391944704e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,-0.0312914293978132,0.00360132995352036,-0.0383500361067131,-0.0242328226889133,3.84574233660548e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,29478,-0.0216540297586652,0.00249296658405148,-0.0265402442634061,-0.0167678152539243,3.94301373816345e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,24229,-0.0502683667686381,0.00578931168901032,-0.0616154176790983,-0.0389213158581779,4.09485529306719e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,-0.0514413987014469,0.00592620261425833,-0.0630567558253932,-0.0398260415775005,4.14616996817e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,29434,-0.0335408775485105,0.00386685649279774,-0.0411199162743941,-0.0259618388226269,4.38513877977987e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,24381,-0.0275013677115394,0.00317244638656118,-0.0337193626291993,-0.0212833727938795,4.63318831549748e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,-0.0446746569021121,0.00515444147330537,-0.0547773621897907,-0.0345719516144336,4.70183595706587e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,29349,0.00907786431551555,0.00104869683619326,0.00702241851657675,0.0111333101144543,5.11689775591964e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,0.0118151570791914,0.00136661451703117,0.00913659262581027,0.0144937215325724,5.6216212611198e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNST,Consortin,29478,-0.0646124125558419,0.00748057543780309,-0.0792743404139359,-0.0499504846977478,6.0380545035217e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,-0.0297280693558435,0.00344647986441117,-0.0364831698900894,-0.0229729688215976,6.68857205546828e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,29536,-0.0343728230967943,0.00398662348437322,-0.0421866051261658,-0.0265590410674228,6.90043117576596e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,-0.0372842606151094,0.00432424104393887,-0.0457597730612296,-0.0288087481689892,6.96838337437765e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,-0.0443448684499989,0.00515024799090378,-0.0544393545121703,-0.0342503823878275,7.64837684685381e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,28916,-0.0344295316829781,0.00400364401337186,-0.0422766739491869,-0.0265823894167692,8.40069038400518e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,24820,-0.0649362708426777,0.0075551025285527,-0.079744271798641,-0.0501282698867144,8.80765202812428e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,29163,0.0288219673266473,0.00335408378348775,0.0222479631110113,0.0353959715422833,8.88135211019115e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,29786,0.0234379793381843,0.00273642020848002,0.0180745957295634,0.0288013629468051,1.13008466256594e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,24381,0.0191977794257077,0.00224122741558156,0.0148049736911678,0.0235905851602475,1.13635469084949e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,29725,-0.0236791301663306,0.0027687566717587,-0.0291058932429777,-0.0182523670896836,1.26402650731198e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0267070168350543,0.00312754841701182,0.0205770219377111,0.0328370117323974,1.4143538507119e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,23389,-0.0144215340484173,0.00169439993382179,-0.017742557918708,-0.0111005101781266,1.82193604036883e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.0161617682047441,0.00190059849292505,-0.0198869412508772,-0.012436595158611,1.92558587145862e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,-0.0335267000601012,0.00394423223631577,-0.0412573952432801,-0.0257960048769223,1.98103573726144e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,-0.0607186849735952,0.00715608108400604,-0.0747446038982471,-0.0466927660489434,2.27779909918956e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,29400,-0.053746313137487,0.0063359598266798,-0.0661647943977795,-0.0413278318771946,2.30116028000588e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,-0.0396568181658376,0.00467726404410069,-0.0488242556922749,-0.0304893806394002,2.38381399365995e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,-0.0299896675415665,0.00353855356997251,-0.0369252325387126,-0.0230541025444204,2.47708833497966e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,-0.0157759879307723,0.00186655679462023,-0.019434439248228,-0.0121175366133166,2.99524663815155e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.0247293626533469,0.00292826048098795,-0.0304687531960833,-0.0189899721106105,3.17533401278754e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.0180207303069724,0.00213385890879925,0.0138383668457258,0.0222030937682189,3.20071933488903e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,29581,-0.0387739774374861,0.00459240244743569,-0.04777508623446,-0.0297728686405121,3.23043592380012e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,-0.0723821890826018,0.00857422444366149,-0.0891876689921783,-0.0555767091730253,3.26582151372295e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,28774,-0.0375895848247398,0.00445774427257958,-0.0463267635989957,-0.0288524060504838,3.54202147823854e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,29652,-0.0216037187615844,0.00257214895159638,-0.0266451307067133,-0.0165623068164555,4.69752478020833e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,-0.0492887615392914,0.00587442654384617,-0.0608026375652299,-0.0377748855133529,5.06418078084078e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,-0.0413431286852207,0.00492951197809647,-0.0510049721622897,-0.0316812852081516,5.21817684221726e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,-0.0402822071732708,0.00480462969288432,-0.0496992813713241,-0.0308651329752176,5.38888948790887e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,-0.0244482385217338,0.00292002709419545,-0.0301714916263569,-0.0187249854171107,5.88254908807276e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,24025,0.0364203754618859,0.00435005862382549,0.027894260559188,0.0449464903645839,5.95065045260461e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_E,,29434,-0.0167592737206831,0.00200485879115535,-0.0206887969513476,-0.0128297504900186,6.58216597282836e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,29218,0.0243390897079256,0.00291689114849233,0.0186219830568807,0.0300561963589706,7.48263044149348e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.0183221497539056,0.0022031917678333,0.0140038938889524,0.0226404056188589,9.47068296404624e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,-0.0154866424680797,0.00186262236643738,-0.019137382306297,-0.0118359026298625,9.61036992638053e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,-0.0229741995046641,0.00276455767214015,-0.0283927325420588,-0.0175556664672694,9.97716153412023e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,-0.0607135638625827,0.00732498075462197,-0.0750705261416418,-0.0463566015835237,1.19446431755492e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,29820,-0.0142920982624716,0.00172458409148926,-0.0176722830817905,-0.0109119134431526,1.20681745487739e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,-0.0430198438905674,0.00519603634970833,-0.0532040751359957,-0.0328356126451391,1.29987938921856e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,29820,0.017348303745028,0.00209917967337937,0.0132339115852044,0.0214626959048516,1.46250112242803e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,29395,-0.0473528648893088,0.00573490586102431,-0.0585932803769164,-0.0361124494017011,1.5563282301516e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,-0.0329755558596023,0.00399798211759502,-0.0408116008100885,-0.025139510909116,1.67601395899641e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,28795,-0.0283301750241113,0.00343669049016007,-0.035066088384825,-0.0215942616633975,1.74360426312642e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,-0.0216689845403774,0.00263156823085451,-0.0268268582728523,-0.0165111108079026,1.8800902392316e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,-0.0285884076800705,0.00347633273253493,-0.035402019835839,-0.021774795524302,2.07121883192518e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,-0.0437946643779045,0.00532896817615825,-0.0542394420031747,-0.0333498867526343,2.14917776722879e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,-0.0235711929360525,0.00286830277254689,-0.0291930663702444,-0.0179493195018606,2.17444781570091e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,-0.0163674009389426,0.00199722464615172,-0.0202819612454,-0.0124528406324853,2.62640135620181e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,-0.0453034385625569,0.00552961739210322,-0.0561414886510792,-0.0344653884740345,2.67569038806514e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,-0.0296908807171085,0.00362611811442206,-0.0367980722213757,-0.0225836892128413,2.76312273676735e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,24407,0.0175191471373498,0.0021433936528886,0.0133180955776882,0.0217201986970115,3.1384604262058e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,24951,0.0339343222958326,0.00415664012385245,0.0257873076530818,0.0420813369385834,3.39621204410013e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,-0.0155525769291262,0.00190559936215769,-0.0192875516789553,-0.0118176021792971,3.46422692685972e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,-0.0469857919641921,0.00576132319674582,-0.0582779854298139,-0.0356935984985703,3.64412251518055e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0145836287466126,0.00178918753104788,0.0110768211857587,0.0180904363074664,3.75046953311655e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,-0.0476062506631757,0.00585643134547107,-0.059084856100299,-0.0361276452260524,4.53806154978667e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,24805,-0.0601247868429407,0.00739718853373987,-0.0746232763690708,-0.0456262973168105,4.56413795762901e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,-0.038930678853925,0.00479452867956206,-0.0483279550658667,-0.0295334026419834,4.88393287244591e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,-0.0334301317507804,0.00412494118016352,-0.0415150164639009,-0.0253452470376599,5.54364577655303e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,24966,-0.0174568992917861,0.00215555122131762,-0.0216817796855687,-0.0132320188980036,5.81256867723089e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.0113287457334054,0.00140014271487021,0.00858446601225982,0.014073025454551,6.13524201322045e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,-0.0354314758787727,0.00438132086901109,-0.0440188647820345,-0.026844086975511,6.35103208922905e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,0.0202176140446649,0.00250330704835873,0.0153111322298817,0.025124095859448,6.92756672293598e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,29435,-0.0221105740912356,0.00273793621614171,-0.0274769290748734,-0.0167442191075978,6.96694546384257e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,-0.041009923587192,0.00508301382632125,-0.0509726306867817,-0.0310472164876024,7.41564718133262e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,-0.0227304284258983,0.00282063367258563,-0.0282588704241661,-0.0172019864276305,8.00180573998145e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,-0.0386224434720282,0.00479983235535273,-0.0480301148885195,-0.0292147720555368,8.88952459763005e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,24793,-0.0552122044166428,0.00686826322815753,-0.0686740003438316,-0.0417504084894541,9.4785909431178e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,29694,-0.0201030743110194,0.00250165502803314,-0.0250063181659643,-0.0151998304560744,9.63066310178919e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,28931,-0.0391098069927894,0.00486936742880986,-0.0486537671532568,-0.0295658468323221,9.96728850375378e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,24381,0.0120045552056246,0.00149456484787583,0.00907520810378795,0.0149339023074612,1.00089208212226e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,-0.0540265415909098,0.00672837541550678,-0.0672141574053031,-0.0408389257765165,1.01365692170781e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,-0.0339235271936268,0.00423255055766341,-0.042219326286647,-0.0256277281006065,1.14266816317181e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,0.0173138779491199,0.00216309438114053,0.0130742129620845,0.0215535429361554,1.24605271889734e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,24845,0.020708201263406,0.00258760719113518,0.015636491168781,0.0257799113580309,1.26863198459153e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,-0.0291941712281269,0.0036499372329616,-0.0363480482047316,-0.0220402942515221,1.31352676574589e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,29349,-0.0288903322848749,0.00361282023486972,-0.0359714599452196,-0.0218092046245303,1.32558081403549e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,-0.0533604028356281,0.00670012488015829,-0.0664926476007383,-0.0402281580705178,1.72402404665641e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,29434,0.0235042305994691,0.00295493756335604,0.0177125529752913,0.0292959082236469,1.8668725504558e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,24966,-0.00941671360758599,0.00118416661691719,-0.0117376801767437,-0.0070957470384283,1.9096645393071e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,29594,-0.0169755598426486,0.00213549847718464,-0.0211611368579304,-0.0127899828273667,1.9431880086294e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,28765,-0.0216451241955349,0.00272946243200146,-0.0269948705622578,-0.016295377828812,2.26721914986787e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,24805,-0.0464415212613275,0.00585816631502669,-0.0579235272387798,-0.0349595152838752,2.32674208206794e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,-0.0624764542371125,0.00788948848815987,-0.0779398516739059,-0.0470130568003192,2.47917236929869e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,29434,-0.0443437087273759,0.00560620545145368,-0.0553318714122251,-0.0333555460425267,2.66888206974103e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,29132,0.0371144991787515,0.00469930632490518,0.0279038587819374,0.0463251395755657,2.9365082375907e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,-0.014077154771336,0.00178596130136418,-0.0175776389220097,-0.0105766706206622,3.32998945030415e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,-0.0521111089112374,0.00661778085579553,-0.0650819593885967,-0.0391402584338782,3.53978528981509e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,29311,-0.0189731003024782,0.00241070390433238,-0.0236980799549697,-0.0142481206499867,3.65767108833619e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,-0.0220297083104547,0.00280218612386371,-0.0275219931132276,-0.0165374235076819,3.94839067390466e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,29478,-0.0192311778177879,0.00244650495914826,-0.0240263275377185,-0.0144360280978573,3.95045045014769e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,-0.0411640403972508,0.00523870530852893,-0.0514319028019676,-0.0308961779925341,4.07424875933402e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,-0.0250639294611094,0.0031905421916337,-0.0313173921567115,-0.0188104667655073,4.11055016532611e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,24273,0.0186887352128696,0.0023794398509769,0.0140250331049549,0.0233524373207844,4.18729312695717e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,29383,-0.0156703795435441,0.00199610287572187,-0.019582741179959,-0.0117580179071292,4.28469661818128e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,-0.034344659554255,0.00438074917716996,-0.0429309279415081,-0.0257583911670019,4.68833377090924e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.0163721927334453,0.00209191856569768,-0.0204723531222127,-0.0122720323446778,5.22000915637486e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,-0.0439766559361253,0.00563004273248011,-0.0550115396917863,-0.0329417721804643,5.89420396422702e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,-0.0481737545279802,0.0061694488142926,-0.0602658742039937,-0.0360816348519667,5.98362109767902e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,-0.011993013217596,0.00154085424153952,-0.0150130875310135,-0.0089729389041786,7.33578368602178e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,-0.0282344566815135,0.0036319868163378,-0.0353531508415356,-0.0211157625214915,7.91653211962783e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0140597243363157,0.00180875512191719,0.0105145642973581,0.0176048843752734,7.9590850292431e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,28916,-0.0305081793421475,0.00392722532792235,-0.0382055409848753,-0.0228108176994197,8.21216740419125e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,29443,-0.0240083558107957,0.0030911946261364,-0.030067097278023,-0.0179496143435683,8.31726953174766e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,-0.0589747751171524,0.00759970345312799,-0.0738701938852832,-0.0440793563490215,8.76362633009833e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,-0.027625673631969,0.00357127138645855,-0.0346253655494278,-0.0206259817145103,1.06334499651364e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,-0.026388593920376,0.00341361574825083,-0.0330792807869477,-0.0196979070538044,1.1070124082128e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F3,Tissue factor,29541,0.0145753621414172,0.00188974399839264,0.0108714639045677,0.0182792603782668,1.26876283265163e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,29218,-0.0281774885625846,0.0036547794831451,-0.0353408563495489,-0.0210141207756202,1.30046815807467e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,29820,0.0156747910537898,0.00203495650914122,0.011686276295873,0.0196633058117066,1.37273793926065e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGN,Mimecan,29443,-0.0223840663890536,0.0029089326738342,-0.0280855744297686,-0.0166825583483385,1.45978429138681e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,-0.0169513690224072,0.00220425714408458,-0.021271713024813,-0.0126310250200014,1.522838268198e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,28931,0.0212724292625737,0.00276917077837601,0.0158448545369567,0.0267000039881907,1.61722926654857e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,-0.0107409342535434,0.0013982646103712,-0.0134815328898709,-0.00800033561721581,1.61974738387498e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,24867,0.0247474794986894,0.00322168497962978,0.0184329769386151,0.0310619820587638,1.62981662118661e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,24381,-0.0277852725608726,0.00362274575373563,-0.0348858542381944,-0.0206846908835507,1.78871803125807e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,-0.0121702081634459,0.00158966472301383,-0.015285951020553,-0.00905446530633876,1.97948737502229e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,24922,-0.0483644313209345,0.00632074329004931,-0.0607530881694312,-0.0359757744724379,2.05510608873507e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,-0.0303995804396718,0.00397468342641942,-0.0381899599554539,-0.0226092009238898,2.09903796856717e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0205731709317926,0.00269746515322703,0.0152861392314677,0.0258602026321176,2.47793733850248e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,29566,-0.0299766437104978,0.00393314840052105,-0.0376856145755191,-0.0222676728454766,2.58169135533798e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,29786,-0.0246812312241387,0.00324250224080659,-0.0310365356161196,-0.0183259268321578,2.78322252538187e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,24229,-0.0297587920533776,0.00391205544063154,-0.0374264207170155,-0.0220911633897398,2.90849792988272e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,29434,-0.0480628931775044,0.00632261312278121,-0.0604552148981555,-0.0356705714568532,3.00854647447624e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,-0.0229838315842546,0.00302428362518619,-0.0289114274896195,-0.0170562356788897,3.07420851486887e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,29640,-0.0379546438736621,0.00500473049497217,-0.0477639156438075,-0.0281453721035166,3.45520084191263e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,0.0142700425580733,0.00188296851601646,0.010579424266681,0.0179606608494655,3.59760865431722e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,29495,-0.0243534685648778,0.00321789989488057,-0.0306605523588437,-0.0180463847709119,3.89692500665764e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,0.0301105412062952,0.003981277303658,0.0223072376911255,0.0379138447214649,4.05133639576539e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,-0.0258231117323735,0.0034146056581966,-0.0325157388224389,-0.0191304846423082,4.06671092149791e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0135495063548587,0.0017944171213156,0.0100324487970802,0.0170665639126373,4.46975032289082e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,-0.029974840148917,0.00397750261573369,-0.037770745275755,-0.0221789350220789,4.98145408473563e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,28931,0.0158300556410019,0.0021017143454098,0.0117106955239987,0.0199494157580051,5.14375901480359e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,29786,-0.025539549956387,0.00339711619075958,-0.0321978976902758,-0.0188812022224983,5.71806566272902e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,-0.0119034886030819,0.00158367566936432,-0.015007492915036,-0.00879948429112787,5.8257786955768e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,24381,-0.0364551135248553,0.00485270452102484,-0.045966414386064,-0.0269438126636466,6.00797764109298e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0197690322741267,0.00263379796564931,0.014606788261454,0.0249312762867993,6.27368064433986e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,29169,0.0166265910083357,0.00222272476801658,0.0122700504630232,0.0209831315536482,7.62556688281923e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,-0.0442153986797435,0.00591334992391043,-0.0558055645306079,-0.032625232828879,7.84888216138133e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,-0.0535684726783546,0.00716546009175886,-0.067612774458202,-0.0395241708985072,7.8793779603985e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,-0.0215742406902482,0.00288832408327956,-0.0272353558934761,-0.0159131254870203,8.27704948243243e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.00816131691171793,0.00109585944617472,0.00601343239721547,0.0103092014262204,9.77639672844986e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,24240,-0.0207304238693979,0.00279161157836504,-0.0262019825629934,-0.0152588651758024,1.15650276275357e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,28347,-0.0161852872284248,0.00218185196880635,-0.0204617170872853,-0.0119088573695644,1.22104560318007e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,29694,-0.0146359888039207,0.00197361826686949,-0.0185042806069849,-0.0107676970008565,1.24107679310322e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,24966,-0.0183158341683448,0.00247876291889785,-0.0231742094893846,-0.013457458847305,1.52463085232585e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,-0.0582158745647954,0.00789433025179944,-0.0736887618583223,-0.0427429872712685,1.70276492730856e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,24922,-0.0288438093399718,0.00391190163429354,-0.0365111365431871,-0.0211764821367564,1.7158459934447e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,-0.0390221754999314,0.00530299435444426,-0.0494160444346421,-0.0286283065652206,1.90838066705791e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,-0.01898254616052,0.00258106795050414,-0.0240414393435082,-0.0139236529775319,1.97679997199156e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,29456,0.0324758465542018,0.00441778466611513,0.0238169886086162,0.0411347044997875,2.01602974546806e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,28705,-0.0353054952441398,0.00481263035416623,-0.0447382507383056,-0.025872739749974,2.25885683895577e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,29434,-0.048158180735055,0.00656703220205639,-0.0610295638510855,-0.0352867976190244,2.30299209867516e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,29454,-0.0133545264597132,0.00182233599659938,-0.016926305013048,-0.00978274790637842,2.39174765260882e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,-0.0224993656850065,0.00307266435760701,-0.0285217878259163,-0.0164769435440968,2.51055211653546e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,-0.0191386705597691,0.00261480176748474,-0.0242636820240392,-0.014013659095499,2.55646326967132e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,24903,0.0182274940430591,0.00249342889524046,0.0133403734083878,0.0231146146777304,2.74763556041828e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,24229,0.0133851485589154,0.00183217880221793,0.0097940781065683,0.0169762190112626,2.84588309196163e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0166053035303112,0.0022733984790618,0.0121494425113501,0.0210611645492724,2.8597835102007e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,-0.0364475692371111,0.00499594163996361,-0.0462396148514398,-0.0266555236227824,3.06639333956643e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,-0.0168631925160889,0.00231253004396606,-0.0213957514022624,-0.0123306336299155,3.13032585104242e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,29624,-0.0341852738242708,0.00469371217263072,-0.043384949682627,-0.0249855979659146,3.34102227502923e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFP,Properdin,24966,0.0116196481477204,0.00159642561334573,0.00849065394556276,0.014748642349878,3.47426611596934e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0229001507486255,0.00314825577881626,0.0167295694221456,0.0290707320751054,3.59820432702928e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,29498,-0.0467151646254443,0.00642756262540728,-0.0593131873712426,-0.034117141879646,3.74060191641982e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,24938,-0.0204787846312526,0.00282462488364655,-0.0260150494031998,-0.0149425198593053,4.28629741174591e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,-0.0255178227730064,0.00352304119503787,-0.0324229835152806,-0.0186126620307322,4.49476873902161e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00883063954909818,0.00121951937608364,0.00644038157197423,0.0112208975262221,4.56014557560481e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,29757,0.0230778178123243,0.00318791493514709,0.016829504539436,0.0293261310852126,4.6241508565285e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLU,Clusterin,24966,0.015865949227857,0.00220092745174025,0.0115521314224461,0.0201797670332678,5.80716097646601e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,29218,-0.0332395400914616,0.0046143995981935,-0.0422837633039208,-0.0241953168790023,6.01333864107204e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,-0.0184239105845122,0.00256059327327835,-0.0234426734001377,-0.0134051477688866,6.3875838057164e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,-0.042780197054777,0.00595566498579001,-0.0544533004269254,-0.0311070936826286,6.97554556609119e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BGN,Biglycan,28750,0.0593485174096279,0.00827441561355361,0.0431306628070629,0.075566372012193,7.54023845206647e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,24326,-0.0564951925802954,0.00787828517051332,-0.0719366315145015,-0.0410537536460893,7.65807335405665e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,-0.0352220652080385,0.00491597535883492,-0.044857376911355,-0.0255867535047221,7.97347560855817e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,-0.0474618679956299,0.00662427187295403,-0.0604454408666198,-0.03447829512464,7.97392868384869e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,29725,0.0220823014917806,0.00308545694471739,0.0160348058801345,0.0281297971034266,8.44348613443114e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,28353,0.0155759623848709,0.00217849880627135,0.0113061047245791,0.0198458200451628,8.89690547106269e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,24528,-0.0139040953809748,0.00194499113957814,-0.0177162780145479,-0.0100919127474016,9.00788521326633e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,24938,0.0246556695174699,0.00345594006579391,0.0178820269885139,0.031429312046426,9.99486192928462e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,23907,-0.035072034014311,0.00492104424718615,-0.0447172807387959,-0.0254267872898262,1.05532607797852e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,-0.0409715735982751,0.00575253524191104,-0.0522465426724207,-0.0296966045241295,1.09048585764927e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,24793,-0.0194587439959248,0.00273498787961332,-0.0248193202399669,-0.0140981677518827,1.15167849160471e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.0135514026609111,0.00190778521232617,0.00981214364475176,0.0172906616770704,1.24634128917642e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELN,Elastin,24922,-0.017233843046358,0.00243267150861967,-0.0220018792032525,-0.0124658068894634,1.43436064710725e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,24240,-0.0251638558157327,0.00355200971761067,-0.0321257948622496,-0.0182019167692158,1.43468087016324e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,-0.0272541297533371,0.00384861241967904,-0.034797410095908,-0.0197108494107662,1.45824177888173e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,24111,-0.033103924156199,0.00469251404771825,-0.0423012516897267,-0.0239065966226712,1.77747802423812e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,-0.0295253765296415,0.00418754206715281,-0.037732958981261,-0.021317794078022,1.81872029277288e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.0238194968402401,0.00338475803548029,0.0171853710906987,0.0304536225897815,2.01229283442787e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,29674,-0.0137348915518077,0.00195375337911513,-0.0175642481748734,-0.00990553492874206,2.10994616297259e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,-0.0374725319148922,0.00533242217138406,-0.047924079370805,-0.0270209844589795,2.15990455291233e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,24805,-0.0487236756414561,0.0069401411799763,-0.0623263523542096,-0.0351209989287025,2.26677351789203e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,29566,-0.0401018437121898,0.00571557048640374,-0.0513043618655411,-0.0288993255588384,2.32817291335595e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,24951,0.0119359476137789,0.0017037053881262,0.00859668505305155,0.0152752101745063,2.51683614851287e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,29478,0.0339504343851675,0.00484681422230138,0.0244506785094568,0.0434501902608782,2.52843131649253e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,28797,-0.0296295733236565,0.00423170811879836,-0.0379237212365012,-0.0213354254108117,2.58237149874614e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,-0.031550441424066,0.00450845774876045,-0.0403870186116365,-0.0227138642364955,2.66255073859087e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,-0.0155594005104243,0.00222769045832422,-0.0199256738087398,-0.0111931272121088,2.91795366629898e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAYN,Layilin,29163,-0.0168701622513273,0.00241575861701255,-0.0216050491406719,-0.0121352753619828,2.94335221415151e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,29274,0.0138656229739088,0.00198649417926116,0.00997209438255687,0.0177591515652606,3.01584154240272e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,24867,-0.0375828635754161,0.00540248899034126,-0.048171741996485,-0.0269939851543473,3.57268554159778e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,28797,-0.0356805703053502,0.00512981537212038,-0.0457350084347062,-0.0256261321759943,3.58750008924059e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,-0.0169421622621497,0.00243747831371064,-0.0217196197570226,-0.0121647047672769,3.72719117013675e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,-0.018539462800302,0.0026695851946259,-0.0237718497817688,-0.0133070758188353,3.88611113565263e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,-0.0523353132438267,0.00755478371596619,-0.0671426893271204,-0.037527937160533,4.39026950040705e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDK,Midkine,29455,-0.0243179081198304,0.00351146120876169,-0.0312003720890033,-0.0174354441506575,4.43994662093928e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,-0.0230939961924054,0.0033373135454928,-0.0296351307415713,-0.0165528616432395,4.62851749618868e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,24111,-0.0206583320042071,0.00298723730877014,-0.0265133171293966,-0.0148033468790176,4.77761206653041e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,-0.0464887266751961,0.00673531631790353,-0.059689946658287,-0.0332875066921052,5.22291013967248e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,-0.0389788686151626,0.00564970237242966,-0.0500522852651248,-0.0279054519652005,5.33153880274532e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,-0.0163530489645612,0.00238018385370487,-0.0210182093178228,-0.0116878886112997,6.52551939009893e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,-0.0344308123478873,0.00501310924924402,-0.0442565064764056,-0.024605118219369,6.63214837296528e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,29335,-0.0217636237760239,0.00317514514184747,-0.027986908254045,-0.0155403392980029,7.30440889575157e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,-0.0289828018412024,0.00423289966413971,-0.0372792851829163,-0.0206863184994886,7.69123721176914e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,24845,-0.0299032578571127,0.00437047813969357,-0.0384693950109121,-0.0213371207033133,7.98527589198735e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,-0.0265874925150557,0.00389339556670165,-0.0342185478257909,-0.0189564372043204,8.72490696987226e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,24951,0.0284262213587894,0.00416651057039873,0.0202598606408079,0.0365925820767709,9.14852718399453e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,-0.0124627824872231,0.00182870006799536,-0.016047034620494,-0.00887853035395225,9.60017858040315e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,29786,-0.0177148335509917,0.00260175226686868,-0.0228142679940543,-0.012615399107929,1.0027778274206e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,-0.03954903571478,0.00583099873536078,-0.0509777932360871,-0.0281202781934729,1.20309639468867e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,-0.0546079267431718,0.00805987680920106,-0.0704052852892059,-0.0388105681971377,1.26531722416392e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,29349,-0.0479095756508132,0.00707811584241591,-0.0617826827019484,-0.034036468599678,1.32398600648473e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,-0.0176379035367919,0.00260595018952858,-0.0227455659082679,-0.0125302411653159,1.32774981846861e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,-0.0397799602648405,0.00588029988207394,-0.0513053480337054,-0.0282545724959756,1.3589163665997e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,24793,-0.00994291818963987,0.00147287969485985,-0.0128297623915652,-0.00705607398771457,1.50417618356643e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,23693,-0.0109605447759276,0.00162470435966108,-0.0141449653208633,-0.00777612423099191,1.55289596914834e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,0.0235240850946146,0.00349139037416852,0.0166809599612443,0.0303672102279849,1.64390657241426e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,24565,-0.051102673879449,0.00759068978173329,-0.0659804258516462,-0.0362249219072517,1.70703094152236e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,24804,-0.0274088636028608,0.00407457338778651,-0.0353950274429224,-0.0194226997627993,1.77201930440185e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,28654,-0.0327819271921348,0.00487944213659865,-0.0423456337798682,-0.0232182206044015,1.87200617451601e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,-0.0213047243723644,0.0031731174172041,-0.0275240345100844,-0.0150854142346443,1.92646544434325e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,-0.014192012977297,0.00211453091598838,-0.0183364935726342,-0.0100475323819598,1.95887851154238e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,0.032768692218853,0.00488560833265687,0.0231928998868456,0.0423444845508605,2.02678716273277e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,24240,-0.0242017077340855,0.00361075079019646,-0.0312787792828706,-0.0171246361853004,2.09124253699506e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,-0.0296117980128362,0.00442059278610865,-0.0382761598736092,-0.0209474361520633,2.14294351293005e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,24922,-0.0380887056722483,0.00568808075870031,-0.0492373439593009,-0.0269400673851957,2.18411610745694e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,-0.0275947245637597,0.00412145594211404,-0.0356727782103032,-0.0195166709172162,2.19681019307463e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,-0.0452498942330636,0.00676090743836208,-0.0585012728122533,-0.0319985156538739,2.23486815068168e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,23498,-0.0572352419889443,0.00855203066823399,-0.073997222098683,-0.0404732618792057,2.24191988233776e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,29566,-0.024758784035875,0.00370325189843471,-0.032017157756807,-0.0175004103149429,2.33932287834524e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,24381,-0.023461071109791,0.00351334983046353,-0.0303472367774995,-0.0165749054420825,2.47954079006383e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,29786,-0.0434403244262382,0.00650956346767596,-0.0561990688228831,-0.0306815800295933,2.54484000786707e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0158437266051386,0.00237590378080954,0.0111869551947519,0.0205004980155253,2.63008146429158e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0232963640919376,0.00349386776707364,0.0164483832684733,0.030144344915402,2.65118122252766e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,-0.0455365014642289,0.00683130452371272,-0.0589258583307058,-0.032147144597752,2.67716670799271e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,-0.012873002766627,0.00193226444155933,-0.0166602410720833,-0.00908576446117075,2.7465157677139e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,24111,-0.0353451482685391,0.00530841423972583,-0.0457496401784017,-0.0249406563586765,2.82921352178645e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,29478,0.0370943699668008,0.00558417697375832,0.0261493830982345,0.0480393568353671,3.13209758689607e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,24922,-0.0314471498223424,0.00474028931435609,-0.0407381168784803,-0.0221561827662044,3.3337346038083e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,-0.0272601110155656,0.00411078647664729,-0.0353172525097943,-0.019202969521337,3.39605351120863e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,-0.0210726371188698,0.00317855341158089,-0.0273026018055684,-0.0148426724321713,3.42341875364862e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,-0.0247784227147558,0.00374108931214743,-0.0321109577665647,-0.0174458876629468,3.57291435779277e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,29443,0.00899365163167194,0.00135919380835234,0.00632963176730135,0.0116576714960425,3.73096380924074e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,29694,-0.0198122042372754,0.00300022600431911,-0.0256926472057408,-0.0139317612688099,4.0814189464897e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,-0.0515682109051965,0.00781139371703421,-0.0668785425905836,-0.0362578792198095,4.14898956180023e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),24484,0.0813895338005263,0.0123888493340715,0.0571073891057462,0.105671678495306,5.14706413254448e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,-0.0263458858968843,0.0040115444659543,-0.0342085130501547,-0.0184832587436139,5.21713105785845e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,-0.0343385325720542,0.00522957109872028,-0.0445884919255459,-0.0240885732185624,5.24701786314328e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,29478,-0.0242389703152806,0.00369516971902381,-0.0314815029645672,-0.0169964376659939,5.48319067002101e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,28534,-0.0346971256946092,0.00529005375480015,-0.0450656310540175,-0.0243286203352009,5.51194854144699e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,24890,-0.0212089060024233,0.00323564795348737,-0.0275507759912585,-0.014867036013588,5.68211193135489e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,-0.0150516873131185,0.00230014917072785,-0.0195599796877451,-0.0105433949384919,6.11976697339185e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,29343,-0.0139256386513207,0.00213162989849952,-0.0181036332523797,-0.00974764405026162,6.5581509966121e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,24951,-0.0321681012435465,0.00493737634983638,-0.0418453588892258,-0.0224908435978672,7.39661796786355e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,0.025056361395327,0.0038506845345518,0.0175090197076054,0.0326037030830485,7.79047229922787e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,0.0101253754892344,0.00155644039669876,0.00707475231170481,0.0131759986667639,7.86999991825171e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,-0.0185536167422682,0.00285877553716492,-0.0241568167951115,-0.012950416689425,8.71922643040137e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,-0.0261447829175623,0.00403363903921435,-0.0340507154344224,-0.0182388504007022,9.21724930880544e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,-0.0197289398805768,0.00304410258662208,-0.025695380950356,-0.0137624988107975,9.25454113252671e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.019088369173582,0.0029453493954158,0.0133154843585671,0.024861253988597,9.26414316516386e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,-0.0344079860398934,0.00530925739171814,-0.0448141305276609,-0.0240018415521258,9.30203100415038e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,24381,-0.0138860317471397,0.00214320681327222,-0.0180867171011532,-0.00968534639312614,9.40385704875223e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.0289291150943221,0.00447490906725403,0.0201582933225042,0.03769993686614,1.03057175964578e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,29725,0.0204740822382486,0.00316967511120262,0.0142615190202914,0.0266866454562057,1.06768781890056e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,-0.0133244903314566,0.00206307803715459,-0.0173681232842797,-0.00928085737863364,1.0766720695119e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,-0.0333017668968072,0.00516217570005044,-0.0434196312689061,-0.0231839025247084,1.13129445873074e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,28580,0.0298208462123828,0.00462483544759922,0.0207561687350883,0.0388855236896773,1.15159763797329e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,24951,-0.01231338792802,0.00191000575795955,-0.0160569992136207,-0.00856977664241927,1.1634035353362e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,29169,-0.0228266742298228,0.00354397470907588,-0.0297728646596116,-0.0158804838000341,1.20551609490457e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,-0.0237616693824892,0.00369311328142145,-0.0310001714140753,-0.0165231673509032,1.26172188215168e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,0.0266872433031986,0.00415720647503201,0.0185391186121358,0.0348353679942613,1.39179660042396e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,0.0156104727492086,0.00243925366179394,0.0108295355720924,0.0203914099263247,1.58032201703872e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,-0.0151168257787057,0.00236247012885395,-0.0197472672312594,-0.010486384326152,1.58998950988259e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,29349,-0.0597660508293426,0.00934412319643573,-0.0780805322943566,-0.0414515693643285,1.6178299302511e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,-0.0186732141368874,0.00293082492661338,-0.0244176309930496,-0.0129287972807251,1.90694977016097e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,29434,-0.0358906106565211,0.00563539643330676,-0.0469359876658023,-0.0248452336472399,1.93347133992445e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,-0.0234648221659656,0.00369118137587242,-0.0306995376626756,-0.0162301066692557,2.08806928785419e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,28797,-0.0245170074297266,0.00385921586619756,-0.0320810705274738,-0.0169529443319794,2.14523501304844e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,-0.0223582804010392,0.00353162630993315,-0.0292802679685082,-0.0154362928335703,2.47289609688459e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,-0.0345645991579296,0.00546135861940363,-0.0452688620519608,-0.0238603362638985,2.50490694578569e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,-0.0139134741646761,0.00220129817977875,-0.0182280185970425,-0.00959892973230979,2.64272532766076e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,29694,-0.0264277434742144,0.0041864135981561,-0.0346331141266003,-0.0182223728218284,2.7800947576865e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,-0.0341383672637071,0.00541081513047016,-0.0447435649194286,-0.0235331696079856,2.85149914576245e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,29478,-0.0235711160830772,0.0037391814309497,-0.0308999116877386,-0.0162423204784158,2.94513041780921e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,28835,-0.0168508493424573,0.00267559383445959,-0.0220950132579981,-0.0116066854269165,3.05887611650868e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,24938,0.0105232627628172,0.00167185951480132,0.00724641811380657,0.0138001074118278,3.13837972055901e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,-0.0224766867876296,0.00357416337658394,-0.0294820470057342,-0.0154713265695251,3.24820775033726e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,24445,-0.0559678391478891,0.00891755476282245,-0.0734462464830211,-0.0384894318127571,3.52907121812887e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,24240,-0.0320363473304883,0.00511284406926404,-0.0420575217062458,-0.0220151729547308,3.77022143435324e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,29434,-0.0361810795499245,0.00578840641768041,-0.0475263561285781,-0.0248358029712709,4.14453954984675e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,28797,-0.0174977799501644,0.00280270976967952,-0.0229910910987363,-0.0120044688015926,4.3478526340587e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,29694,-0.0249240646902111,0.00399519768572768,-0.0327546521542373,-0.0170934772261848,4.47727279211076e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PI3,Elafin,29014,-0.023753118601307,0.0038103294307019,-0.0312213642854827,-0.0162848729171312,4.61298205318409e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,-0.0145936650071553,0.00235000836391367,-0.0191996814004261,-0.0099876486138845,5.36762185963889e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,24951,-0.00994253522034361,0.0016035409230198,-0.0130854754294624,-0.0067995950112248,5.72168310346614e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,-0.0270452296959937,0.00436975537699019,-0.0356099502348945,-0.018480509157093,6.14215533869438e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,24845,-0.030358335970543,0.00491047247830379,-0.0399828620280184,-0.0207338099130676,6.4131552640194e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,-0.0217022042648132,0.00351131198928494,-0.0285843757638117,-0.0148200327658147,6.48266381933123e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,29536,0.0353548766469675,0.00572487183382327,0.0241341278526739,0.0465756254412611,6.67450603575199e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,29536,0.013454620040993,0.00217911963979565,0.00918354554699352,0.0177256945349925,6.73064775465808e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,-0.0310407910611516,0.00502775184732989,-0.0408951846819182,-0.0211863974403851,6.76876183183931e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,-0.0108139317804218,0.00175272392180013,-0.0142492706671501,-0.00737859289369354,6.94356270503533e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,0.00871281310979537,0.00141564797241559,0.0059381430838608,0.0114874831357299,7.62109622985534e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,24922,-0.0191131788231976,0.003107561283688,-0.0252039989392261,-0.0130223587071691,7.83945719021768e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,-0.0338356518460984,0.00550929684759898,-0.0446338736673924,-0.0230374300248044,8.29599050508235e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,24914,0.00960369537755308,0.00156657703542537,0.00653320438811936,0.0126741863669868,8.89926598190028e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,-0.0226698307988839,0.00370373036932907,-0.0299291423227689,-0.015410519274999,9.45499305167294e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,29497,0.0125735760508697,0.00205677421623111,0.00854229858705668,0.0166048535146826,9.88458430251227e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,29349,-0.0129156373336465,0.0021127717907501,-0.0170566700435167,-0.00877460462377632,9.89299801883178e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,24845,-0.0347942460724935,0.00569847880661731,-0.0459632645334634,-0.0236252276115236,1.03749945228919e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,-0.0217541451455304,0.00356833615666102,-0.028748084012586,-0.0147602062784748,1.09835070364059e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,-0.037314882826064,0.00612205712140868,-0.049314114784025,-0.0253156508681029,1.10942248736429e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,-0.0397609958251463,0.00653845504181298,-0.0525763677070997,-0.0269456239431929,1.20841077076067e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,24867,-0.0440553448144447,0.00725523007254338,-0.0582755957566298,-0.0298350938722597,1.27984003210761e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,0.0481117784516039,0.00793397240776659,0.0325611925323814,0.0636623643708264,1.34387450639056e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,29218,-0.0255936503570144,0.00422068260217931,-0.0338661882572858,-0.0173211124567429,1.34517931790367e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,-0.0575206929427734,0.00949690696580799,-0.0761346305957571,-0.0389067552897898,1.40559143182222e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,24606,0.0129761612216627,0.00215091941408133,0.00876035917006334,0.0171919632732622,1.6340021063609e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,0.0327287587416894,0.00542940962103188,0.0220871158844669,0.0433704015989119,1.67918976136733e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,24793,-0.0200709716366154,0.00333508753243962,-0.026607743200197,-0.0135342000730337,1.78927128470164e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,29618,0.0172365624524183,0.0028643081652537,0.011622518448521,0.0228506064563155,1.78983383450322e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,29594,0.0125614171499072,0.00208966723600393,0.00846566936733945,0.0166571649324749,1.86304052082847e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,29566,0.0115986526167654,0.00192969423573153,0.00781645191473155,0.0153808533187992,1.86981988562761e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,-0.0266281157810759,0.00443889964933684,-0.0353283590937761,-0.0179278724683757,2.0158797310282e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,24381,-0.017790644644279,0.00297073750521113,-0.0236132901544928,-0.0119679991340652,2.14581527816615e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,-0.0348999952021085,0.00583248418238728,-0.0463316641995876,-0.0234683262046294,2.20615053781876e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,29242,0.020538732377397,0.00343399029153974,0.0138081114059791,0.0272693533488149,2.24331612576631e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,0.0130892192898884,0.00219015794030539,0.00879650972688983,0.017381928852887,2.30737343943693e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,28774,-0.0339677292184695,0.00568690862129098,-0.0451140701161998,-0.0228213883207391,2.35708278414888e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,-0.0110983884268729,0.00186045878418944,-0.0147448876438842,-0.00745188920986163,2.46806987266527e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,-0.027435216296635,0.00460465571634978,-0.0364603415006806,-0.0184100910925894,2.58076402598377e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,-0.0181492619902563,0.00304643049649641,-0.0241202657633893,-0.0121782582171234,2.59554580371399e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,29349,-0.0388656835338568,0.0065252967519218,-0.0516552651676236,-0.0260761019000901,2.61178675360357e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,29349,-0.0298560896374522,0.00501381419882306,-0.0396831654671454,-0.020029013807759,2.63405175284764e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,24229,-0.022581518746294,0.00379410041406017,-0.0300179555578519,-0.015145081934736,2.68948368124529e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,-0.0268756817446969,0.00451686194840852,-0.0357287311635776,-0.0180226323258162,2.71048846470599e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,-0.0300508490384538,0.00505061311090073,-0.0399500507358192,-0.0201516473410884,2.71822534118507e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,-0.0497496050864563,0.00837815977627752,-0.0661707982479603,-0.0333284119249524,2.92439777907716e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,29218,-0.0171581937867272,0.00289095922919509,-0.0228244738759496,-0.0114919136975048,2.9693820937351e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,-0.0141980446697104,0.00239342243228522,-0.0188891526369894,-0.00950693670243137,3.0241595193754e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,-0.031478751568305,0.0053067834367401,-0.0418800471043156,-0.0210774560322944,3.03614207420769e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,28797,-0.0401259576526577,0.00676646953646265,-0.0533882379441245,-0.0268636773611909,3.06169601120572e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,-0.0238677715633115,0.00402755631821235,-0.0317617819470077,-0.0159737611796153,3.14350611922062e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,24793,-0.0162305876678867,0.00274158195078257,-0.0216040882914205,-0.0108570870443528,3.25874814794901e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,29434,-0.0349462283728159,0.00590388845174401,-0.0465178497382342,-0.0233746070073977,3.27116322169247e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,24793,-0.0257369033010152,0.00435202065607979,-0.0342668637869316,-0.0172069428150989,3.38722871915629e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,0.0117287602455025,0.00198366534948725,0.0078407761605075,0.0156167443304975,3.40406397543674e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,28774,-0.0292412469388224,0.00494696527716929,-0.0389372988820742,-0.0195451949955706,3.43979658538107e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,24805,-0.0288411590965079,0.00489672000429175,-0.0384387303049197,-0.0192435878880961,3.91429116309874e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,-0.0389237206298185,0.00663528112983283,-0.0519288716442908,-0.0259185696153462,4.50774511668409e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,24195,0.0127024193679886,0.00216858938206068,0.00845198417914969,0.0169528545568276,4.76091097069177e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,-0.030980999284255,0.00529123550851403,-0.0413518208809425,-0.0206101776875675,4.82574030412372e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,29478,0.0106609888033219,0.00182099614417713,0.0070918363607347,0.0142301412459091,4.83567010228269e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,24229,-0.013447187476615,0.00229677663564258,-0.0179488696824744,-0.0089455052707555,4.83720969281092e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,0.0105673300909015,0.00180568068154013,0.00702819595508283,0.0141064642267202,4.90969751838341e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,24805,-0.0278579567095841,0.00476168857911763,-0.0371908663246547,-0.0185250470945136,4.96444107042141e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,-0.00804551036204309,0.00137539763331561,-0.0107412897233417,-0.00534973100074449,4.98005132203941e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,-0.0205300133695667,0.00351320126930317,-0.0274158878574009,-0.0136441388817325,5.16995871721366e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,24720,0.0113869916070185,0.00194971780749158,0.00756554470433496,0.015208438509702,5.27504810282253e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,-0.0253031831055308,0.00433394778403407,-0.0337977207622376,-0.016808645448824,5.33881372812813e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,-0.0414870129916785,0.0071144786325971,-0.0554313911115688,-0.0275426348717882,5.55516019139263e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,-0.0323963624831435,0.00556042406125664,-0.0432947936432065,-0.0214979313230805,5.74087541879784e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,24229,-0.0141296100672802,0.00242701029669757,-0.0188865502488074,-0.00937266988575295,5.89458016198335e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,24805,-0.0419285543717996,0.00721667905489306,-0.0560732453193899,-0.0277838634242092,6.32550275732888e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,29165,0.0192833287581798,0.00332324231424687,0.0127697738222559,0.0257968836941036,6.59833171670466e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,-0.0239208149334137,0.00412818906679539,-0.0320120655043326,-0.0158295643624947,6.92363153135962e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,24688,-0.0376468867676381,0.00649823148968872,-0.050383420487428,-0.0249103530478482,6.98114223677939e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,28719,-0.0184274813858602,0.00318150254213275,-0.0246632263684404,-0.01219173640328,7.02495008519473e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,-0.0261577268715385,0.00451768922792021,-0.0350123977582621,-0.0173030559848148,7.10663771013142e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,-0.0156096224115709,0.00269592820905974,-0.020893641701328,-0.0103256031218138,7.12192230125843e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,24761,-0.0113877697658663,0.0019684426664526,-0.0152459173921133,-0.00752962213961917,7.33128299873521e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,-0.024950043337169,0.00431913946484578,-0.0334155566882667,-0.0164845299860713,7.71519486074492e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.011336502379696,0.00196299075027265,0.00748904050916157,0.0151839642502304,7.76714406254294e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0392738283048659,0.00680136791548311,0.025943147190519,0.0526045094192128,7.79998131865191e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,-0.0157870814889379,0.00273661842447412,-0.0211508536009072,-0.0104233093769686,8.06416385235394e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,-0.0267326094545509,0.0046373352793319,-0.0358217866020414,-0.0176434323070604,8.26638424777099e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,-0.0147945291684851,0.00257163571459432,-0.01983493516909,-0.00975412316788025,8.87218025059166e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,29786,-0.0164226809864769,0.00285493878745105,-0.022018361009881,-0.0108270009630729,8.88588286487442e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,24845,-0.00882897722757792,0.00153577171992641,-0.0118390897986337,-0.00581886465652215,9.08852864913391e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWC2,Brorin,29114,-0.0158307202314015,0.00275572057976611,-0.0212319325677431,-0.0104295078950599,9.30146284604645e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,-0.0106924164676612,0.00186260073132341,-0.0143431139010551,-0.00704171903426734,9.52725618594047e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,29218,0.0222890300004721,0.00388511913988708,0.0146741964862934,0.0299038635146508,9.73045317717789e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,-0.0111284891975007,0.0019414648050979,-0.0149337602154926,-0.00732321817950882,1.00217097558544e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,28774,0.0140003833226325,0.00244360913512409,0.00921090941778926,0.0187898572274757,1.01799132487642e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,24240,-0.0272631996556917,0.00475850346302926,-0.0365898664432291,-0.0179365328681544,1.02002071332543e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,-0.0337989228541191,0.00590898505890316,-0.0453805335695693,-0.0222173121386689,1.07799934823242e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,24845,-0.0244429965295888,0.00427733319433636,-0.0328265695904881,-0.0160594234686895,1.11258983289193e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COCH,Cochlin,24922,-0.0182950524112104,0.00320504542418926,-0.0245769414426214,-0.0120131633797995,1.15471290612507e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,-0.0152595744908446,0.0026743971012361,-0.0205013928092673,-0.0100177561724218,1.16903209732853e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,-0.0164873626466497,0.00288952271323858,-0.0221508271645973,-0.0108238981287021,1.17037917405072e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,-0.0150648357990674,0.00264294897153243,-0.020245015783271,-0.00988465581486384,1.20944556406375e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,24938,0.0123943458323193,0.00217510153619212,0.00813114682138277,0.0166575448432559,1.22383643844128e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0144973500584188,0.00254426535387893,0.00951058996481608,0.0194841101520215,1.22556791573082e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,29694,-0.0233321692955651,0.00409511111575371,-0.0313585870824424,-0.0153057515086878,1.22678294757265e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00981895192814747,0.00172443011679609,-0.0131988349570678,-0.00643906889922714,1.25473179562464e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.00880221782523703,0.00154659702429634,0.0057708876576162,0.0118335479928579,1.27256536271233e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.0234125764743594,0.00411755430223483,-0.0314829829067397,-0.0153421700419792,1.31271169902096e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,28797,-0.0230685554149902,0.00406649765576034,-0.0310388908202804,-0.0150982200096999,1.41802869272701e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,29218,-0.0139393605858816,0.00246019707253862,-0.0187613468480573,-0.00911737432370592,1.47584464281583e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,29344,-0.0343012504565404,0.0060642820116545,-0.0461872431993833,-0.0224152577136976,1.56131575955427e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,29434,-0.0265665925498515,0.00469878810175574,-0.0357762172292927,-0.0173569678704102,1.58276821501737e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,24240,-0.0185469908470212,0.00328083369735529,-0.0249774248938376,-0.0121165568002049,1.5932029564829e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,29443,-0.0224485844468199,0.00397461882792844,-0.0302388373495597,-0.0146583315440802,1.63836086639932e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,29478,0.0180750332087343,0.00320385037078346,0.0117954864819987,0.0243545799354699,1.69962243572644e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,-0.0370407545848473,0.00656820377456502,-0.0499144339829948,-0.0241670751866999,1.72196435651781e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,0.0101673516913353,0.00180442621090387,0.00663067631796374,0.0137040270647069,1.76971937005426e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,29169,-0.0178651760462968,0.00317099771258595,-0.0240803315629653,-0.0116500205296284,1.77772285138212e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,29163,-0.0311528416297009,0.00553720290072405,-0.0420057593151201,-0.0202999239442818,1.86021813297124e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,29466,-0.0206510725444425,0.0036713664767156,-0.0278469508388051,-0.0134551942500799,1.87296593113766e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,24922,-0.0121601120803531,0.00216861676262037,-0.016410600935089,-0.00790962322561721,2.0766903034281e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,29345,-0.0166917645012892,0.00297929490760386,-0.0225311825201928,-0.0108523464823856,2.13065767904793e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F2,Prothrombin,24966,0.005746605992944,0.00102682628012753,0.00373402648389404,0.00775918550199396,2.21051528793203e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,0.0316950271967693,0.00566385988606823,0.0205938618200756,0.042796192573463,2.21282226088269e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,-0.0310146199521963,0.00554523614155928,-0.0418832827896525,-0.0201459571147401,2.25498364566437e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,-0.0130857635665533,0.00234016451011041,-0.0176724860063697,-0.00849904112673691,2.27132476955947e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0270062049396677,0.00483014063081419,0.0175391293032719,0.0364732805760635,2.27539882472975e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,29368,-0.0264846134787028,0.00474021415190116,-0.035775433216429,-0.0171937937409765,2.32778691272534e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,24951,0.00871737808782847,0.00156287711444731,0.00565413894351174,0.0117806172321452,2.46138335730719e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,-0.0117212944576069,0.00210582872792019,-0.0158487187643305,-0.00759387015088336,2.63179557294864e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,29443,0.00929472731045988,0.00167165669964271,0.00601828017916018,0.0125711744417596,2.71818777625397e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,0.0189541804784518,0.00340911044427749,0.0122723240076679,0.0256360369492356,2.72324375318182e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,24845,0.0161838836958346,0.00291215358448899,0.0104760626702362,0.021891704721433,2.76697048461372e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,29443,-0.0249766619680875,0.00449778893882023,-0.0337923282881751,-0.0161609956479998,2.83071891842392e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,29594,-0.0385183670264825,0.00693851339438739,-0.0521178532794818,-0.0249188807734832,2.85842663788323e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,-0.0265548585779519,0.00478382815590304,-0.0359311617635219,-0.017178555392382,2.87078820693893e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,29694,-0.0301977174020492,0.00544118068412253,-0.0408624315429294,-0.0195330032611691,2.88360514210653e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,-0.0427468934930296,0.00770699041746096,-0.0578525947112531,-0.0276411922748061,2.9395573091622e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,29498,-0.0249962331468903,0.00450810485226528,-0.0338321186573302,-0.0161603476364503,2.96924803429632e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,-0.0258418201522675,0.00466423345863182,-0.0349837177311859,-0.0166999225733492,3.04862300425649e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,24867,-0.0212042515314919,0.00383060066609669,-0.0287122288370414,-0.0136962742259424,3.13492785613106e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,-0.0346201087829767,0.00625780806076021,-0.0468854125820667,-0.0223548049838866,3.19234387006141e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,0.0109285876637181,0.00197610868640139,0.00705541463837141,0.0148017606890649,3.22279018592186e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.014029289479139,0.00254046125310596,0.00904998542305127,0.0190085935352267,3.37306583359182e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,-0.0247032967974762,0.00447853898431065,-0.033481233206725,-0.0159253603882273,3.50408379308568e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,-0.0411648260379933,0.0074779908268282,-0.0558216880585766,-0.02650796401741,3.73247146070537e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,-0.00863403439619238,0.00156927982743951,-0.0117098228579738,-0.00555824593441094,3.7880603569718e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.0116115867456905,0.00211555215980408,0.00746510451247454,0.0157580689789065,4.08363955262833e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,24195,-0.0172589300052622,0.00314442684115347,-0.023422006613923,-0.0110958533966014,4.08883629237121e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,29786,-0.0213253862084802,0.0038928520746137,-0.028955376274723,-0.0136953961422373,4.33423199616243e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,29694,0.0110185419311287,0.002016546273043,0.00706611123596438,0.0149709726262929,4.6908780154585e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NBN,Nibrin,28931,-0.0197951282057637,0.00362721946156347,-0.0269044783504281,-0.0126857780610993,4.87166167274846e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,-0.0261640485632697,0.00479541747619759,-0.035563066816617,-0.0167650303099225,4.9082722922092e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,-0.032630168436293,0.00598283828046319,-0.0443565314660008,-0.0209038054065851,4.96678700161255e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,29820,-0.0209617180223813,0.00384971668495002,-0.0285071627248833,-0.0134162733198792,5.22132819149609e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.0114612787441873,0.00210502545983981,-0.0155871286454734,-0.00733542884290132,5.2297613906008e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,28797,-0.0108742264948394,0.00199761267404562,-0.0147895473359688,-0.00695890565371,5.26373247801688e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,24888,-0.0166972216228576,0.00307911323166471,-0.0227322835569204,-0.0106621596887947,5.92397167864559e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,29581,-0.0177411211966516,0.00327606109048248,-0.0241622009339973,-0.011320041459306,6.16343025338246e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,-0.0121962770627313,0.00225466153269548,-0.0166154136668145,-0.00777714045864817,6.37379875531541e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,-0.033768827753911,0.00625038646584469,-0.0460195852269666,-0.0215180702808554,6.62720632027613e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,-0.0119035268314109,0.00220352996843438,-0.0162224455695422,-0.00758460809327948,6.64977336431508e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,28916,-0.0500517713935992,0.00927255058429248,-0.0682259705388125,-0.031877572248386,6.7977433846116e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,-0.0193912612326638,0.00359337608189652,-0.026434278353181,-0.0123482441121466,6.85178499301908e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,24445,0.0138014441416297,0.00256015735700498,0.00878353572189993,0.0188193525613594,7.07718144102369e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,29322,-0.031374077857553,0.00582126994984786,-0.0427837669592548,-0.0199643887558512,7.11754028096265e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,-0.0166826558775395,0.00309523408414548,-0.0227493146824647,-0.0106159970726144,7.11996746358418e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,-0.0283685169497381,0.00527506251933322,-0.0387076394876312,-0.018029394411845,7.59509745496931e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0119931951184912,0.00223529820362001,-0.0163743795975864,-0.00761201063939596,8.15215075433003e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,-0.0109761007587449,0.00204615294405566,-0.014986560529094,-0.00696564098839584,8.20052748398987e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,24845,-0.0206929480513489,0.00385835466977876,-0.0282553232041153,-0.0131305728985825,8.25121125589314e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,24801,-0.0119483054910394,0.00222868527518303,-0.0163165286303981,-0.00758008235168067,8.34350224719938e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,28774,-0.0269866364249523,0.00503832692319464,-0.0368617571944138,-0.0171115156554908,8.56095203117824e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,28774,-0.0250041565507583,0.00467290215866434,-0.0341630447817405,-0.0158452683197762,8.81945035854868e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,24966,0.0083930457146967,0.00156979033542289,0.00531625665726783,0.0114698347721256,9.04075341614491e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.0172926516719494,0.0032347445421765,0.0109525523692834,0.0236327509746153,9.07571618407929e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,29443,0.00888365321415891,0.00166374874195276,0.00562270567993151,0.0121446007483863,9.38727070939917e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,24845,0.0112935659785361,0.00211536994131564,0.00714744089355743,0.0154396910635148,9.43779021873176e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,-0.0247023482050737,0.00462794947193664,-0.0337731291700695,-0.0156315672400779,9.50129760173379e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.00822473124138616,0.0015419915000426,0.00520242790130267,0.0112470345814696,9.68684769185711e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,24845,-0.0277803094502483,0.0052203732129911,-0.0380122409477109,-0.0175483779527858,1.03796893728678e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,24229,0.0158533611602286,0.00298008397249738,0.0100123965741338,0.0216943257463235,1.0482087576681e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0127895382080977,0.00240495901583484,0.00807581853706139,0.017503257879134,1.05677379610207e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,24445,-0.0200210235877816,0.00376565491066158,-0.0274017072126783,-0.0126403399628849,1.06567883221606e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,-0.0234231267138957,0.00441246720615234,-0.0320715624379542,-0.0147746909898371,1.11540133436966e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,29694,-0.0450548942176565,0.0084938504677696,-0.0617028411344849,-0.0284069473008281,1.13844885416088e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,-0.0173650117423969,0.00327357163731336,-0.0237812121515311,-0.0109488113332628,1.13884066943974e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,24111,-0.0175645595945589,0.0033145958431029,-0.0240611674470406,-0.0110679517420772,1.17361672361158e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,29349,-0.0270517364617625,0.0051059718200373,-0.0370594412290356,-0.0170440316944894,1.17884192150311e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,-0.037533766738555,0.00710249928512478,-0.0514546653373996,-0.0236128681397105,1.2705405668369e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,29466,0.014579945855615,0.00276369221243317,0.009163109119246,0.019996782591984,1.33306444915391e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,-0.0116849139267185,0.00221677561830241,-0.0160297941385912,-0.00734003371484577,1.36539825558528e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,-0.0378574789959216,0.00719568705494497,-0.0519610256236138,-0.0237539323682295,1.44165472229845e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,-0.0246488587004401,0.00468605937017534,-0.0338335350659838,-0.0154641823348965,1.4525391499852e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,24229,-0.0180949907994276,0.00344505883571971,-0.0248473061174383,-0.011342675481417,1.51359299166049e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,-0.0197709414754325,0.00376547698357952,-0.0271512763632483,-0.0123906065876166,1.52894413771849e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,24951,0.0526181176417646,0.010021555190238,0.0329758694688982,0.0722603658146311,1.52934232716449e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,29390,-0.0102510756628748,0.00195276478433703,-0.0140784946401754,-0.00642365668557424,1.53556050124202e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,-0.0139348311343426,0.00266126648358927,-0.0191509134421776,-0.00871874882650767,1.65098808968979e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0175052053290503,0.00334365265959001,-0.0240587645418467,-0.0109516461162539,1.65799002460859e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,29443,-0.0165687684580078,0.00317187291694748,-0.0227856393752249,-0.0103518975407907,1.76618965261062e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.013866269336844,0.00265504822940704,-0.0190701638664819,-0.00866237480720624,1.77610540080386e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,29632,-0.0214464146978226,0.00410663081559417,-0.0294954110963872,-0.013397418299258,1.77823960313841e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,24845,0.0273136284987156,0.00523269139133055,0.0170575533717077,0.0375697036257235,1.80551968746946e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,-0.0104650727655451,0.00200519709435083,-0.0143952590704727,-0.00653488646061746,1.81127633285911e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,-0.0337047755280188,0.00646147447791617,-0.0463692655047345,-0.0210402855513031,1.83822456522677e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,24922,-0.0269763696668718,0.00517503264347813,-0.037119433648089,-0.0168333056856547,1.87502722984891e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,29694,-0.0233807037307758,0.00448792418694278,-0.0321770351371837,-0.014584372324368,1.90416500106548e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,29082,-0.0169401353120036,0.00325310331215378,-0.023316217803825,-0.0105640528201822,1.92831668114437e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EZR,Ezrin,29694,-0.00863598620476442,0.0016591813385528,-0.0118879816283279,-0.00538399078120093,1.95320111458772e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,24111,-0.0142227212142416,0.00273346679326016,-0.0195803161290315,-0.00886512629945171,1.97509930199749e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,29395,-0.0239015281162153,0.00459414713584261,-0.0329060565024668,-0.0148969997299638,1.97833241297325e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0147100200559073,0.00282861142354972,0.00916594166574984,0.0202540984460647,2.00162023231724e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,-0.0260613870304559,0.00501372430071942,-0.035888286659866,-0.0162344874010459,2.03070447684757e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,-0.0193381194851084,0.00372273219258784,-0.0266346745825806,-0.0120415643876363,2.06508495277162e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,29497,0.0119477579886366,0.0023016520473188,0.00743651997589178,0.0164589960013815,2.10611280261362e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,-0.0205157308186989,0.0039527008975465,-0.0282630245778901,-0.0127684370595078,2.11371902110743e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,-0.0107688829945018,0.00207812924079014,-0.0148420163064504,-0.00669574968255309,2.2095668938942e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.00728650807351093,0.00140621611828352,0.00453032448167523,0.0100426916653466,2.21395773848984e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,-0.0213524708731946,0.00413508093548384,-0.029457229506743,-0.0132477122396463,2.43669844196283e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,-0.00982870345707526,0.0019036663489124,-0.0135598895009436,-0.00609751741320695,2.4453369227614e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,28452,-0.021529457423859,0.00417031132466542,-0.0297032676202033,-0.0133556472275148,2.45241240784872e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,24793,-0.0296130796074239,0.00574240764560549,-0.0408681985928107,-0.0183579606220372,2.52988549218008e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,24177,-0.0156144150438945,0.0030289835593006,-0.0215512228201236,-0.00967760726766528,2.55625748222611e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.009520023985954,0.00184696975176814,0.00589996327248845,0.0131400846994196,2.56082203322302e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,24813,-0.0265819779328928,0.00515960826992846,-0.0366948101419526,-0.016469145723833,2.59782438524105e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.01209667058112,0.00235043230212074,-0.0167035178932767,-0.00748982326896337,2.66988824020183e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.0169710489534025,0.00330252840232687,-0.0234440046219631,-0.0104980932848418,2.78256659356902e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,-0.0106634198127359,0.00207655756477856,-0.0147334726397019,-0.00659336698576996,2.84060997301164e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,-0.0332029509675846,0.00647672882491109,-0.0458973394644104,-0.0205085624707589,2.97389242518435e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,29725,-0.0152444161369354,0.00297918659837058,-0.0210836218697418,-0.00940521040412908,3.12409462848572e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,-0.0193658935337847,0.00379056519475708,-0.0267954013155085,-0.0119363857520608,3.25943246080558e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,29820,0.0112193781893387,0.00219843881868608,0.00691043810471396,0.0155283182739634,3.35760047494928e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,-0.0203876752593123,0.00399570626141029,-0.0282192595316765,-0.0125560909869481,3.37478797531175e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0178167922275636,0.00350059118201401,0.0109556335108161,0.0246779509443111,3.60976096534903e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,-0.036442953952861,0.00716682167829542,-0.0504899244423201,-0.022395983463402,3.699768641917e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,29434,-0.0206150928799088,0.00405594437730746,-0.0285647438594314,-0.0126654419003862,3.74411073813566e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENG,Endoglin,29820,0.00604818064830632,0.00119085439192323,0.00371410604013679,0.00838225525647586,3.81996434757459e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,0.0124853703207808,0.00245872333516312,0.00766627258386105,0.0173044680577005,3.84198780671069e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,24793,-0.0126718114181485,0.00249640496448761,-0.0175647651485442,-0.00777885768775278,3.88201816141841e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,29786,-0.0147104552935292,0.0029010079580501,-0.0203964308913074,-0.00902447969575098,3.98503136364141e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,-0.0206652999526767,0.0040767697551993,-0.0286557686728674,-0.0126748312324861,4.02699242291365e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,-0.0272086800397169,0.00536801799586915,-0.0377299953116205,-0.0166873647678134,4.03489740797429e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,-0.0180138228392913,0.00355420917794141,-0.0249800728280565,-0.0110475728505261,4.04321419060718e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,0.0143181790579342,0.00282931501051796,0.00877272163731897,0.0198636364785494,4.20346200152501e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,24867,-0.0233782774918479,0.00462127896782593,-0.0324359842687867,-0.014320570714909,4.24832243820717e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,29786,-0.0162215159313107,0.00320697484434406,-0.022507186626225,-0.00993584523639632,4.25746994083601e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,24793,-0.0237101169406031,0.00469078261531486,-0.0329040508666202,-0.014516183014586,4.34319728981976e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,24845,-0.0132530565922338,0.00262394998870869,-0.0183959985701029,-0.00811011461436482,4.43068965231206e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,24016,-0.0178688941941402,0.00353842233821513,-0.0248042019770418,-0.0109335864112385,4.45134911318364e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00962703913819704,0.00191143942692688,0.00588061786142035,0.0133734604149737,4.76809410285417e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,29227,-0.0252131284337545,0.00500784294475184,-0.0350285006054681,-0.0153977562620409,4.81369781791465e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,24938,-0.00981739894592985,0.00195008233450261,-0.013639560321555,-0.00599523757030474,4.8280922855802e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,28868,-0.0133012374742516,0.00264561468345515,-0.0184866422538237,-0.0081158326946795,4.99484608090634e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,24867,-0.0240240504778105,0.00478035454422426,-0.03339354538449,-0.0146545555711309,5.05396825819905e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,24867,-0.0191143673563669,0.00380571494543852,-0.0265735686494264,-0.0116551660633074,5.13446246976613e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,24922,-0.0223849286388133,0.00446238259052358,-0.0311311985162395,-0.0136386587613871,5.30208134135008e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,0.0122576814892048,0.00244670837174544,0.00746213308058377,0.0170532298978259,5.48411655294966e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,29291,-0.0194429969690778,0.00388140167146361,-0.0270505442451465,-0.0118354496930091,5.49538550215335e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,-0.0223819609544289,0.00447054640283416,-0.0311442319039839,-0.013619690004874,5.57380766265458e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELP,P-selectin,29594,-0.0196271604336224,0.00392617865784448,-0.0273224706029976,-0.0119318502642473,5.79425140426078e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,-0.0115730679947862,0.00232541743293779,-0.0161308861633443,-0.00701524982622815,6.50151173234494e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCN,Decorin,28916,0.00788615967312493,0.00158500060295455,0.00477955849133401,0.0109927608549159,6.54550333306189e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,24195,-0.0168126097829111,0.00338199504486551,-0.0234413200708475,-0.0101838994949747,6.69909540792722e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,29396,-0.00891286196496045,0.00179373799162865,-0.0124285884285526,-0.0053971355013683,6.77200508093489e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,-0.0123421017887069,0.00248999699040341,-0.0172224958898975,-0.00746170768751618,7.21967707377077e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,29820,-0.0144913567719275,0.00292905286982208,-0.0202323003967788,-0.00875041314707621,7.55992889012146e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,-0.0149494973937791,0.0030223444097897,-0.0208732924369669,-0.00902570235059125,7.6133814738983e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,28797,0.0189247751232163,0.00382664897602849,0.0114245431302004,0.0264250071162321,7.63675543185682e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,29478,-0.041590560830614,0.00841026273983189,-0.0580746758006845,-0.0251064458605435,7.64776748569654e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,24016,-0.0123168985933898,0.00250213682530997,-0.0172210867709973,-0.00741271041578224,8.59892429499861e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,24922,0.00905979038256524,0.00184222090783942,0.00544903740319997,0.0126705433619305,8.80509302710798e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,28797,-0.0327337350231646,0.0066607692819951,-0.045788842815875,-0.0196786272304542,8.95403326502351e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,29518,0.0153736485922094,0.0031304633238494,0.00923794047746457,0.0215093567069542,9.11056140462308e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,24845,-0.0129840912100465,0.00264550266835581,-0.0181692764400239,-0.0077989059800691,9.25991826250628e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,29725,-0.0130375729626079,0.00265712094943516,-0.0182455300235008,-0.00782961590171501,9.31331006929366e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,24845,0.0134432211210469,0.00274026953642849,0.0080722928296471,0.0188141494124468,9.36345975784665e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,24966,-0.00703818901113556,0.00143497887230598,-0.00985074760085528,-0.00422563042141585,9.41425697398177e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,24111,-0.0226347187017755,0.0046151593429667,-0.0316804310139902,-0.0135890063895607,9.4309825908413e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,-0.0243004038292079,0.00496111804311317,-0.0340241951937097,-0.0145766124647061,9.72393185200149e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0125411823163238,0.0025607462089627,0.00752211974675692,0.0175602448858907,9.77027972402167e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,-0.012187624720449,0.00248986108740298,-0.0170677524517588,-0.00730749698913914,9.89874528934605e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,0.0116548704969963,0.00238276876435159,0.00698464371886722,0.0163250972751254,1.0069050773481e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,24381,0.0116458449906328,0.00238107067578239,0.00697894646609933,0.0163127435151663,1.00957996442201e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,-0.0227218631613429,0.00465454844606971,-0.0318447781156395,-0.0135989482070462,1.05747619811691e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,-0.0143333625615039,0.00294644592500638,-0.0201083965745164,-0.00855832854849143,1.1527506543339e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,-0.016188394237739,0.00333262357283982,-0.022720336440505,-0.00965645203497294,1.19568454812784e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,-0.0221523311703859,0.00456250146748532,-0.0310948340466571,-0.0132098282941146,1.20932074116848e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,0.00889899299434291,0.00183324541957369,0.00530583197197847,0.0124921540167073,1.21587111625783e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,24229,0.0114678472602073,0.0023645140008019,0.00683339981863554,0.016102294701779,1.24239721368515e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,29478,0.0257709995691016,0.00532437214784159,0.0153352301593321,0.0362067689788712,1.30367897520986e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,-0.0160697568620678,0.00332107701806199,-0.0225790678174693,-0.00956044590666632,1.31463955217435e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,24845,-0.0359688342193261,0.0074442864214597,-0.0505596356053871,-0.0213780328332651,1.36154174186107e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,-0.0208118273419728,0.00431030786567588,-0.0292600307586975,-0.0123636239252481,1.38462535036622e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,-0.0223414644814447,0.00462845407135172,-0.0314132344612941,-0.0132696945015954,1.39311468640314e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,29674,-0.0191282451762866,0.00396687339500581,-0.0269033170304979,-0.0113531733220752,1.4283311872492e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,-0.0164663010400727,0.00341685762269282,-0.0231633419805507,-0.00976926009959482,1.44916111644637e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,-0.0213513722816218,0.0044362094876414,-0.0300463428773989,-0.0126564016858446,1.49452780200887e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,28490,0.00875754503435425,0.00182205724721051,0.00518631282982164,0.0123287772388868,1.54451363175702e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,29443,0.0162888106480535,0.00338919409164396,0.0096459902284313,0.0229316310676756,1.54660287215082e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,29434,-0.0130398923884397,0.00271590962593321,-0.0183630752552688,-0.0077167095216106,1.58414341059337e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,29581,-0.021986695948378,0.00461611668098045,-0.0310342846430997,-0.0129391072536563,1.91612343134212e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,0.00909056275232244,0.0019088508165975,0.00534921515179134,0.0128319103528535,1.92453845002245e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,-0.0109611850265129,0.00230231468420289,-0.0154737218075506,-0.00644864824547524,1.9361076864459e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,-0.0214756815277032,0.00451411834190488,-0.0303233534778368,-0.0126280095775697,1.97006082302696e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.00885316072252546,0.0018670101437899,0.00519382084069725,0.0125125006043537,2.1272491181083e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,-0.0175154738769989,0.00369412833985202,-0.0247559654231088,-0.0102749823308889,2.13404650706053e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,-0.0342334826027516,0.0072240672649539,-0.0483926544420613,-0.020074310763442,2.16189277420754e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,-0.0256405211454831,0.00541419636432569,-0.0362523460195615,-0.0150286962714048,2.19222492325075e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,-0.0319254182449733,0.00674170297643682,-0.0451391560787895,-0.0187116804111572,2.19738445419356e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,24816,-0.0277453367114398,0.00586430301829002,-0.0392393706272882,-0.0162513027955913,2.24397914339132e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,29478,-0.0186534701938938,0.00394362948971434,-0.0263829839937339,-0.0109239563940536,2.25530213713381e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,-0.00765616106826536,0.00161934195347145,-0.0108300712970694,-0.00448225083946131,2.27851999472693e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,23862,-0.0264935014772696,0.00560462962058271,-0.0374785755336117,-0.0155084274209275,2.29077888608178e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,-0.0219566461371846,0.00465395361355757,-0.0310783952197575,-0.0128348970546118,2.39471608292619e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,29787,0.0140518085114329,0.00298149233116237,0.00820808354235467,0.0198955334805112,2.45184790018705e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,-0.0317564860128992,0.0067468520921101,-0.044980316113435,-0.0185326559123634,2.52952883751953e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,24966,-0.0135456022995493,0.00288168912870174,-0.0191937129918047,-0.00789749160729387,2.60811947207999e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.0163226410272822,0.00347291403285387,-0.0231295525316758,-0.00951572952288867,2.61578857542741e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,29795,-0.010998271227246,0.00234148267947228,-0.0155875772790116,-0.00640896517548029,2.65006282100524e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,24867,-0.021554367890185,0.00459415607931175,-0.030558913805636,-0.0125498219747339,2.72395687924036e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,-0.0351906670964467,0.00751686797816836,-0.0499237283336567,-0.0204576058592368,2.86206250653685e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,-0.0196193974566793,0.0041918822516755,-0.0278354866699633,-0.0114033082433953,2.87932896679177e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,-0.0235916638926324,0.00504352413667218,-0.0334769712005098,-0.0137063565847549,2.91543084691835e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,29694,-0.00730103595433807,0.00156091943260842,-0.0103604380422506,-0.00424163386642557,2.9182186825692e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,0.00921858521747353,0.00197203041399915,0.00535340560603519,0.0130837648289119,2.95733765053803e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,-0.0140089279845792,0.00299836584446209,-0.0198857250397249,-0.00813213092943349,2.99326151763539e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,-0.0251113062491763,0.00537522173587895,-0.0356467408514991,-0.0145758716468536,3.00098438743033e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,-0.0131649446185691,0.0028181754035983,-0.0186885684096217,-0.00764132082751639,3.0065813437597e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,24938,-0.0284081087553122,0.00608198001366148,-0.0403287895820887,-0.0164874279285357,3.01497970476602e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,-0.0203722658752863,0.00436387229676332,-0.0289254555769424,-0.0118190761736302,3.05152389897022e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,29333,-0.0109979392410981,0.00236681926397512,-0.0156369049984893,-0.00635897348370685,3.38724680560339e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,29443,-0.0243435758242331,0.00523894611752405,-0.0346119102145802,-0.014075241433886,3.38820640262306e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,-0.0249712996617481,0.0053760969408471,-0.0355084496658084,-0.0144341496576878,3.42069960086912e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,24793,-0.0128933189801647,0.00277597395959847,-0.0183342279409777,-0.00745241001935166,3.42466986349761e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,24845,-0.00900028381808094,0.00194060482571314,-0.0128038692764787,-0.00519669835968319,3.53801670705562e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,24951,-0.0233510683064516,0.00504922311669583,-0.0332475456151754,-0.0134545909977278,3.77049726849015e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,28916,0.0123411431396956,0.00266905619541125,0.00710979299668956,0.0175724932827017,3.78429130954042e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,-0.0399558790259175,0.00864434324198999,-0.0568987917802178,-0.0230129662716171,3.81295480706111e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.018187306850255,0.00393515245994762,0.0104744080287577,0.0259002056717523,3.82127425241312e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,29694,-0.00852415174907814,0.00184672588900166,-0.0121437344915214,-0.0049045690066349,3.93186730489257e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,24752,-0.0138986548595548,0.00301124401671257,-0.0198006931323115,-0.0079966165867982,3.93955815408074e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,29694,-0.011023553875164,0.00239066371929526,-0.0157092547649827,-0.00633785298534524,4.02241565873891e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,29581,-0.0336152619057042,0.00729150431451818,-0.0479066103621598,-0.0193239134492485,4.03971484803976e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,24966,0.00666996620559661,0.00145030334590706,0.00382737164761878,0.00951256076357444,4.26577586983108e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,28870,-0.0158940998638005,0.00345680828191298,-0.02266944409635,-0.00911875563125111,4.28555429020326e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,-0.0189720691462152,0.00413860033990284,-0.0270837258124247,-0.0108604124800056,4.57660712270231e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,-0.0173568183277375,0.00378808358307321,-0.024781462150561,-0.00993217450491397,4.62950800113899e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,29581,0.0203964681869195,0.00446151006042089,0.0116519084684945,0.0291410279053444,4.85854097360883e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,-0.0216608194747227,0.0047400664014474,-0.0309513496215596,-0.0123702893278858,4.90710202733782e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,24867,-0.0183335624110423,0.0040153812406937,-0.026203709642802,-0.0104634151792826,4.99897804115763e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,24240,-0.0193169559190082,0.00423730449960656,-0.0276220727382371,-0.0110118390997794,5.17021379728238e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,29434,-0.022144883676101,0.00486262122137509,-0.0316756212699962,-0.0126141460822058,5.28201226239904e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,24938,0.0105197778717501,0.0023101318955456,0.00599191935648073,0.0150476363870195,5.29456637940494e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,-0.0156464240831809,0.00343996233957963,-0.0223887502687569,-0.0089040978976048,5.4315525393804e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,0.0189128725400248,0.00416092658604615,0.0107574564313744,0.0270682886486753,5.50597809395526e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.032809012747817,0.00722481268606604,-0.0469696456125064,-0.0186483798831275,5.61676510904807e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.0118811190596261,0.00261712763285676,0.00675154889922689,0.0170106892200254,5.6551493719859e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,29349,0.00661313082299093,0.00145762700091151,0.00375618190120436,0.00947007974477749,5.73090449606098e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,29786,-0.0274429362723109,0.00606777247044545,-0.039335770314384,-0.0155501022302379,6.12806389162808e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,-0.010477594914041,0.00232075034314807,-0.0150262655866112,-0.00592892424147074,6.36377854980938e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,24111,-0.0207756461305797,0.00461907074655297,-0.0298290247938236,-0.0117222674673359,6.89813742958988e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,-0.00864124208501426,0.00192492937281379,-0.0124141036557293,-0.00486838051429924,7.18478219878045e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,0.00636070659447641,0.00142044629788704,0.0035766318506178,0.00914478133833501,7.57042681486189e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,28722,-0.0280022351018193,0.00625665067927412,-0.0402652704331966,-0.0157391997704421,7.64915630099863e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,29434,-0.0105143306074165,0.00235153294798994,-0.0151233351854767,-0.00590532602935617,7.80481710656308e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,-0.0323335236783681,0.00723366386793098,-0.0465115048595128,-0.0181555424972234,7.85620127439837e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0102389099857145,0.0022907822202661,0.00574897683399292,0.014728843137436,7.87163299031211e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,-0.0133641545436317,0.00299119150599779,-0.0192268898953874,-0.00750141919187606,7.93642372769924e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,-0.0137352658073527,0.00307743325154565,-0.0197670349803822,-0.00770349663432325,8.10427239404376e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MB,Myoglobin,29820,-0.0161605682080427,0.00363033312083681,-0.0232760211248828,-0.00904511529120256,8.5566249925477e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,29566,-0.00920313674961322,0.00206807963453997,-0.0132565728333116,-0.00514970066591488,8.6148485405753e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,-0.0139225905818766,0.00312963311229608,-0.0200566714819769,-0.00778850968177628,8.6741962870808e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,24867,0.010956238960075,0.00246280965181098,0.00612913204252553,0.0157833458776246,8.67765785480191e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,24101,-0.012259448065101,0.00275835101640439,-0.0176658160572536,-0.00685308007294839,8.8495850359036e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,24240,-0.0188769094935093,0.00424955595190729,-0.0272060391592476,-0.0105477798277711,8.94835808402657e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,-0.0460595529092059,0.0103775221784405,-0.0663994963789494,-0.0257196094394625,9.09608804674814e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,28954,0.0127111423582686,0.00286684670949167,0.00709212280766497,0.0183301619088723,9.29093243724904e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",28774,-0.0166276973531293,0.00375196909556931,-0.0239815567804451,-0.00927383792581341,9.3827231852361e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,-0.0169682835939996,0.00384138791530633,-0.024497403908,-0.0094391632799992,1.00327329101207e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,24805,-0.020663438569839,0.00468052409045677,-0.0298372657871342,-0.0114896113525437,1.01544378933168e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,28931,-0.0347365332039354,0.00786918740758221,-0.0501601405227965,-0.0193129258850742,1.01729162636888e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,-0.0427398059823072,0.00969068858609683,-0.0617335556110569,-0.0237460563535574,1.0361431448778e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,-0.0156675763903932,0.00355255146005535,-0.0226305772521017,-0.00870457552868474,1.03634262523184e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,0.00693408168021813,0.00157280956718896,0.00385137492852777,0.0100167884319085,1.04417698997781e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,29581,0.00640550183487819,0.00145537363071396,0.00355296951867882,0.00925803415107756,1.07992414161178e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,-0.0078378446985369,0.0017848859269327,-0.011336221115325,-0.00433946828174881,1.1310217131515e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,-0.0203837571754758,0.00465232131691521,-0.0295023069566296,-0.011265207394322,1.18392794069496e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,29218,-0.020427311646617,0.00469072504787828,-0.0296211327404584,-0.0112334905527756,1.33623058559385e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,28774,-0.00920279921255892,0.00211506966944793,-0.0133483357646769,-0.00505726266044098,1.35946211369937e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.00726717436224109,0.00167391620247431,0.00398629860539145,0.0105480501190907,1.42038220640278e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,-0.0208413482267116,0.00480044505487364,-0.030250220534264,-0.0114324759191593,1.4205459498409e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,28774,-0.0134170508279506,0.00309095676427733,-0.0194753260859341,-0.00735877556996699,1.42485839853928e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,-0.0147106785139436,0.00339028889541893,-0.0213556447489647,-0.00806571227892244,1.43670370146172e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,0.0204457607772086,0.00471982077593796,0.0111949120563702,0.029696609498047,1.48412262533994e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,29329,-0.023434764523676,0.00541317104812171,-0.0340445797779946,-0.0128249492693575,1.50139731525341e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,24657,0.0089636823368916,0.00207163485137485,0.00490327802819689,0.0130240866455863,1.51842323513545e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,0.00866571243549954,0.00200670894316467,0.00473256290689679,0.0125988619641023,1.57813498556018e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,29163,-0.0190164314865001,0.00441223869128355,-0.0276644193214158,-0.0103684436515843,1.63842639590199e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,-0.0144518400571188,0.00335462583852798,-0.0210269067006336,-0.00787677341360398,1.653620762075e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,0.0118681865770999,0.00275691917270874,0.0064646249985908,0.0172717481556091,1.67737463265851e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,0.0118900531687659,0.00277105817988826,0.0064587791361849,0.0173213272013469,1.78604848464889e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0117478569403822,0.00274389503711791,0.00636982266763105,0.0171258912131333,1.86394083999255e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,24867,-0.0142887789286838,0.00333780327478964,-0.0208308733472715,-0.00774668451009613,1.86841943203209e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,-0.0101402433262762,0.00237109956710807,-0.014787598477808,-0.00549288817474439,1.90476176310416e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.00888193788281482,0.00207918299402848,0.00480673921451901,0.0129571365511106,1.94480943311952e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,24805,-0.0131936836338799,0.00309445962425789,-0.0192588244974253,-0.0071285427703344,2.01860625209856e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,-0.0199367466296253,0.00468273737015568,-0.0291149118751305,-0.0107585813841202,2.07361960879302e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.0149209323639898,0.00351222974041259,0.00803696207278115,0.0218049026551985,2.16085596639466e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00763563229427497,0.00179963865895339,0.00410834052272634,0.0111629240658236,2.215035511186e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,-0.0281348690000963,0.00663698475329083,-0.0411433591165464,-0.0151263788836463,2.25097426721779e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,-0.013972125189008,0.00329614099754447,-0.0204325615441952,-0.00751168883382085,2.25391672083634e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,28879,-0.012524824845726,0.00295712196437849,-0.0183207838959078,-0.00672886579554415,2.28772096364246e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,29218,-0.0281105167669071,0.00667048513250826,-0.0411846676266233,-0.0150363659071909,2.51457792945282e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,24922,0.0101275812789925,0.00240342595196226,0.00541686641314646,0.0148382961448385,2.51981606397583e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,0.00977352573576891,0.00232233329838036,0.0052217524709434,0.0143252990005944,2.57842576714154e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0117702891293764,0.00279682258381574,-0.0172520613936553,-0.00628851686509756,2.57895583297431e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,29218,-0.00995593484796229,0.00236757883307283,-0.014596389360785,-0.00531548033513953,2.61729399013636e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,24229,-0.0131916103238185,0.00314160653798724,-0.0193491591382735,-0.00703406150936351,2.69052060254486e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,28722,-0.0206387373553472,0.00492289650124046,-0.0302876144977785,-0.0109898602129159,2.7684853273114e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,24195,-0.0198544708939458,0.00473773561917977,-0.0291404327075381,-0.0105685090803534,2.79071271528501e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,-0.0292115151926843,0.00698070021911865,-0.0428936876221568,-0.0155293427632117,2.86483352308454e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,-0.0153897230092776,0.00369036009267444,-0.0226228287909195,-0.00815661722763566,3.05298349801885e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,24229,-0.0121645806985266,0.00292233420585666,-0.0178923557420057,-0.00643680565504756,3.15697094193624e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,-0.0132460591603463,0.00318328865109017,-0.019485304916483,-0.00700681340420953,3.17586620528771e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0175524646840918,0.00422161957060875,0.00927809032569866,0.025826839042485,3.22298484249263e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,-0.00668721838495186,0.00161207434230041,-0.00984688409586065,-0.00352755267404306,3.36036199061509e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,24195,-0.0376049820731035,0.00906935383033056,-0.0553809155805514,-0.0198290485656556,3.38925284630706e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,-0.00805651008919687,0.00194536535136257,-0.0118694261778675,-0.00424359400052624,3.46387884010534e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,-0.0153579317940461,0.00371711434043076,-0.0226434759012904,-0.00807238768680181,3.61321298971138e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,29349,0.0219367207098707,0.00532086803539255,0.0115078193605013,0.0323656220592401,3.75370724728826e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,-0.014142662827801,0.00343329750940369,-0.0208719259462323,-0.0074133997093698,3.81344436426547e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,29642,-0.0115845559587069,0.0028172875061946,-0.0171064394708483,-0.0060626724465655,3.93382040712302e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.0135368604047859,0.0032962649516507,-0.0199975397100212,-0.00707618109955048,4.02413648312985e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,29434,-0.0137199779613457,0.00334159763845915,-0.0202695093327256,-0.00717044658996578,4.03980921735284e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,29820,0.00555284410676702,0.00135359779812229,0.00289979242244732,0.00820589579108671,4.10175704959614e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,-0.00823388723806653,0.0020106841922147,-0.0121748282548073,-0.00429294622132571,4.23384582881936e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,-0.0111540335427491,0.00272881960476467,-0.0165025199680878,-0.00580554711741029,4.37199907153504e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.0248027950836629,0.0060690052910051,0.0129075447132929,0.0366980454540329,4.38530661150309e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,29218,-0.0146536340663021,0.00359829394877061,-0.0217062902058925,-0.00760097792671172,4.66570395971197e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,-0.0221192460755638,0.00543324122287706,-0.0327683988724028,-0.0114700932787247,4.69174846778957e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,28774,-0.00981735999235186,0.00241231169612542,-0.0145454909167577,-0.00508922906794603,4.72014558135909e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,0.0133192674653278,0.00328499872141686,0.00688066997135071,0.0197578649593048,5.03837977188861e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,-0.0054985051678461,0.00135638286889674,-0.0081570155908837,-0.0028399947448085,5.05256123218921e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,24793,-0.0118369704687347,0.00292094714031637,-0.0175620268637548,-0.00611191407371466,5.08402121849643e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,-0.0203168851141857,0.00501487212234685,-0.0301460344739855,-0.0104877357543858,5.10827018996609e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,-0.0103792115024227,0.002564659966273,-0.0154059450363178,-0.00535247796852761,5.20324574390977e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,24229,-0.0161197072632446,0.00398499770597071,-0.0239303027669472,-0.008309111759542,5.24632475776125e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,24016,-0.0102515482333768,0.00253522964515629,-0.0152205983378831,-0.00528249812887047,5.27926958793633e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,-0.0198036590032937,0.00489794821124922,-0.0294036374973421,-0.0102036805092452,5.28477085177196e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,24240,-0.0253705453316607,0.00627602456252883,-0.0376715534742172,-0.0130695371891042,5.30579431932082e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,29443,-0.0108625197927739,0.00268882571930203,-0.0161326182026059,-0.00559242138294195,5.36153592090409e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,-0.010129112971039,0.002507205167389,-0.0150432350991215,-0.00521499084295659,5.3615664737671e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,-0.0291269803975262,0.00721230036345141,-0.0432630891098909,-0.0149908716851614,5.39270618256766e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.00998735081275371,0.00248534600861766,0.0051160726358631,0.0148586289896443,5.87166391916565e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,24805,0.0191619455593674,0.00476848735159556,0.0098157103502401,0.0285081807684947,5.87542340592405e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,29478,-0.0107965298832784,0.00268969983537733,-0.0160683415606179,-0.00552471820593881,5.98389172259036e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,24951,-0.00729723591674573,0.00181944312784425,-0.0108633444473205,-0.00373112738617099,6.07159963953627e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,0.00378377173235124,0.000943839539054051,0.0019338462358053,0.00563369722889718,6.11791191992039e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,24240,-0.00845819186351374,0.00211070814491226,-0.0125951798275418,-0.00432120389948572,6.16064360961344e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.0117442058945879,0.00293250339343648,0.00599649924345243,0.0174919125457234,6.22399473311699e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,24966,-0.00514215573358668,0.00128482580686953,-0.00766041431505095,-0.00262389715212241,6.29320901418547e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,28931,-0.0226553236897802,0.00566365858599574,-0.0337560945183319,-0.0115545528612286,6.34673444611909e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,29820,0.00657513267142477,0.00164486605963568,0.00335119519453885,0.0097990701483107,6.4205177914182e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,24195,-0.0124673810612504,0.00311912085915652,-0.0185808579451972,-0.00635390417730363,6.43183415876817e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSPN,Persephin,29434,-0.0259655989265343,0.00650147543705763,-0.0387084907831673,-0.0132227070699014,6.51804228571728e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,29581,-0.0117253933820918,0.00293768947391875,-0.0174832647509726,-0.00596752201321109,6.58522951438693e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0116080768462663,0.00291523375167104,0.00589421869299103,0.0173219349995415,6.85707097452572e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,-0.0157554364387035,0.00395774308432341,-0.0235126128839774,-0.00799825999342967,6.88153783054132e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,29545,0.00711001246079706,0.00178818328141577,0.00360517322922214,0.010614851692372,7.02186164888454e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.010742401807142,0.00270236938219397,0.00544575781804181,0.0160390457962422,7.04947130014619e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,29566,0.0103560399727766,0.00260702550751312,0.00524626997805091,0.0154658099675024,7.13331546846879e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,-0.00968133290463394,0.00244123131556942,-0.01446614628315,-0.00489651952611789,7.33685476045984e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,-0.0234399071542878,0.0059166752710493,-0.0350365906855444,-0.0118432236230312,7.46022744117159e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,24822,-0.0267069960739232,0.00674150712004071,-0.039920350029203,-0.0134936421186434,7.46645977785106e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,29349,-0.0119790894430937,0.00302447132995695,-0.0179070532498094,-0.0060511256363781,7.48999823939076e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,24381,-0.0184631866265428,0.00466151572164069,-0.0275997574409586,-0.00932661581212708,7.49211993518265e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.0109601821629896,0.00276866321820308,-0.0163867620706677,-0.00553360225531158,7.55893091767131e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,-0.0325041351095353,0.00822370585426889,-0.0486225985839023,-0.0163856716351682,7.75619725535732e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,29349,0.00776890754889142,0.00196626068813049,0.00391503660015566,0.0116227784976272,7.79723212521807e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,29349,-0.00892179118265261,0.00225808052473571,-0.0133476290111346,-0.00449595335417063,7.79907756443997e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,-0.0173038966615509,0.00438097071962789,-0.0258905992720215,-0.00871719405108022,7.84368588370971e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,28797,-0.0146258383685148,0.00370561248717541,-0.0218888388433786,-0.007362837893651,7.9343630860691e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,28774,-0.0123815346900362,0.00314091636161697,-0.0185377307588055,-0.00622533862126694,8.09915627735383e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,-0.013382035514868,0.00339798961262152,-0.0200420951556062,-0.00672197587412983,8.23123020240389e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,29478,0.0104596403039332,0.00265646662094996,0.00525296572687125,0.0156663148809951,8.25497048014802e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPARC,SPARC,29566,-0.0190926443020503,0.00485917395515719,-0.0286166252541584,-0.0095686633499422,8.54243413388417e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,-0.0198923873337676,0.00506582450748837,-0.0298214033684448,-0.00996337129909041,8.62859127626825e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,-0.0139417371095056,0.00355142655516268,-0.0209025331576245,-0.00698094106138674,8.66825266042671e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,-0.0148299705221348,0.00378101189462518,-0.0222407538356002,-0.00741918720866946,8.79383771795008e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,28774,-0.0168000187278988,0.00428392452224373,-0.0251965107914965,-0.00840352666430111,8.81515648167839e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.00803650305988478,0.00205217541449331,0.0040142392474779,0.0120587668722917,9.02434171914647e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,-0.0247874611512989,0.00633529885191389,-0.0372046469010501,-0.0123702754015476,9.15192406841714e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0120161897492497,0.00307160932450897,0.00599583547321212,0.0180365440252873,9.17730437425515e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,0.00858726780201445,0.00219990068836022,0.00427546245282842,0.0128990731512005,9.50304354748858e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,29443,-0.0197472788723477,0.00506416885092442,-0.0296730498201595,-0.0098215079245358,9.66406627492752e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,29349,-0.00881562879774022,0.00226105839980763,-0.0132473032613632,-0.00438395433411726,9.68477248868476e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,24938,0.0239097098276364,0.00613584435901819,0.0118834548839608,0.0359359647713121,9.77562491583272e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,29218,0.00327401982969049,0.000841640478429426,0.00162440449196881,0.00492363516741216,0.000100447444748695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,-0.0125511759965446,0.0032315013254465,-0.0188849185944198,-0.0062174333986695,0.000102971335172292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,29379,-0.0277187275355385,0.00713957441155593,-0.0417122933821881,-0.0137251616888889,0.000103654148249103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,29434,-0.0224631715387564,0.00578628640056998,-0.0338042928838735,-0.0111220501936392,0.000103767378696875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,29478,-0.00653837811568236,0.00168454927309466,-0.00984009469094788,-0.00323666154041683,0.000104090998316674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,-0.00621421451724465,0.00160145483683729,-0.00935306599744574,-0.00307536303704356,0.000104528077648398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,-0.0204446629187272,0.00527002275945927,-0.0307739075272674,-0.0101154183101871,0.000104973100953375
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,24938,-0.0125674271674491,0.00324088519619133,-0.0189195621519841,-0.00621529218291412,0.000105686109976716
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,29725,0.00668205427231628,0.0017239359270368,0.00330313985532416,0.0100609686893084,0.000106395868947967
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,24240,-0.0206240023672535,0.00533288665754526,-0.0310764602160422,-0.0101715445184648,0.000110323534469903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,29566,-0.0183376567343457,0.00474532245007619,-0.027638488736495,-0.00903682473219634,0.000111616521634136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,-0.0158944772200614,0.00411339780178429,-0.0239567369115586,-0.00783221752856419,0.000111794942442075
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,29137,0.0167382115670968,0.0043323654920204,0.00824677520273687,0.0252296479314568,0.000112003448732879
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,-0.0102390984174369,0.00265222291814696,-0.0154374553370049,-0.00504074149786883,0.000113369039556389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,-0.0298919636553657,0.00775739453507344,-0.0450964569441096,-0.0146874703666217,0.000116759431045762
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,28774,-0.0138859917856345,0.00360491051202637,-0.0209516163892061,-0.00682036718206278,0.000117427421236913
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,-0.0177796883348837,0.00461680252095922,-0.0268286212759638,-0.00873075539380362,0.000117896643817932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,24037,-0.0147093574912351,0.00382163051259114,-0.0221997532959138,-0.00721896168655651,0.000118920435384475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,-0.00975652391255321,0.00253665209055408,-0.0147283620100392,-0.0047846858150672,0.000120262346258081
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,-0.0128409324868762,0.00333898239375632,-0.0193853379786386,-0.00629652699511383,0.000120436711277247
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0164526969875278,0.0042846018567816,-0.0248505166268198,-0.0080548773482359,0.000123309049888567
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.0084486386652777,0.00220230145908958,0.00413212780546212,0.0127651495250933,0.000125178792421639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,24793,-0.0136713430207721,0.00356689162066679,-0.020662450597279,-0.00668023544426515,0.000126982538579603
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,-0.0273021875074305,0.00712367610660323,-0.0412645926763728,-0.0133397823384881,0.000127117212887094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,29169,-0.013895387349522,0.00362725881222774,-0.0210048146214884,-0.00678596007755565,0.000127982721233461
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-0.00751804730436819,0.00196525611599713,-0.0113699492917226,-0.00366614531701382,0.00013083753910685
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLPS,Colipase,29400,0.0187387985913815,0.00490088965166124,0.00913305487412543,0.0283445423086375,0.000131815074684105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,28931,0.0090218340170849,0.00236279468052553,0.00439075644325485,0.0136529115909149,0.000134660480833322
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,-0.0166875501513825,0.00437044026684571,-0.0252536130744,-0.00812148722836488,0.000134668756142025
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,24349,0.00974340787535105,0.00255187717523197,0.00474172861189638,0.0147450871388057,0.000134798386944656
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,-0.0100411882853828,0.0026300951962287,-0.015196174869991,-0.00488620170077452,0.000134972370290427
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,24229,-0.011740175639813,0.00307589724468812,-0.0177689342394017,-0.0057114170402243,0.000135513712077747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,-0.0054017182165542,0.001416169354433,-0.00817741015124289,-0.00262602628186552,0.000136836353357118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,24922,0.00782866174489294,0.00205441729066383,0.00380200385519183,0.0118553196345941,0.000138935969400317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,-0.0105685226254265,0.00278033749801771,-0.0160179841215412,-0.00511906112931181,0.000144361013183685
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LXN,Latexin,29117,0.0176841154237397,0.00465243254839308,0.00856534762888928,0.0268028832185901,0.0001443794368555
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,0.0126363864580219,0.00332645479469852,0.00611653506041283,0.019156237855631,0.000145717692964155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,28931,-0.0216121289074592,0.00569013068818849,-0.0327647850563086,-0.0104594727586098,0.000146061695299075
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,29123,0.00675458458015958,0.0017809744330769,0.00326387469132886,0.0102452944689903,0.000149358731394774
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,-0.0147330833682513,0.00388644774420302,-0.0223505209468892,-0.00711564578961338,0.000150469224918203
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,-0.0146909267777348,0.00388515709655412,-0.0223058346869809,-0.00707601886848875,0.000156389038641474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,29786,-0.00909670302933879,0.00240685130974026,-0.0138141315964297,-0.00437927446224789,0.000157447685838748
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,29820,0.00687023956314533,0.00182224546476118,0.00329863845221341,0.0104418406740773,0.000163427960909396
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,29199,0.0332450219463628,0.00881965864405787,0.0159584910040094,0.0505315528887162,0.000163947666965319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,29434,-0.0160120916032737,0.00424805408622072,-0.0243382776122663,-0.00768590559428104,0.000164040950857017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,29434,0.0101190396480468,0.00268784251607605,0.00485086831653774,0.0153872109795558,0.000167043710910014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,24240,-0.0139300973748347,0.00370322395990427,-0.0211884163362471,-0.00667177841342237,0.000169218084121364
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,24805,-0.014798128011436,0.00393657900222461,-0.0225138228557962,-0.00708243316707575,0.000170893657895719
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,-0.00773592985151426,0.00205843186977686,-0.0117704563162769,-0.00370140338675162,0.000171495901014061
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.00852955182878024,0.00226979483765035,0.00408075394698555,0.0129783497105749,0.000171710083267142
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,29491,-0.0275011866424187,0.00732635506089526,-0.0418608425617735,-0.013141530723064,0.000174554173480206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,-0.0222684221700036,0.00594735661541229,-0.0339252411362117,-0.0106116032037955,0.000181346478351919
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,-0.0166200146751293,0.00445089511750427,-0.0253437691054377,-0.00789626024482091,0.000188821358226063
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,24101,-0.0165778693772696,0.0044403837103102,-0.0252810214494776,-0.0078747173050616,0.000189323070134045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,-0.0229002449139401,0.00613553298553008,-0.034925889565579,-0.0108746002623011,0.000190088798163272
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.0106132937758206,0.00284563292474755,0.00503585324331542,0.0161907343083258,0.000192079951016519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,24229,0.00439405498518383,0.00117821055049695,0.00208476230620982,0.00670334766415785,0.000192350132140458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,29478,0.0299554476928376,0.00808711602941835,0.0141047002751776,0.0458061951104975,0.000212533946599246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,29434,0.0228214239585116,0.00616410647532936,0.0107397752668661,0.0349030726501572,0.000214036571031522
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,29349,-0.015187846908174,0.00410551247235136,-0.0232346513539826,-0.00714104246236529,0.000216522072298227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,28774,-0.010928622632752,0.00296388400188661,-0.0167378352764497,-0.00511940998905419,0.00022709504765042
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,24445,-0.0135306454942704,0.00366956760611663,-0.020722998002259,-0.00633829298628184,0.000227173545654505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,-0.022047370188065,0.00598728323711809,-0.0337824453328165,-0.0103122950433136,0.00023156984265471
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.0151625965448391,0.0041196942691839,0.00708799577723865,0.0232371973124396,0.000233179806955585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,28604,0.0177874725110716,0.00483666455413885,0.00830760998495946,0.0272673350371837,0.000235840449487732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,-0.021516980383195,0.00586404637049364,-0.0330105112693625,-0.0100234494970274,0.000243648621254314
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,-0.0183449243792566,0.00500129773769421,-0.0281474679451373,-0.00854238081337596,0.000244854639631397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.00919466939629199,0.00251102478728094,0.00427306081322134,0.0141162779793626,0.0002510456696736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,-0.00661539881069593,0.00180974091802173,-0.0101624910100185,-0.00306830661137334,0.000257190751860985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-0.0147564621991634,0.00403989463340879,-0.0226746556806447,-0.00683826871768221,0.000259966258068895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,-0.0098815098299702,0.00270623191932834,-0.0151857243918537,-0.00457729526808665,0.000261271740235286
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,-0.00799012930824665,0.00218874451659472,-0.0122800685607723,-0.00370019005572101,0.000262136584748224
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,-0.0247604677739988,0.00678602145029359,-0.0380610698165743,-0.0114598657314234,0.000263989123773887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,-0.0141876313080699,0.00389869111150819,-0.021829065886626,-0.00654619672951386,0.000274182434481289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,-0.0145894560963978,0.00401051064458986,-0.022450056959794,-0.00672885523300169,0.000275542322305562
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,24951,-0.0119273104026771,0.0032806297398846,-0.018357344692851,-0.00549727611250332,0.000277809232724246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,24111,-0.02000711521039,0.00550853107395571,-0.0308038361153431,-0.00921039430543676,0.000281790604743728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,-0.0158469156415784,0.00436514667377754,-0.0244026031221824,-0.00729122816097441,0.000283647012575315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,24101,0.0227488428516829,0.00627573768052365,0.0104483969978566,0.0350492887055093,0.000289682769858609
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,-0.0147750277445567,0.0040761296179697,-0.0227642417957774,-0.00678581369333612,0.000289701852721133
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,-0.0116672809162949,0.00322215353738431,-0.0179827018495681,-0.00535185998302162,0.000294098846162427
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,24938,0.0118910716590279,0.00328588156616341,0.00545074378934761,0.0183313995287082,0.000296514699210841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.0184291025014095,0.0050999500529384,-0.0284250046051688,-0.00843320039765025,0.000302495829101144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,-0.00852005166103634,0.00236195363583188,-0.0131494807872668,-0.00389062253480586,0.000310121239285359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,28722,-0.015372897354444,0.00426496076340038,-0.0237322204507087,-0.00701357425817921,0.000313327064271151
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,29386,-0.0169138952719219,0.00469685007731612,-0.0261197214234615,-0.00770806912038226,0.000317378024689663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,23801,0.00978230444900828,0.00271853009484927,0.00445398546310371,0.0151106234349128,0.000320855249361583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.00680582824480204,0.00189144124643884,0.00309860340178191,0.0105130530878222,0.00032092147388088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0107709276180903,0.00299775226652571,0.00489533317569992,0.0166465220604807,0.000327520223908566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,29157,0.00700233243573543,0.00194932320615083,0.0031816589516798,0.0108230059197911,0.00032845464014088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,0.00793421768261593,0.00221321154337396,0.00359632305760297,0.0122721123076289,0.000337826903379179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,24111,0.00892264663703258,0.00249170978512152,0.0040388954581944,0.0138063978158707,0.000343042445434059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,-0.0102532378289691,0.00286470118506233,-0.0158680521516912,-0.00463842350624689,0.000345370790381102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,0.0118999961769562,0.00332536907126106,0.00538227279728452,0.0184177195566279,0.000346185012257236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,-0.0197618736704517,0.00552258105289385,-0.0305861325341237,-0.00893761480677977,0.000346289946155433
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,24920,-0.0091394287483022,0.00255411459675211,-0.0141454933579363,-0.00413336413866807,0.000346471701312969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,29328,-0.0105950965354157,0.002962926073608,-0.0164024316396874,-0.00478776143114406,0.000349600275827551
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,29331,-0.00708537045252135,0.00198168270735494,-0.010969468558937,-0.00320127234610566,0.00035021293467604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,24111,0.0137695136685567,0.0038555308991002,0.00621267310632029,0.0213263542307931,0.000355815197649475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,-0.00670588284962955,0.00187978918393805,-0.0103902696501481,-0.00302149604911098,0.000361165295461829
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,24229,-0.0189825899089872,0.00533264467835527,-0.0294345734785636,-0.00853060633941092,0.000371996170786856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,-0.0106952497512807,0.00300459734589166,-0.0165842605492284,-0.00480623895333307,0.000372091954220776
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,24445,-0.00837554616915327,0.00235505300468023,-0.0129914500583265,-0.00375964227998002,0.000376660707492457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,29349,-0.0220702938473899,0.006213111308069,-0.0342479920112051,-0.00989259568357465,0.000382604562480452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,-0.0157022680666212,0.00442300071510558,-0.0243713494682282,-0.00703318666501431,0.000385641881009312
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,-0.0067127887372657,0.00189143899098583,-0.0104200091595979,-0.00300556831493347,0.000387241458812397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,24111,0.0177885077903238,0.0050178253585544,0.0079535700875572,0.0276234454930905,0.00039326258252199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,-0.0127567370507,0.00360053591839432,-0.0198137874507528,-0.0056996866506471,0.000396313901621603
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,-0.0222257358568882,0.00627716640860304,-0.0345289820177502,-0.00992248969602627,0.000399774193151267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,29544,-0.00728781719811236,0.00205985146961913,-0.0113251260785659,-0.00325050831765885,0.000403742054163423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,-0.0148437059688947,0.00420771787980164,-0.0230908330133059,-0.00659657892448349,0.000419890257008473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,-0.019749186021197,0.00560207461173868,-0.0307292522602048,-0.00876911978218924,0.000423729096898114
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,28591,-0.0205679860216443,0.00583778315104198,-0.0320100409976866,-0.00912593104560206,0.000426949836125368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,28671,-0.0115651742560124,0.00328390685210409,-0.0180016316861365,-0.00512871682588843,0.000429337301227869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIT,Vitrin,24922,0.00919159334579038,0.00261065146927927,0.00407471646600301,0.0143084702255778,0.000431008242102254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,29443,-0.0218602599812684,0.00621463145354258,-0.0340409376302118,-0.00967958233232489,0.000436210882664971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,24966,0.00472960714991888,0.00134595187031617,0.00209154148409919,0.00736767281573858,0.000442277927709134
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,24922,-0.0243077746678479,0.00692212523868024,-0.0378751401356612,-0.0107404092000347,0.000446196095094014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.00706723609303387,0.00201432020242513,0.00311916849628063,0.0110153036897871,0.000451310429437155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.016957068179221,0.00484442289342771,-0.0264521370503393,-0.00746199930810269,0.000465498476196144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,24111,0.00766581923466826,0.00219518811905734,0.00336325052131588,0.0119683879480206,0.000480094705876247
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.0171882958327967,0.00492274373539455,-0.02683687355417,-0.00753971811142337,0.000480819779206255
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,29434,-0.0162231756106311,0.00466510622496513,-0.0253667838115628,-0.00707956740969947,0.000506734973096221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,24445,0.00819891237500931,0.00235926012120873,0.00357476253744019,0.0128230622125784,0.000511348711052676
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,0.00628367392368654,0.00181090843501379,0.00273429339105951,0.00983305445631357,0.000521529003042569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,-0.0172512682500754,0.00497178030724319,-0.026995957652272,-0.00750657884787873,0.000521674434315693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,29443,-0.00641642973274222,0.0018500529556252,-0.0100425335257676,-0.00279032593971684,0.000524625718187278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,24845,-0.0159163565790181,0.004606088394264,-0.0249442898317756,-0.00688842332626069,0.000550182928704932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,24229,0.00680369778324584,0.00196915069514255,0.00294416242076644,0.0106632331457252,0.000550942476272202
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,24101,-0.0130932132949045,0.00379119048597023,-0.0205239466474062,-0.00566247994240288,0.000554130886623549
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAT,Catalase,24587,-0.0128336153830836,0.00371858062483867,-0.0201220334077674,-0.0055451973583998,0.000559009981180951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,-0.0121643507568414,0.00352877629218189,-0.0190807522895179,-0.00524794922416491,0.000567245859094534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,29218,-0.0192005633598417,0.00558393835181837,-0.0301450825294057,-0.00825604419027765,0.000585688274041108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,-0.00498889333771352,0.0014525279867421,-0.00783584819172804,-0.002141938483699,0.000594188135208929
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,28867,-0.0141632546224857,0.00413644020775788,-0.0222706774296912,-0.00605583181528028,0.00061787792488122
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,24833,0.00613347376388884,0.00179269415934435,0.00261979321157391,0.00964715431620376,0.000624064023783998
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,24343,-0.0136776904563324,0.00400407646876755,-0.0215256803351168,-0.00582970057754799,0.000636657792992138
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,28797,0.0192726715783602,0.0056465189186602,0.00820549449778617,0.0303398486589342,0.000642943188702922
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,-0.00946238045745109,0.00277255779850684,-0.0148965937425245,-0.00402816717237767,0.0006438527645897
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,-0.00930206474682191,0.00273293864513123,-0.0146586244912791,-0.00394550500236469,0.000665880729022477
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00643235532284398,0.00189863234631176,0.00271103592407292,0.010153674721615,0.000705238898369598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,28774,-0.0158888441208384,0.00470587582572561,-0.0251123607392606,-0.00666532750241622,0.000735425196018835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,0.0101001900201848,0.00299492291559493,0.00423014110561869,0.0159702389347508,0.000746030333426485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,24538,-0.00768386665694559,0.00227843594883088,-0.0121496011166541,-0.00321813219723707,0.000746230602180409
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,29566,-0.0166138476743139,0.00493320417133728,-0.026282927850135,-0.00694476749849282,0.000758782149475427
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,0.00534556152794754,0.00158947562984129,0.00223018929345861,0.00846093376243648,0.000771716837555971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,29786,0.00972811277664089,0.00289268801122061,0.00405844427464851,0.0153977812786333,0.00077197199326168
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.0163323798507756,0.00486579689474767,-0.025869341764481,-0.00679541793707015,0.000790345716256742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.0065456969202171,0.00195264657406462,-0.0103728842053837,-0.00271850963505045,0.000802673605964149
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,28774,-0.0119358290834609,0.00356154789964225,-0.0189164629667597,-0.0049551952001621,0.00080535546561952
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,24240,-0.00992915452028326,0.00296315358637934,-0.0157369355495868,-0.00412137349097975,0.000806799873854596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,24111,-0.00921934836663362,0.00275386479304478,-0.0146169233610014,-0.00382177337226584,0.000815847411039551
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,29443,-0.0120627950218314,0.0036052445790273,-0.0191290743967249,-0.00499651564693785,0.000821179420603527
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,24793,-0.00752046598855691,0.00225009788162734,-0.0119306578365465,-0.00311027414056732,0.000832149418550983
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,24195,-0.0187317207954469,0.00560782873701469,-0.0297230651199957,-0.00774037647089808,0.000838204158726536
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,29725,-0.00654443772627939,0.00196181627294523,-0.010389597621252,-0.00269927783130674,0.00085125581558554
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,24240,-0.0119320564559692,0.00358592478907571,-0.0189604690425576,-0.0049036438693808,0.000877689299696309
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,-0.0338173967827645,0.0101646062358312,-0.0537400250049937,-0.0138947685605354,0.000879216904912716
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,24922,-0.0123413968596312,0.00370995764334288,-0.0196129138405832,-0.00506987987867912,0.000880522309755487
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,29453,-0.0177047124483962,0.00532561660177106,-0.0281429209878675,-0.00726650390892497,0.000887032688183102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,24845,-0.0163330333679868,0.00491590176406899,-0.0259682008255621,-0.0066978659104116,0.000893467800434566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,28931,0.0108382716466069,0.00326426547673274,0.00444031131221075,0.0172362319810031,0.000900388069575037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,0.0103155686704608,0.00311473172061189,0.00421069449806145,0.0164204428428601,0.000927879528694159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,0.0107440286365635,0.00324457993692417,0.00438465196019214,0.0171034053129349,0.000929496663621097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,24706,0.0165403846590485,0.00499778957122996,0.00674471709943773,0.0263360522186592,0.000935831630668781
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,24845,-0.0313136667956341,0.00946400514196336,-0.0498631168738823,-0.0127642167173859,0.000938594991637205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,-0.0245270677321075,0.00742377241358299,-0.0390776616627301,-0.00997647380148483,0.000954998956075866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,-0.00916979307474982,0.00277654220205993,-0.0146118157907873,-0.00372777035871236,0.000959303079277687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,-0.0090727334185954,0.00274980527322479,-0.014462351754116,-0.00368311508307481,0.000970033424175342
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,28774,0.0106460112134446,0.00323120155479286,0.00431285616605061,0.0169791662608386,0.000986272635904266
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERVV_1,,24111,0.0105718999955221,0.00320976876741213,0.0042807532113943,0.0168630467796499,0.000990331027067738
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,0.0106417651816235,0.00323116462214592,0.00430868252221755,0.0169748478410295,0.000990951260310133
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,0.0144056646660795,0.00437798910403444,0.00582480602217198,0.022986523309987,0.00100161407125605
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,28797,-0.0099197059353793,0.00301726871020418,-0.0158335526073795,-0.0040058592633791,0.00101150477705873
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,29491,-0.0146824536610686,0.00446630402481404,-0.0234364095497041,-0.00592849777243309,0.00101241322497627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,-0.0668980351043087,0.0204291203156089,-0.106939110922902,-0.0268569592857153,0.00105918441628568
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,28797,0.0196727459146335,0.00601335070861159,0.00788657852575477,0.0314589133035122,0.00107100092721909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,24195,-0.0111106966857728,0.0034064172136464,-0.0177872744245197,-0.00443411894702583,0.00110901305224395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,28751,-0.0195603750092246,0.00600531921388685,-0.0313308006684428,-0.00778994935000638,0.00112657533849066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0120870866152444,0.0037171426070588,0.00480148710540915,0.0193726861250797,0.00114843129978439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,-0.01278549823628,0.00393336057713564,-0.0204948849674658,-0.00507611150509412,0.00115323302753927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,24951,-0.0143939650169009,0.00442933394783637,-0.0230754595546601,-0.00571247047914158,0.00115683671041691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,-0.0141336821748096,0.0043512093431429,-0.0226620524873697,-0.00560531186224953,0.00116258812725631
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,-0.0151644133853041,0.00468238741863379,-0.0243418927258263,-0.00598693404478187,0.00120272554400487
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,28931,-0.0126364921368994,0.00390545879126492,-0.0202911913677787,-0.00498179290602021,0.00121524946488829
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,0.00975728711844284,0.00301569145837864,0.0038465318600207,0.015668042376865,0.00121590438854328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,-0.00959508957574132,0.00296659973318314,-0.0154096250527803,-0.00378055409870235,0.00122044716983332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,28774,0.0100247522603018,0.00310060310211719,0.00394757018015212,0.0161019343404515,0.00122566097395459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,28931,-0.0177742931868285,0.00549851527516187,-0.0285513831261458,-0.00699720324751123,0.00122822826200024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,24732,-0.0104289774555465,0.0032274440222926,-0.01675476773924,-0.00410318717185305,0.00123371415148678
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,28277,-0.00515923721514058,0.00159684022978327,-0.0082890440655158,-0.00202943036476536,0.00123540628746977
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALLD,Palladin,24229,0.00895331702620055,0.00277347142176922,0.00351731303953287,0.0143893210128682,0.00124738222579456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,0.0089887442337104,0.00278534631023295,0.00352946546565382,0.014448023001767,0.00125189840432252
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,24101,0.00630158895417265,0.00195469740256637,0.00247038204514255,0.0101327958632027,0.0012666214839078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,24867,-0.0139177402289512,0.00432445914858196,-0.0223936801601718,-0.00544180029773053,0.00129083559686531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,-0.00721765387656811,0.00224297091340801,-0.0116138768668478,-0.00282143088628841,0.00129303096672157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,-0.00893561406458773,0.00277690143323833,-0.0143783408737349,-0.0034928872554406,0.00129326730798613
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,0.00571082037764881,0.00177733941547656,0.00222723512331474,0.00919440563198287,0.00131465224780008
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,29454,0.00516946534243635,0.00160956795339201,0.002014712153788,0.0083242185310847,0.00132089306912503
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,24845,-0.0151264094698994,0.00470986833002091,-0.0243577513967404,-0.00589506754305843,0.00132146991250823
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,-0.0167895696135477,0.00523564343228131,-0.0270514307408191,-0.00652770848627634,0.00134374525526766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,29736,-0.00613083203168073,0.00191246646174448,-0.0098792662966999,-0.00238239776666155,0.00134867399082837
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,29434,-0.0147535833769597,0.00460577161278478,-0.0237808957380178,-0.00572627101590149,0.00136015736091003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,-0.0204334568700273,0.00638590903751944,-0.0329498385835654,-0.00791707515648916,0.00137713187789491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00693628158823356,0.00216950200624254,0.00268405765599817,0.0111885055204689,0.00138929180194276
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,29349,-0.0121822118399335,0.00381508411563766,-0.0196597767065833,-0.00470464697328369,0.00140868646254077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,-0.00935078329463365,0.00292986938765985,-0.015093327294447,-0.00360823929482034,0.00141699075498576
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C3,Complement C3,23779,-0.0103286852471807,0.0032369105589229,-0.0166730299426696,-0.00398434055169179,0.00142010530540182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,-0.00702537554853457,0.00220331406843537,-0.0113438711226679,-0.00270687997440124,0.00143136370795789
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,0.0130672321566183,0.00410212746996725,0.00502706231548245,0.0211074019977541,0.00144699798069394
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00722074130323684,0.00227052696391322,0.00277050845396693,0.0116709741525068,0.00147357182294573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,24195,-0.00925010484955041,0.0029108202040686,-0.0149553124495249,-0.00354489724957596,0.00148566094219603
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.0106070945564554,0.00333864335619372,-0.017150835534595,-0.00406335357831566,0.00148959169940285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,-0.00777981063634981,0.00244938137817625,-0.0125805981375753,-0.00297902313512435,0.0014935419885337
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,24016,0.00773883626016945,0.00243783915040365,0.0029606715253783,0.0125170009949606,0.00150302255594028
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,-0.0148178130937484,0.00467477278417109,-0.0239803677507238,-0.00565525843677308,0.00152731578975206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,-0.00850641893034594,0.00269384551482409,-0.0137863561394011,-0.00322648172129073,0.00159167442502031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,-0.0168088085162555,0.00532490200116026,-0.0272456164385296,-0.00637200059398141,0.00159794597077407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,-0.0179248532116501,0.00569066250368115,-0.0290785517188651,-0.00677115470443501,0.00163504968216463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,29786,-0.0107947618496338,0.00342997193144754,-0.017517506835271,-0.00407201686399666,0.00165012227985748
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,24381,-0.016135424750386,0.0051281441641107,-0.0261865873120429,-0.00608426218872898,0.00165467138085593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,-0.0108500459429368,0.00345230428016599,-0.0176165623320621,-0.00408352955381143,0.00167513980741211
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.00889769998741707,0.0028326048660932,0.00334579444987441,0.0144496055249597,0.00168470945548845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,24240,-0.00650339915550758,0.00207166332357664,-0.0105638592697178,-0.00244293904129737,0.0016960375020188
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,28774,-0.00728089529611056,0.00232327358258394,-0.0118345115179751,-0.00272727907424604,0.00172675957992731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,29433,-0.00806262678002186,0.00257415408682692,-0.0131079687902026,-0.00301728476984109,0.00173703599375662
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,0.00818867425721823,0.0026180763340567,0.00305724464246711,0.0133201038719694,0.0017636290437356
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,24016,-0.0121861683882152,0.00389644947915601,-0.019823209367361,-0.00454912740906942,0.0017650703586602
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,0.0071938654727484,0.002305637994693,0.00267481500315013,0.0117129159423467,0.00180991275751747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,29536,-0.0123588793022036,0.00396412762205807,-0.0201285694414374,-0.00458918916296978,0.00182456000733972
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,28669,0.019425542209992,0.00623097019006784,0.00721284063745898,0.0316382437825249,0.00182523442490856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.011381646056897,0.00365116553223595,0.00422536161371452,0.0185379305000794,0.00182752866068958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.00739448980344439,0.00237441484371236,-0.0120483428971206,-0.00274063670976816,0.00184631575673163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,24297,-0.0140991677422845,0.00455533280755217,-0.0230276200450867,-0.00517071543948221,0.00196976493519798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,0.00650614673891285,0.00210284547392962,0.0023845696100108,0.0106277238678149,0.00197722458000355
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,24966,-0.00701381296163183,0.00227173129513279,-0.0114664063000921,-0.00256121962317156,0.00202116208558988
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,28628,-0.0238958775607236,0.00775043921372225,-0.0390867384196192,-0.00870501670182798,0.00205006871477091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,-0.0119947969544941,0.00389612246905519,-0.0196311969938422,-0.00435839691514589,0.00208173410370635
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,24101,0.0204385261084848,0.00663920794537519,0.00742567853554945,0.0334513736814202,0.00208308348195258
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,-0.00754280475802304,0.00245963277245905,-0.0123636849920428,-0.0027219245240033,0.00216678270450095
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,-0.018492357243527,0.00604043990509149,-0.0303316194575063,-0.00665309502954766,0.00220526930929617
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,24111,-0.0261205768502423,0.00853780077920195,-0.0428546663774781,-0.00938648732300648,0.0022202181846095
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,29694,-0.013409331374756,0.00438389588393566,-0.0220017673072699,-0.00481689544224214,0.00222445319474532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,-0.00570040871472903,0.00186687878639646,-0.0093594911360661,-0.00204132629339196,0.002264697343525
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,29536,-0.00632371038244605,0.00207346972377628,-0.0103877110410476,-0.00225970972384455,0.00229181084343511
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00627740694971335,0.0020590349678557,-0.0103131154867105,-0.00224169841271618,0.00230065394865415
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,-0.0249955882100837,0.00820938029934426,-0.0410859735967985,-0.00890520282336896,0.00233110093268761
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,-0.0198149465058544,0.00650838733303721,-0.0325713856786073,-0.00705850733310147,0.00233255641562321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,24793,-0.00859773091428374,0.00282519587638494,-0.0141351148319982,-0.00306034699656925,0.00234295727727836
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,29478,-0.026893825150571,0.00884209490475382,-0.0442243311638885,-0.00956331913725351,0.00235556958556097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,-0.0130669869825569,0.00429863889775158,-0.02149231922215,-0.00464165474296384,0.00236991169850151
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.00710857670881851,0.0023398419589791,0.00252248646921946,0.0116946669484176,0.0023835428835957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,-0.0071330150822855,0.00234900236593077,-0.0117370597195098,-0.00252897044506119,0.00239457963041344
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.00777830974932474,0.00256213164400054,0.00275653172708369,0.0128000877715658,0.00240092475275796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,-0.0128183021204053,0.00422554571726153,-0.0211003717262379,-0.00453623251457275,0.00241924744241632
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,24556,-0.0129589662832608,0.00427705492259754,-0.021341993931552,-0.00457593863496965,0.00244904911585081
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,29023,-0.0156984215675001,0.00519723817744534,-0.025885008395293,-0.00551183473970728,0.00252551103941403
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,28797,-0.0079711925966073,0.00264412574316061,-0.0131536790532021,-0.00278870614001249,0.00257474722988798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,29443,0.00703338773158168,0.00233312836593723,0.0024604561343447,0.0116063193288187,0.00257559773250063
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,-0.00655720700347572,0.00217756718392814,-0.0108252386839749,-0.00228917532297657,0.0026043308475419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,29446,-0.00900378743640176,0.00299903754622953,-0.0148819010270116,-0.00312567384579189,0.0026823831544599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,-0.0141740070565565,0.00472115915837166,-0.0234274790069649,-0.00492053510614801,0.00268275663378306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.0122529082678261,0.00409616974957841,0.00422441555865241,0.0202814009769998,0.00278065564494595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,24111,0.00838247912929764,0.00280234357075918,0.00288988573060965,0.0138750725279856,0.00278128998988582
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,24793,0.011985506605569,0.00401524064173636,0.00411563494776571,0.0198553782633722,0.00283852014731832
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,24454,0.00520029649982143,0.0017423013575848,0.00178538583895521,0.00861520716068764,0.00284110890029279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,24793,0.0231172385291159,0.00774731967650873,0.00793249196315878,0.038301985095073,0.00284875790976451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,-0.0108502269503151,0.00363661154296544,-0.0179779855745273,-0.00372246832610282,0.00285154430954238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0118611458929599,0.00398163919865642,0.00405713306359329,0.0196651587223264,0.00289461234689422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,29443,0.00566897794019733,0.00190441914032194,0.00193631642516633,0.00940163945522833,0.00291559304452449
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,29296,-0.00634952519564328,0.00213381394975655,-0.0105318005371661,-0.00216724985412045,0.00292588388266596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,28931,0.00980413266910137,0.00329725427283046,0.00334151429435367,0.0162667510438491,0.00294740817597074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00467333653069003,0.00157348688135743,0.00158930224322947,0.00775737081815059,0.00297987351599629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,28984,-0.00699574772369629,0.00235759305286881,-0.0116166301073192,-0.00237486534007342,0.00300647414463105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,-0.0182654445068481,0.00615876622541186,-0.0303366263086554,-0.00619426270504091,0.0030217556426863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,29218,-0.0205434532773557,0.00694646961126145,-0.0341585337154281,-0.00692837283928322,0.00310498920333866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,-0.0156624508846438,0.00529676073248337,-0.0260441019203112,-0.00528079984897639,0.00310962915590683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,29536,-0.0177176502314064,0.00599529858646566,-0.0294684354608791,-0.00596686500193374,0.00312655065534625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,-0.0128491576167549,0.00435639630635259,-0.0213876943772059,-0.00431062085630378,0.00318600623157448
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,28916,-0.00911585946578806,0.00309243377277312,-0.0151770296604234,-0.00305468927115275,0.00320305499311666
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.00606213514516318,0.00206037683451539,0.00202379654951301,0.0101004737408133,0.00326093893002859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,0.00836568731865325,0.00284483242156635,0.00278981577238321,0.0139415588649233,0.00327820709070909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00861978753051178,0.00293399845026313,0.00286915056799604,0.0143704244930275,0.00330757394476254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,0.00683232737497334,0.00232665317761492,0.00227208714684809,0.0113925676030986,0.00332147430123077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,24111,-0.0127603816857623,0.00434792734287166,-0.0212823192777907,-0.00423844409373385,0.00334056712030279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,29725,-0.00927956973058839,0.00316381789744891,-0.0154806528095883,-0.00307848665158852,0.00335928785524024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0117123866424634,0.00399517153067603,0.00388185044233839,0.0195429228425884,0.00337447524108467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,24966,-0.0108386507113536,0.00370139050340015,-0.0180933760980179,-0.00358392532468928,0.00341167910255029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,-0.018055833535708,0.00616713842224377,-0.0301434248433058,-0.00596824222811021,0.00341735892346087
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,-0.0238932057367745,0.00817215053515034,-0.0399106207856692,-0.00787579068787985,0.00346171456022856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,0.00590280641285986,0.00202004606165501,0.00194351613201604,0.00986209669370367,0.0034793154759943
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,-0.00972416384551997,0.00333120838021801,-0.0162533322707473,-0.00319499542029268,0.00351355342626773
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,-0.012067535490358,0.00414217162222535,-0.0201861918699197,-0.00394887911079635,0.00357865222589133
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,0.0108330425675124,0.00371867987852096,0.00354443000561136,0.0181216551294135,0.00358087663877127
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,29676,0.00873884545531469,0.00300166648956577,0.00285557913576577,0.0146221117748636,0.00360160144884564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,-0.00604082120370054,0.00207495509018644,-0.010107733180466,-0.00197390922693513,0.00360201873694577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,29581,-0.0185538450358853,0.00638913590893241,-0.0310765514173928,-0.00603113865437773,0.00368738676911375
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,0.0126663764957991,0.00436513503308541,0.00411071183095169,0.0212220411606465,0.00371462514805733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,24111,0.00726536798631572,0.00250691059538661,0.00235182321935796,0.0121789127532735,0.00375726052344756
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,29349,0.00383181568909959,0.00132322953930972,0.00123828579205253,0.00642534558614665,0.00378465613602301
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,24845,-0.00927023327718868,0.00320339988749036,-0.0155488970566698,-0.00299156949770757,0.0038085278151696
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,-0.0123768611808096,0.00427997733083222,-0.0207656167492407,-0.00398810561237845,0.00383320781483446
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,-0.0153993530791768,0.00532660950680427,-0.0258395077125132,-0.00495919844584043,0.00384270313529652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,24951,-0.0183189213976045,0.00633818658082235,-0.0307417670960163,-0.00589607569919268,0.00385271857320684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,24793,0.00544084862513647,0.00188325594973424,0.00174966696365736,0.00913203028661557,0.00386724187680505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,29169,0.00923328400672988,0.00319968410864586,0.00296190315378399,0.0155046648596758,0.00390847892457245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,24922,-0.0110274164458789,0.00382137729232234,-0.0185173159388307,-0.00353751695292715,0.00390857416829655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,24867,-0.0151031801904351,0.0052426856654733,-0.0253788440947628,-0.00482751628610745,0.00396994115667713
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,24756,0.0117476068773373,0.00407902653013505,0.00375271487827258,0.019742498876402,0.00398013160857377
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,0.00685672245406454,0.0023840676522055,0.00218394985574176,0.0115294950523873,0.00403025868802384
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,28797,-0.011523925473344,0.00401446852024032,-0.019392283773015,-0.00365556717367293,0.00409994744542714
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,-0.00643313835316754,0.00224109457367859,-0.0108256837175776,-0.00204059298875751,0.0041012414780136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,28774,-0.00973748855852694,0.00340315050305788,-0.0164076635445204,-0.00306731357253351,0.00422190641413786
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,24726,0.00688377503446307,0.00240598829040836,0.00216803798526268,0.0115995120836635,0.00422526931854031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,29566,0.0110791969534947,0.00387922897517324,0.00347590816215519,0.0186824857448343,0.00429272656452485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,-0.0167935255767816,0.00588225444108868,-0.0283227442813154,-0.00526430687224779,0.00430740830816154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,-0.0151554298747623,0.00531116223301574,-0.0255653078514731,-0.00474555189805142,0.00432699732958392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,24101,-0.00867391313390711,0.00304046505165677,-0.0146332246351544,-0.00271460163265985,0.00433694515231696
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,29478,-0.0134787392833004,0.00472563887837246,-0.0227409914849104,-0.00421648708169033,0.00434401097187177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,-0.0145122197770832,0.00509416924843391,-0.0244967915040137,-0.00452764805015277,0.00439227704922281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,0.00631326598900436,0.00222027091015136,0.00196153500510769,0.010664996972901,0.00446632536611725
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,29174,-0.0114723876200092,0.00403880938636622,-0.019388454017287,-0.00355632122273141,0.00450688344091571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,29301,-0.0130768153381707,0.00460412412569191,-0.0221008986245269,-0.00405273205181459,0.00451107432128072
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,24867,0.00432260702160245,0.00152219760094394,0.00133909972375233,0.00730611431945257,0.00451905400006141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,24951,0.00953208964878604,0.00335775339399656,0.00295089299655279,0.0161132863010193,0.00453159225687339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",24445,-0.00902415934873086,0.00318086317273161,-0.0152586511672848,-0.0027896675301769,0.00455748201941157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,24546,0.00673203634241326,0.00237548261729611,0.00207609041251289,0.0113879822723136,0.00460117924847014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,-0.00559606198890469,0.00197531030970248,-0.00946767019592156,-0.00172445378188783,0.00461498409361371
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,29434,-0.0132901678617117,0.00469217273741363,-0.0224868264270424,-0.00409350929638103,0.00462296192294174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,24101,-0.0166541670164176,0.00588315724048822,-0.0281851552077745,-0.0051231788250607,0.00464670962495943
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,24755,-0.0172861181449023,0.00610901055095924,-0.0292597788247824,-0.00531245746502216,0.00466422723221957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,0.0054200305787682,0.00191720539840833,0.00166230799788787,0.00917775315964852,0.00470180709660732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGMN,Legumain,29581,-0.00700243978053309,0.00247853406992013,-0.0118603665575766,-0.00214451300348962,0.00472776808908991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,28890,-0.0108496462215184,0.0038418507079666,-0.018379673609133,-0.00331961883390388,0.00474508506425104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,0.00793082723477214,0.00281747005244381,0.00240858593198227,0.013453068537562,0.00488283086096308
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,24381,-0.00645465741898049,0.00229448166699192,-0.0109518414862846,-0.00195747335167634,0.00491022576334955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,-0.0134929951327551,0.00480089363695055,-0.0229027466611782,-0.00408324360433204,0.004949468090251
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,29639,0.0049361525183427,0.00176080184748679,0.0014849808972686,0.0083873241394168,0.00506068525813144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,24240,-0.0175063291829577,0.00625884590822425,-0.0297736671630772,-0.00523899120283818,0.00516115936916845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,-0.0155274671249536,0.00555408033067347,-0.0264134645730736,-0.0046414696768336,0.00518303979189054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0108429722523789,0.00388470699450019,-0.0184569979615993,-0.00322894654315851,0.00525477638681264
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,24805,-0.0218969981619055,0.00785874732454868,-0.0373001429180209,-0.00649385340579006,0.00533504450212108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00963708734131097,0.00346905601561035,0.00283773755071468,0.0164364371319073,0.00547345024837227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,29599,0.0215506108127679,0.00776312529676245,0.00633488523111349,0.0367663363944223,0.00550629654235583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,0.00500719620669669,0.00180374153077027,0.00147186280638696,0.00854252960700642,0.00550661835995858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,24069,-0.0188799805473468,0.00681649861257193,-0.0322403178279878,-0.00551964326670584,0.00561427474364609
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,-0.00875107911925044,0.00317649243253536,-0.0149770042870198,-0.00252515395148113,0.00587450872138698
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,-0.0168019010560063,0.00609892667477965,-0.0287557973385744,-0.00484800477343814,0.00587553376401185
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0105854097361013,0.00385318098335402,0.00303317500872739,0.0181376444634751,0.00601522082175659
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,24329,-0.0196098177498706,0.00714335167816382,-0.0336107870390717,-0.00560884846066954,0.00605213109187827
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,29566,-0.00606912487016002,0.0022115733412661,-0.0104038086190416,-0.00173444112127846,0.0060684697396136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,0.011672151262169,0.00426569571422611,0.0033113876622858,0.0200329148620522,0.00621830622089712
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.00740804693542072,0.00271661233200404,0.0020834867646928,0.0127326071061486,0.00639628293805784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,23970,0.00773396800208573,0.00283723690741831,0.00217298366354583,0.0132949523406256,0.00641768650638104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,28931,-0.011223918191846,0.00412049266867632,-0.0193000838224516,-0.00314775256124038,0.00645496424670234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,-0.0072457767211139,0.0026693124453493,-0.0124776291139985,-0.00201392432822928,0.00664285374278461
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,-0.0106505110402554,0.00392384973061516,-0.0183412565122612,-0.00295976556824974,0.00664543865670846
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,28931,-0.0123618594977769,0.00456755636625464,-0.021314269975636,-0.00340944901991777,0.00680468775707237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,-0.0147994782241162,0.00548169647994096,-0.0255436033248005,-0.00405535312343192,0.00694213502753587
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,29725,-0.0205949799002221,0.00763265724488466,-0.0355549881001961,-0.00563497170024818,0.00697399861844234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,24101,0.0092179418143422,0.00342302959831462,0.00250880380164554,0.0159270798270389,0.0070878454794691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.00915368198499898,0.00339988389640677,-0.0158174544219562,-0.00248990954804171,0.0070990201422208
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,24240,-0.00544465798409623,0.00202638220765118,-0.00941636711109253,-0.00147294885709992,0.00721707768935177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,-0.00673073090239737,0.0025093641141639,-0.0116490845661586,-0.00181237723863613,0.00731707007040221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,24229,-0.00755704503291772,0.00282373836872371,-0.0130915722356162,-0.00202251783021925,0.00744999985868144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,28931,0.00907124881745506,0.0033910610416375,0.00242476917584557,0.0157177284590646,0.00747607427100732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,29820,0.00757981383610038,0.00283365038007516,0.00202585909115306,0.0131337685810477,0.00747858551933749
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,29694,0.005819251552283,0.00217674022714711,0.00155284070707466,0.0100856623974913,0.0075132441845002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,-0.0160027419126286,0.00599285029698518,-0.0277487284947196,-0.00425675533053768,0.00758328334623885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRN,Progranulin,29313,-0.00454717928775074,0.00170451728335637,-0.00788803316312923,-0.00120632541237225,0.00764092779566843
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,-0.00704869989810052,0.00264490617031595,-0.0122327159919198,-0.00186468380428126,0.00770367531780849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,-0.00576356053945287,0.00216731657772359,-0.0100115010317911,-0.00151562004711464,0.00783440604152816
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,-0.00794001253874392,0.00298597718480316,-0.0137925278209581,-0.00208749725652972,0.00783928110088284
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,-0.0114088121691575,0.00429067927946446,-0.0198185435569079,-0.00299908078140718,0.00784304013124414
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,24111,0.00775431988886885,0.00291640313229426,0.0020381697495721,0.0134704700281656,0.00784563651880972
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,0.00495909025537241,0.00188402500839212,0.00126640123892387,0.00865177927182096,0.00848919622133172
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,24845,-0.0106297026254313,0.00404125707130032,-0.0185505664851799,-0.00270883876568263,0.00853631672275712
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,-0.00820306362227228,0.00311945829105316,-0.0143172018727365,-0.00208892537180809,0.00855287102824974
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,-0.0196296179170123,0.00747172970505888,-0.0342742081389277,-0.00498502769509691,0.0086147459247047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,29566,-0.0113656244469162,0.00432987921533593,-0.0198521877089746,-0.00287906118485776,0.00867117018493772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,24016,0.0115283509887055,0.00440066265769149,0.00290305217963018,0.0201536497977808,0.00880663317755029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,24845,-0.00936322538228789,0.00357492921904359,-0.0163700866516133,-0.00235636411296246,0.00882063953968863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,-0.0125888502130957,0.00480874440343824,-0.0220139892438346,-0.00316371118235673,0.00885259738609962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,-0.00861461809138994,0.00329552158896846,-0.0150738404057681,-0.00215539577701176,0.0089533080204464
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,24381,-0.00543556602287503,0.0020818633280919,-0.00951601814593515,-0.00135511389981492,0.00903559060159134
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,24111,0.00727450493948077,0.00278917923656718,0.0018077136358091,0.0127412962431524,0.00910980706345928
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,24240,-0.01322913370728,0.00507625604181528,-0.023178595549238,-0.00327967186532205,0.00916408760621338
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,-0.00672636868541463,0.00258700527918011,-0.0117968990326077,-0.00165583833822161,0.00932627722626731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,-0.0125647962744661,0.00483384720197577,-0.0220391367903386,-0.00309045575859363,0.00934602676491869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00718984403872513,0.0027671967394232,-0.0126135496479946,-0.00176613842945567,0.00937597277347406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,-0.0158601502348137,0.00610991472659528,-0.0278355830989405,-0.00388471737068695,0.00944164876603712
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,-0.0163232207238709,0.00629067268570485,-0.0286529391878524,-0.00399350225988945,0.00946950019129801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,0.00607986099156517,0.0023443357726592,0.00148496287715314,0.0106747591059772,0.00950720679540186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,24240,-0.00410978652516647,0.00158594978489688,-0.00721824810356435,-0.00100132494676859,0.00956513046620992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,24445,0.00702116826250849,0.0027112611020705,0.0017070965024503,0.0123352400225667,0.00961356004343773
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,24111,0.00801984092409913,0.00309802314349727,0.00194771556284449,0.0140919662853538,0.00963978987176298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,-0.0104259249043721,0.00402756405572565,-0.0183199504535944,-0.00253189935514981,0.00964027234765833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,24016,0.00559343400476522,0.00216299477842339,0.00135396423905538,0.00983290377047505,0.0097164451606036
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,0.00912730041815283,0.00353291796981213,0.00220278119732105,0.0160518196389846,0.00978612466874156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,24111,0.00970531816077426,0.00375938612292945,0.00233692135983253,0.017073714961716,0.00983954017305507
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,29589,0.00610422161247201,0.0023662456647003,0.00146638010965942,0.0107420631152846,0.00989318395324114
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,-0.00390930737791973,0.00151690047655616,-0.0068824323119698,-0.000936182443869668,0.00996717605870077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,-0.00347619442034962,0.00135282830891805,-0.00612773790582901,-0.000824650934870235,0.0101880838388861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,28916,-0.00889253845571735,0.00346350301743902,-0.0156810043698978,-0.00210407254153687,0.0102485083906514
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,-0.0118998489729519,0.0046369218871753,-0.0209882158718154,-0.00281148207408827,0.0102842548190374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,0.00507261531970326,0.00197723526949329,0.00119723419149642,0.0089479964479101,0.0103073936262321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,28774,-0.0126704686629735,0.00494017309842726,-0.0223532079358909,-0.00298772939005609,0.0103290821527204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,24805,-0.0107086919961567,0.00417566806178698,-0.0188930013972591,-0.00252438259505419,0.010336928543393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,24938,-0.0148731390205494,0.00580470894803765,-0.0262503685587032,-0.00349590948239563,0.0104053445900003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,-0.0147939369270026,0.00577860918038656,-0.0261200109205602,-0.00346786293344491,0.0104685084488673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,28774,0.00580706984150323,0.00226987151767253,0.00135812166686508,0.0102560180161414,0.010522839719334
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,24381,-0.00959122221181836,0.00375222774315069,-0.0169455885883937,-0.002236855835243,0.0105900406267411
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,-0.00393577757411915,0.00153988459422187,-0.00695395137879401,-0.000917603769444292,0.0105965367680133
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00921135579476395,0.0036128318310082,0.00213020540598788,0.01629250618354,0.0107899429397982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,24229,0.00472339455331951,0.00185762380641949,0.00108245189273731,0.00836433721390172,0.011005886695877
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,29694,-0.022572425168633,0.00887754936445508,-0.039972421922965,-0.00517242841430105,0.0110068393538981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00663419899948143,0.00261429450628657,0.00151018176715976,0.0117582162318031,0.0111657084101586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,-0.0119034153237161,0.00469715028013243,-0.0211098298727757,-0.00269700077465654,0.0112773350795233
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,-0.00529092303218644,0.00208797899083113,-0.00938336185421546,-0.00119848421015743,0.0112831904516878
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,29674,-0.00541197336234204,0.00213914879280768,-0.0096047049962451,-0.00121924172843899,0.0114124947742569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,24111,0.0117127120195131,0.00463033626529533,0.00263725293953427,0.020788171099492,0.0114268941532502
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,29434,0.00980292364151203,0.00387567539846855,0.00220659986051368,0.0173992474225104,0.0114327125746423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,24805,-0.0179965485184556,0.00712915256510475,-0.0319696875460609,-0.00402340949085028,0.0115971011944833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,24101,0.00615588827945809,0.00244133871775583,0.00137086439265667,0.0109409121662595,0.0116912469054311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,24845,-0.0146687258185441,0.00582165083444981,-0.0260791614540658,-0.00325829018302251,0.0117522135203964
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,29384,-0.0197390828086409,0.00786392661461307,-0.0351523789732825,-0.00432578664399926,0.0120757227812038
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,29192,-0.00828184798202599,0.00330269341543473,-0.0147551270762781,-0.00180856888777391,0.0121606589694462
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,-0.00775842294798432,0.00309536222050875,-0.0138253329001815,-0.00169151299578718,0.0121998136537983
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,24938,-0.00754493292543104,0.00301361903450796,-0.0134516262330666,-0.00163823961779543,0.0122996163467234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,24805,0.0198327206556652,0.00792755727245738,0.00429470840164871,0.0353707329096816,0.0123647095215086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.0187882244941541,0.00751207883177734,0.00406454998387047,0.0335118990044376,0.0123886380698371
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.00427944368113469,0.00171360610202349,0.000920775721168646,0.00763811164110072,0.0125185633921395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,-0.0075483217696899,0.00302397100164685,-0.0134753049329177,-0.00162133860646207,0.0125609680341875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,28931,-0.0159263430559783,0.00638545465675986,-0.0284418341832276,-0.00341085192872901,0.0126311150396826
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.0134536700796948,0.00540145425050688,0.00286681974870135,0.0240405204106883,0.012754047652336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,29760,-0.00905312852633522,0.00363871282147589,-0.016185005656428,-0.00192125139624248,0.0128516950907082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,28916,-0.00842234875100506,0.00338696019822502,-0.0150607907395261,-0.00178390676248402,0.0128990628246603
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,24101,0.00740008231710392,0.00297678283033177,0.00156558796965365,0.0132345766645542,0.0129279600571023
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0295357936913948,0.0118901974216819,0.00623100674489827,0.0528405806378913,0.0129955109987534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,-0.0150926369172653,0.00607676746590394,-0.027003101150437,-0.0031821726840936,0.0130104705884383
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0132958515906526,0.00535966144665613,0.00279091515520657,0.0238007880260986,0.0131182477277852
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,-0.0204592994335753,0.00825425404059276,-0.0366376373531371,-0.00428096151401347,0.0131940914560321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,28650,-0.00522135925424883,0.00211175642068064,-0.00936040183878289,-0.00108231666971478,0.0134221975594737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,24845,0.0162299166815924,0.00657243175791746,0.00334795043607416,0.0291118829271106,0.0135409262629889
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,29566,0.0047096281976694,0.00190725720687555,0.000971404072193326,0.00844785232314547,0.0135426235061123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,24111,0.00799954203022213,0.00324741015766286,0.00163461812120292,0.0143644659392413,0.0137710791235552
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0087618569742909,0.00357362672160148,0.001757548599952,0.0157661653486298,0.0142209786306021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,24867,-0.0046665298204519,0.00190501557535255,-0.0084003603481429,-0.000932699292760895,0.0143082738420278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,0.00708404319276047,0.00289334847580203,0.00141308018018849,0.0127550062053325,0.0143566984060129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,29349,-0.0152014610596538,0.0062104096472,-0.0273738639681658,-0.00302905815114182,0.0143813990438299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,0.00631811985401289,0.00258224218242792,0.00125692517645416,0.0113793145315716,0.0144218807902623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,-0.0068964067672495,0.00282342370544712,-0.0124303172299259,-0.00136249630457314,0.0145902429052697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,-0.0142503624527794,0.00583555107283178,-0.0256880425555296,-0.00281268235002908,0.0146134371190383
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,28916,0.00553478047772929,0.00227072013648143,0.00108416901022568,0.0099853919452329,0.0147970005702247
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPART,Spartin,24381,-0.0130547000593418,0.00537018666453758,-0.0235802659218355,-0.00252913419684814,0.0150661089987143
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,29786,-0.0106296922086807,0.00437786287195726,-0.0192103034377169,-0.00204908097964445,0.0151859224083099
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,24111,-0.00648815631528507,0.00267269647331583,-0.0117266414029841,-0.00124967122758604,0.0152076517794363
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,24195,0.00459985576781022,0.00189762426094549,0.000880512216357056,0.00831919931926339,0.0153575654090375
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,24381,-0.00938954922824104,0.00387431556912302,-0.0169832077437221,-0.00179589071275992,0.0153773976090457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,24111,0.00575033145556564,0.00237281380735565,0.00109961639314857,0.0104010465179827,0.0153823292878341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,-0.00711805747696063,0.00293967954107917,-0.0128798293774758,-0.00135628557644545,0.0154680240776012
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00593865232680144,0.002455426651863,0.00112601608914997,0.0107512885644529,0.0155884305586359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,0.00364216588897387,0.00150682161738097,0.000688795518907174,0.00659553625904057,0.0156499964893661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00703120583362466,0.00291104674025496,0.00132555422272494,0.0127368574445244,0.0157271285944442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,24789,-0.00955497843600062,0.00395717024271702,-0.017311032111726,-0.00179892476027527,0.0157597480750821
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,24445,0.00697753779502021,0.00289177827604509,0.00130965237397183,0.0126454232160686,0.0158339862144179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,-0.00642038423429583,0.00266114906515488,-0.0116362364019994,-0.00120453206659226,0.015844823392618
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,28774,0.0123551351139483,0.00513196853223976,0.00229647679075841,0.0224137934371383,0.016069097296827
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,28931,-0.00839945574547047,0.00349178676004311,-0.015243357795155,-0.00155555369578597,0.0161570630050669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,-0.012206881320578,0.00507522795455911,-0.0221543281115139,-0.00225943452964218,0.016170388740903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,29581,0.00555735882318171,0.00231191434454129,0.00102600670788078,0.0100887109384826,0.0162321632960421
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,-0.0163268371977756,0.006795989197598,-0.0296469760250677,-0.00300669837048353,0.0162941577949915
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,-0.00685362366420303,0.00285301085838723,-0.012445524946642,-0.00126172238176405,0.0163012054767084
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,24229,0.00728917886263276,0.00305070204900444,0.00130980284658405,0.0132685548786815,0.0168860612868781
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,-0.00474196567273244,0.00198530435228169,-0.00863316220320456,-0.000850769142260321,0.0169232116605316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0105045006070257,0.00440545778893152,0.00186980334071992,0.0191391978733315,0.017113259788911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,24195,-0.0112876621139933,0.00474390722931632,-0.0205857202834533,-0.00198960394453328,0.017348466250892
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,0.00682197016704834,0.00287149361437014,0.00119384268288287,0.0124500976512138,0.0175207791824195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,-0.00576790212931373,0.00242837395231911,-0.0105275150758592,-0.00100828918276828,0.0175465610919731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,24805,-0.0127527234316616,0.00537639875297333,-0.0232904649874893,-0.00221498187583387,0.0177005219626364
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,29820,-0.0144160807711431,0.00608129905093034,-0.0263354269109665,-0.00249673463131961,0.0177675128815746
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,-0.00737537248515804,0.00311169741403378,-0.0134742994166642,-0.00127644555365183,0.0177844724233669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,-0.00965850345338994,0.00407597602612215,-0.0176474164645893,-0.00166959044219053,0.0178130606834684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,24101,0.00759191432497912,0.00320603339172014,0.00130808887720764,0.0138757397727506,0.0178919755641453
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,0.00444311939475476,0.00187666324515901,0.000764859434243099,0.00812137935526642,0.0179132667255776
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0111102546654586,0.00469308282135103,0.00191181233561057,0.0203086969953066,0.0179214599242322
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,29218,0.00572468651804968,0.0024258447994701,0.000970030711088285,0.0104793423250111,0.0182877142958749
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,29169,-0.00842327132130659,0.00356939320271688,-0.0154192819986317,-0.0014272606439815,0.018288341253864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,28797,-0.00855712456310023,0.00362662462961479,-0.0156653088371452,-0.00144894028905524,0.0183048081069183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,0.00675576272786961,0.00286452226516357,0.00114129908814902,0.0123702263675902,0.0183591398794857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,-0.0147861024167763,0.0062768132830485,-0.0270886564515514,-0.00248354838200128,0.0184970284823754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,0.00703642725651991,0.00299469955654344,0.00116681612569476,0.0129060383873451,0.0188002235018344
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,24111,0.00824660722773238,0.00351868065756087,0.00134999313891307,0.0151432213165517,0.0191034176848933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,28797,-0.00575711437596818,0.00245753581061799,-0.0105738845647794,-0.000940344187156926,0.0191547761260405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,24922,0.0158554327192187,0.00678515779093857,0.00255652344897908,0.0291543419894583,0.0194584200100869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,29693,0.005203670170485,0.00222724763655651,0.000838264802834241,0.00956907553813576,0.0194786880363841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,-0.00802454300909208,0.00343621507011145,-0.0147595245465105,-0.00128956147167364,0.0195365660567717
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,-0.00903797695387767,0.00388383944589766,-0.0166503022678371,-0.00142565163991825,0.0199693922284534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,-0.00710620648225439,0.00306325420944518,-0.0131101847327669,-0.00110222823174184,0.0203587860706939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,-0.0113649564926243,0.00490216360897826,-0.0209731971662217,-0.00175671581902694,0.020438237574001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,0.00944930015951096,0.00407770827712869,0.00145699193633873,0.0174416083826832,0.0204953747760491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0045050563468549,0.00194544856852947,0.000691977152537141,0.00831813554117267,0.0205819761274654
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.0123583557757544,0.00535089416171303,-0.0228461083327119,-0.00187060321879686,0.020918069981181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,24845,-0.00614148448419907,0.00266139494985603,-0.0113578185859169,-0.000925150382481242,0.0210285402535733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,-0.0132646923006779,0.00575847277253516,-0.0245512989348468,-0.00197808566650899,0.021257163607845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,24938,-0.0132551250032249,0.00575626865193328,-0.0245374115610141,-0.00197283844543565,0.0213023087920982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,24281,-0.00682520686740902,0.00296994463669783,-0.0126462983553368,-0.00100411537948127,0.0215649995386096
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,24776,-0.0150465552151415,0.00654931664648682,-0.0278832158422557,-0.00220989458802731,0.0216029112272118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,29725,0.00504044991655922,0.00219623464121233,0.000735830019783056,0.00934506981333538,0.021737674679169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,0.0058819274964994,0.00256504345144714,0.000854442331663005,0.0109094126613358,0.0218501973547058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,-0.00578127234639058,0.00252376702779313,-0.0107278557208651,-0.000834688971916048,0.0219875471819682
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,-0.00814141533280571,0.00355647102557357,-0.0151120985429299,-0.00117073212268151,0.0220770550820096
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,28797,-0.0106409143098475,0.00465069380688478,-0.0197562741713416,-0.00152555444835331,0.0221431482382241
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,29443,-0.00536052860437822,0.00234413731587886,-0.00995503774350079,-0.000766019465255641,0.0222156780631878
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,28774,0.00818374514986433,0.00358078502268098,0.0011654065054096,0.0152020837943191,0.0222930427068072
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,-0.00772136603757395,0.00338112008627227,-0.0143483614066676,-0.00109437066848029,0.0223992686223976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,29725,-0.00334296918626086,0.00146534659963121,-0.00621504852153803,-0.000470889850983685,0.0225347576704961
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,24867,0.00818540732369144,0.00359303686467641,0.00114305506892568,0.0152277595784572,0.0227272452558666
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,-0.00499393199883682,0.00219492209484166,-0.00929597930472647,-0.000691884692947165,0.0228998570818744
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,24016,0.00584289605690482,0.00257222738990305,0.000801330372694847,0.0108844617411148,0.0231236226580836
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,0.0060717857868437,0.00267366686060227,0.000831398740063246,0.0113121728336241,0.0231582893217947
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,24229,-0.00455185525858602,0.00200799345394513,-0.00848752242831847,-0.00061618808885357,0.0234070958105348
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,-0.0174169563064536,0.00768372888548429,-0.0324770649220028,-0.00235684769090438,0.0234139418803794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,24951,-0.0108402788696081,0.00478247149551083,-0.0202139230008093,-0.00146663473840682,0.0234189935772061
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,29566,-0.00870989018805037,0.0038441244163981,-0.0162443740441907,-0.0011754063319101,0.0234728562727959
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,29434,-0.00488759490136525,0.00216154291293001,-0.00912421901070807,-0.000650970792022437,0.0237566068725659
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,-0.011473020117119,0.00507410626018727,-0.0214182683870861,-0.00152777184715196,0.0237607578302035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,24867,0.00476252345740159,0.00210637507437841,0.000634028311619899,0.00889101860318328,0.0237675888762999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,28916,-0.0119656494887199,0.0052938928980739,-0.0223416795689448,-0.00158961940849508,0.0238116470817954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,29732,-0.0107771334671666,0.00477011881717844,-0.0201265663488363,-0.00142770058549686,0.0238718899591887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,28774,0.00597633057372362,0.0026476836017424,0.00078687071430851,0.0111657904331387,0.0240035419639752
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,29761,-0.00936123712886822,0.00415306814526199,-0.0175012506935817,-0.00122122356415471,0.0242000585917514
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,24016,0.00407623826976677,0.00180946618690803,0.000529684543427039,0.0076227919961065,0.024285188682854
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,24445,0.00553498232337674,0.00246156892371381,0.000710307232897683,0.0103596574138558,0.0245494584816102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0042030608838935,0.00187101472866066,0.000535872015718612,0.00787024975206839,0.0246866839863715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00462068915780179,0.00206200321974725,-0.00866221546850641,-0.000579162847097173,0.0250430211567885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,0.00439710465511204,0.00196263879954502,0.000550332608003795,0.00824387670222028,0.0250736305129058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,29497,0.00508987150696697,0.00227276388038356,0.000635254301415191,0.00954448871251876,0.0251303454354054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,0.0072827825178707,0.0032554237784747,0.000902151912060292,0.0136634131236811,0.0252874627449717
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,-0.00656034743087632,0.00293795579642669,-0.0123187407918726,-0.000801954069880003,0.0255605479745708
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,24229,0.004325809952681,0.00194060321461621,0.000522227652033223,0.00812939225332878,0.0258160017719422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,0.00613043268106425,0.00275135894120509,0.000737769156302269,0.0115230962058262,0.0258795885798957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,24229,0.00876792093950705,0.00395417905263514,0.00101772999634218,0.0165181118826719,0.0266063252820833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,28797,-0.00739980228670856,0.00334339925796356,-0.0139528648323171,-0.000846739741099986,0.0268877359058987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,24793,0.0053599314108979,0.00242223359613525,0.000612353562472815,0.010107509259323,0.0269201497988914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,-0.00829440208078288,0.0037510059349592,-0.0156463737133029,-0.000942430448262842,0.0270263922660022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,0.00633192044255816,0.00286618653834767,0.000714194827396734,0.0119496460577196,0.0271715358069377
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,-0.0122436166981071,0.0055646402061395,-0.0231503115021405,-0.00133692189407364,0.0277981353862629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,24229,0.00889337273424906,0.0040457942873659,0.000963615931011894,0.0168231295374862,0.0279459096926212
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,24381,0.00876376919301404,0.003990172658119,0.000943030783100802,0.0165845076029273,0.0280771221372723
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,24381,-0.0129753586881843,0.00594630295309308,-0.0246301124762468,-0.00132060490012189,0.0291125274842246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,0.00867728788230951,0.00397939796793533,0.000877667865156266,0.0164769078994628,0.0292260879781679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,28931,0.00434997429993642,0.00199764444580261,0.000434591186163303,0.00826535741370954,0.0294474754223416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,-0.00795489964821156,0.00365476814768826,-0.0151182452176805,-0.000791554078742577,0.0295199296410174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,29439,-0.0088869419389226,0.00408405204853691,-0.0168916839540549,-0.000882199923790265,0.0295623707476217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.00639109680565455,0.00293958658576286,0.000629507097559344,0.0121526865137497,0.0297020910298645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,29519,0.00459931848981535,0.00211764149702876,0.000448741155638981,0.00874989582399172,0.0298706838984013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,24793,0.00835393103064868,0.00384639584873316,0.000814995167131697,0.0158928668941657,0.0298737590939658
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,24229,0.00820885226998019,0.00378139356342818,0.000797320885660947,0.0156203836542994,0.0299519135593052
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,24381,0.00781287806140466,0.00360172537815355,0.000753496320223711,0.0148722598025856,0.0300768155875466
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,-0.00425148673243644,0.00196197635816216,-0.00809696039443428,-0.0004060130704386,0.0302473503544679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,-0.00719805517911497,0.0033229467128695,-0.0137110307363392,-0.000685079621890751,0.030307942432211
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,0.00492776108966785,0.00227799575676874,0.000462889406401113,0.00939263277293459,0.0305355813999571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,-0.00421738250081899,0.00195268495098666,-0.00804464500475283,-0.000390119996885145,0.0307989771780767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,0.0012173791609952,0.00056380675884679,0.000112317913655491,0.00232244040833491,0.0308432688124183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,-0.0160380738504511,0.00743564681631339,-0.0306119416104253,-0.00146420609047682,0.03102165980927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,-0.00873302681032885,0.00404899189098613,-0.0166690509166617,-0.00079700270399603,0.0310277318718971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.00420329556693656,0.00195057118920683,-0.00802641509778195,-0.00038017603609117,0.0311788545414847
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,-0.00990367731133235,0.00459686414664841,-0.0189135310387632,-0.000893823583901464,0.0312151116423623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,24229,0.00692542359113962,0.00321922315913687,0.000615746199231351,0.0132351009830479,0.0314646234611067
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,24101,0.00509667308517179,0.00237140320099693,0.000448722811217808,0.00974462335912578,0.0316266993747215
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,23603,0.0104401807673108,0.00485914942707654,0.000916247890240755,0.0199641136443808,0.0316793340443905
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,24966,0.00398281748429832,0.00185614386197968,0.000344775514818156,0.00762085945377849,0.0319026857249327
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,24445,0.00426330705127643,0.0019868670980792,0.000369047539041187,0.00815756656351167,0.0319032762205913
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,-0.0125967562635943,0.00588461583923863,-0.0241306033085021,-0.00106290921868664,0.0323142659048383
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,24381,-0.00424921036586316,0.00198793180319785,-0.00814555670013094,-0.000352864031595377,0.0325670179072602
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,29383,-0.00699852233354948,0.00327508938836608,-0.013417697534747,-0.000579347132351964,0.0326147653514965
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,28931,0.00489202655100664,0.00229167955943798,0.000400334614508197,0.00938371848750507,0.0327946834852466
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,28931,-0.00426965026855497,0.00200798911066245,-0.00820530892545336,-0.000333991611656573,0.0334841219766197
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,-0.0110495203084912,0.00520761135451538,-0.0212564385633414,-0.000842602053641058,0.033864403023484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,-0.00646788417643742,0.00305004992317908,-0.0124459820258684,-0.000489786327006412,0.0339669526609291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,28774,-0.00526567297344211,0.00248767895026199,-0.0101415237159556,-0.000389822230928613,0.0342937802755711
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,-0.00899436390046668,0.0042501851712312,-0.0173247268360798,-0.000664000964853528,0.0343352461080045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,-0.0105276470546908,0.00498164231286584,-0.0202916659879078,-0.000763628121473754,0.0345846311160144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,24711,-0.00708750515130598,0.0033538799177902,-0.0136611097901748,-0.000513900512437187,0.0345914596456447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,-0.00976517478744955,0.00462599787870281,-0.0188321306297071,-0.000698218945192054,0.0347882837988336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,0.00692203293350656,0.00327967783752622,0.000493864371955167,0.013350201495058,0.0348166316830531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,0.00462619499264052,0.0021920759992554,0.000329726034099936,0.00892266395118111,0.0348327091489086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,24229,0.00383857348402536,0.00181931252251202,0.000272720939901805,0.00740442602814892,0.0348769177781002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,-0.0135228200850915,0.00642685094895825,-0.0261194479450497,-0.000926192225133364,0.0353772132491296
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,0.00547465014726461,0.00260737841364754,0.000364188456515442,0.0105851118380138,0.0357659859025125
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,0.0106350055585972,0.00506838479944253,0.000700971351689889,0.0205690397655046,0.0358887969969975
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,24016,0.00598383614460995,0.00285712314105836,0.000383874788135577,0.0115837975010843,0.0362386405255767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,24240,-0.0170537232563526,0.00814766305466288,-0.0330231428434918,-0.00108430366921335,0.0363522487912787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,-0.00437260951493178,0.0020896680583282,-0.00846835890925505,-0.00027686012060851,0.0364048225199752
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,-0.0046401188893347,0.00222072940735532,-0.00899274852775112,-0.000287489250918269,0.0366751618324291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.00920747545035496,0.00440823928303635,-0.0178476244451062,-0.00056732645560372,0.0367435294003484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,24805,-0.00854803243263381,0.00410061213721262,-0.0165852322215705,-0.000510832643697078,0.0371181297470408
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,-0.00842746537647939,0.00404567725555507,-0.0163569927973673,-0.00049793795559145,0.037254394746657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.00425930394015401,0.00204479226766255,0.000251511095535406,0.00826709678477261,0.0372597584019201
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,29426,0.00956010097887211,0.00459423389425804,0.000555402546126358,0.0185647994116179,0.0374524952451602
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,-0.00683570688042974,0.00329071851009973,-0.0132855151602252,-0.000385898600634272,0.0377870329087847
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,-0.010873678801643,0.00523947904207434,-0.0211430577241087,-0.000604299879177256,0.0379658554922137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,0.00546823978297887,0.00264141596677628,0.000291064488097361,0.0106454150778604,0.0384448826530679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,-0.00287051939860302,0.00138744350568433,-0.00558990866974431,-0.000151130127461727,0.0385632558547695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,-0.0109319658000058,0.00529006393611572,-0.0213004911147926,-0.000563440485218985,0.0387907846010454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,24195,-0.00479037132488502,0.00232941606715319,-0.00935602681650528,-0.000224715833264767,0.0397480625540604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.00540102124000656,0.00262691477809215,-0.0105497742050672,-0.00025226827494595,0.0397898375764809
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,28774,-0.00527266095788811,0.00256569616450394,-0.0103014254403158,-0.000243896475460386,0.0398821686521342
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0065442920256585,0.00319140169598446,0.000289144701528965,0.012799439349788,0.040314838719517
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,24101,0.00763908538975383,0.00373285370600242,0.000322692125989088,0.0149554786535186,0.0407232932411687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,24111,-0.00716120285074127,0.00350158046130779,-0.0140243005549045,-0.000298105146578009,0.0408524424705928
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.0129650552671275,0.00634167024589451,0.000535381585174232,0.0253947289490807,0.0409206784925264
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRL,Prolactin,29694,-0.0107131612637479,0.00524147578328492,-0.0209864537989864,-0.000439868728509507,0.040970181741843
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,24111,-0.00854433879587276,0.00418139701761158,-0.0167398769503915,-0.000348800641354067,0.0410220038106021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,24016,0.00675704501897647,0.00331669929675299,0.000256314397340606,0.0132577756406123,0.0416329410595258
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,-0.00713436051592273,0.00350652838520189,-0.0140071561509184,-0.000261564880927032,0.0419007189483749
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,29623,-0.00831197914887652,0.00408899536568544,-0.01632641006562,-0.000297548232133049,0.0420848657948227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,24016,-0.00879062216592223,0.00432566936712851,-0.0172689341254941,-0.000312310206350341,0.0421444742389879
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.0042155736996405,0.00207447384021731,0.000149604972814583,0.00828154242646642,0.0421509269473094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,-0.00453161873641265,0.00223291885417485,-0.00890813969059535,-0.000155097782229955,0.0424221276223958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,24793,-0.00993472115759119,0.00490211993395924,-0.0195428762281513,-0.000326566087031072,0.0427122519809482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,24445,-0.0104221822159868,0.00514554696730287,-0.0205074542719004,-0.000336910160073145,0.0428293532975735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,-0.00594423494001347,0.00293513704957033,-0.0116971035571713,-0.000191366322855629,0.0428562288302172
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,-0.00644505152516859,0.00318570679737449,-0.0126890368480226,-0.000201066202314597,0.0430723010073536
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,-0.0181595786716994,0.00897840336892855,-0.0357572492747993,-0.000561908068599445,0.0431249967877497
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGN,Cingulin,24195,-0.0055807795166865,0.00277337886562049,-0.0110166020933027,-0.000144956940070335,0.0442028381955765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,24793,-0.0110466207175306,0.00549924478367994,-0.0218251404935433,-0.000268100941517942,0.044574234626364
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,0.00469451144950555,0.00234630769678781,9.57483638014314e-05,0.00929327453520966,0.0454222676305416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,29218,0.00843256769631705,0.0042162743652096,0.000168669940506228,0.0166964654521279,0.0455090220512157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.00486959225273809,0.00243876758627548,8.96077836381468e-05,0.00964957672183803,0.0458640213664819
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.00411926422424629,0.00206564713232214,7.05958448948898e-05,0.00816793260359768,0.0461436840205531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,24867,-0.00687465650856959,0.00345347064579847,-0.0136434589743346,-0.00010585404280458,0.0465301474659994
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,-0.0132174676745142,0.00664130932438744,-0.0262344339503136,-0.000200501398714834,0.0465812243676184
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,24016,0.00642730367032754,0.00323049285555569,9.55376734383898e-05,0.0127590696672167,0.0466492429578879
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,0.00402196886612186,0.00203915329856756,2.52284009294498e-05,0.00801870933131428,0.0485766080619531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,29694,-0.00399387808051632,0.00202534227433806,-0.00796354893821892,-2.42072228137163e-05,0.0486243381237534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,-0.00611958271441737,0.00312087021477265,-0.0122364883353718,-2.67709346297041e-06,0.0499067973476676
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,-0.0197021522998223,0.0100552786100188,-0.0394104983754591,6.19377581456346e-06,0.0500774752069369
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00511264610483744,0.00260940366773087,-1.78508391505353e-06,0.0102270772935899,0.050087314817756
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,-0.0115814522449817,0.00592034420548705,-0.0231853268877363,2.24223977728921e-05,0.0504515159544424
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,0.00485827161933255,0.00249041636779614,-2.29444615478802e-05,0.00973948770021298,0.0510936237344116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,24966,0.00982614707158773,0.00504300801813129,-5.81486439496012e-05,0.0197104427871251,0.0513700107979896
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,0.00342763614115749,0.00176162587407076,-2.51505720211941e-05,0.00688042285433618,0.05169740927724
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,-0.0134289808339953,0.00691105936398483,-0.0269746571874056,0.000116695519414928,0.052013934852178
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,29443,-0.00482765330879633,0.00248489686022753,-0.00969805115484229,4.27445372496362e-05,0.0520500622456342
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,24229,0.0139291149668031,0.00717746691722411,-0.000138720190956159,0.0279969501245624,0.0523095656926719
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,-0.00886785886298706,0.0045948848616648,-0.0178738331918501,0.000138115465875943,0.0536254561400154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00345247711625839,0.00179498069858714,-6.56850529723971e-05,0.00697063928548918,0.054440883491957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,24101,0.0064271953945114,0.00334360997462741,-0.000126280155758327,0.0129806709447811,0.0545883040315426
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,-0.00721324507969113,0.00376264703674246,-0.0145880332717063,0.000161543112324087,0.0552409536555629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.00345423790587841,0.00180658872392968,-8.66759930237587e-05,0.00699515180478058,0.0558848493693096
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,24101,0.00631185428025876,0.00330291339218614,-0.000161855968426084,0.0127855645289436,0.0560169524229272
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0092569241605192,0.00484555781585311,-0.000240369158552894,0.0187542174795913,0.0560943073373328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,-0.0111451616767099,0.00583515555485084,-0.0225820665642176,0.000291743210797731,0.0561427794682245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIM,Vimentin,28916,-0.0154195127672579,0.00807712382572625,-0.0312506754656814,0.000411649931165553,0.0562674588026005
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,-0.0081296533499276,0.00427572422549538,-0.0165100728318985,0.000250766132043338,0.0572675566434939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,-0.015031212512449,0.00790813366348059,-0.030531154492871,0.000468729467972934,0.0573491834095563
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.00907864523153419,0.00478117480196212,-0.000292457380311559,0.0184497478433799,0.0575984065199766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,-0.0061660349586084,0.00326800600911547,-0.0125713267364747,0.000239256819257929,0.0592005022925739
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00504510774706809,0.00267451065780148,-0.000196933142222816,0.010287148636359,0.0592575441347638
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,-0.00794645756762379,0.00422830780717969,-0.016233940869696,0.0003410257344484,0.060206960731473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,29688,-0.0121474988397679,0.0064644384936309,-0.0248177982872844,0.000522800607748692,0.0602369906089147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,21656,-0.0137452640843961,0.00731472188486511,-0.0280821189787317,0.000591590809939545,0.0602410908166
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.00615563532948278,0.00327739076650729,-0.000268050572871511,0.0125793212318371,0.0603622420059107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,24615,-0.00835864272273642,0.00445407647390487,-0.01708863261159,0.000371347166117137,0.0605809827183688
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,24845,-0.012945117706516,0.00690507927010534,-0.0264790730759225,0.000588837662890421,0.06084243485378
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,24111,-0.00768243156169482,0.00409996654803057,-0.0157183659958347,0.000353502872445089,0.0609729725734159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,-0.0110830742494563,0.00591506752621195,-0.0226766066008317,0.000510458101919176,0.0609832256509474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,24805,-0.00451691549130201,0.0024148002750877,-0.0092499240304739,0.000216093047869887,0.0614243759298773
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,-0.00758488035964448,0.00405785060499164,-0.0155382675454281,0.000368506826139131,0.0616089318748825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,24195,0.00488440665096325,0.00261802776357088,-0.000246927765635682,0.0100157410675622,0.0620980020929845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,0.00899350427752758,0.00482475779445304,-0.000463020999600376,0.0184500295546555,0.062329322607842
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,24867,-0.00384120505498184,0.00206124956220137,-0.00788125419689653,0.000198844086932851,0.0623992028379498
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,29594,-0.0060000980270257,0.00322496742906022,-0.0123210341879837,0.00032083813393233,0.062822712947717
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,24922,0.0136675193236059,0.00734742155281183,-0.000733426919905269,0.0280684655671171,0.062871982246674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,24919,0.0140780409585356,0.00759250789189178,-0.000803274509572315,0.0289593564266434,0.0637221240900034
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.00687074009079295,0.00370614881320913,-0.000393311583096936,0.0141347917646828,0.0637669428359489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,24195,0.00444740618430217,0.00240314893809157,-0.000262765734357313,0.00915757810296165,0.0642309950945936
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,-0.0046861365201247,0.00253276120701416,-0.00965034848587245,0.000278075445623057,0.0642955582808913
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.00722571933662811,0.00391146969848361,-0.00044076127239977,0.014892199945656,0.0647136552808642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,29478,-0.00476887921987488,0.00258190328231874,-0.00982940965321962,0.00029165121346985,0.0647513301889478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,-0.0084735061263498,0.00458933734513262,-0.0174686073228097,0.000521595070110138,0.0648522237333856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.00894087580422468,0.0048458642813106,-0.00055701818714409,0.0184387697955935,0.0650397617859329
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.00710171789722971,0.00385451368882569,-0.00045312893286865,0.0146565647273281,0.0654207544710879
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,-0.00523728325405072,0.00284283192456472,-0.0108092338261976,0.000334667318096137,0.0654466283209354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,-0.00712793017048603,0.00387154258717245,-0.014716153641344,0.000460293300371978,0.0656179374633953
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,-0.0105924447708933,0.005757014072677,-0.0218761923533402,0.000691302811553577,0.0657919509057347
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,-0.0139803765522852,0.00759992163435083,-0.0288762229556128,0.000915469851042445,0.0658454964572645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,-0.0047252478403161,0.00257218324098334,-0.00976672699264345,0.000316231312011239,0.0662134149223849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.00848396983813165,0.00461945049561036,-0.000570153133264665,0.017538092809528,0.066282580795784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,-0.00665174489782691,0.00362229704615329,-0.0137514471082874,0.000447957312633547,0.0663183450412387
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,29581,0.00974906578834652,0.00532680699797054,-0.000691475927675746,0.0201896075043688,0.0672316814497826
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,-0.0123355846136598,0.00676415137094095,-0.0255933213007041,0.000922152073384426,0.0682138869369878
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,24195,-0.00641407544550297,0.00352558091749414,-0.0133242140437915,0.000496063152785538,0.0688786362396795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,24381,0.0117762013989751,0.00648459864008247,-0.00093361193558654,0.0244860147335367,0.0693786279113485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,24833,-0.00395499615944805,0.00217794224528462,-0.00822376296020591,0.000313770641309807,0.0693927836729891
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,29786,-0.00764606140834402,0.0042265258831028,-0.0159300521392255,0.000637929322537477,0.0704509382738371
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,0.00714617568801621,0.00395029122330021,-0.000596395109652195,0.0148887464856846,0.070459621867824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.00432180364360952,0.00239175138214619,-0.000366029065397011,0.00900963635261605,0.0707807132363657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,0.00714534712585582,0.00398326065642429,-0.000661843760735778,0.0149525380124474,0.0728506538947292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,-0.0144227513864328,0.00804709102939932,-0.0301950498040555,0.00134954703118988,0.073096216406454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAX,Protein max,28774,-0.0130188415788198,0.00728111141514505,-0.0272898199525041,0.00125213679486455,0.0737817819226524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,0.0049896908807275,0.00279558973318077,-0.000489664996306806,0.0104690467577618,0.0742991721790521
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,29079,0.00469160276183223,0.0026301742563029,-0.000463538780521459,0.00984674430418592,0.0744729085528628
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BSG,Basigin,29760,-0.00253396864765312,0.00142092152671806,-0.00531897484002051,0.000251037544714277,0.0745431759236147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00439194783951888,0.00246325111496591,-0.000436024345814311,0.00921992002485206,0.0746006251688302
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,0.00954309553010442,0.00535458488988605,-0.000951890854072246,0.0200380819142811,0.0747245170751007
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,24805,-0.00528381213615162,0.00297078425158761,-0.0111065492692633,0.000538924996960108,0.0753189815595888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,29434,-0.00720690253733986,0.00405475491808501,-0.0151542221767865,0.000740417102106768,0.0755135435751783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,24240,0.00773638300785466,0.00435268578358735,-0.00079488112797655,0.0162676471436859,0.0755180419775653
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,0.00596153076653613,0.00335838140844451,-0.00062089679401511,0.0125439583270874,0.0758905964924515
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,29632,0.00755415756126339,0.00425561490544786,-0.000786847653414419,0.0158951627759412,0.0758910417205907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,24914,0.00181905658212365,0.00102565039713365,-0.000191218196258296,0.0038293313605056,0.0761475229767266
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.00537049685169272,0.00302883204481442,-0.000566013956143539,0.011307007659529,0.0762186221247196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,0.011760012302176,0.00664134744976414,-0.00125702869936175,0.0247770533037137,0.0766184197905552
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,-0.0048725588662334,0.00275311151508184,-0.0102686574357938,0.000523539703327007,0.0767665732299627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,-0.0051724191983765,0.00292477117797516,-0.0109049707072078,0.000560132310454806,0.0769920676630935
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,29478,-0.00802173799530213,0.00456292381008369,-0.0169650686630662,0.000921592672461894,0.0787534935428596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,0.00407809065697398,0.00232009187965175,-0.000469289427143442,0.0086254707410914,0.0788043716490689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,29478,0.00551845784167797,0.00314473344401348,-0.000645219708588452,0.0116821353919444,0.0792995857241362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,29694,0.00326656205079601,0.00186241595064794,-0.000383773212473957,0.00691689731406597,0.0794514568052188
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,-0.00248320439169319,0.0014160425289648,-0.0052586477484642,0.00029223896507782,0.0795078210137125
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,-0.00746903210810684,0.00426402148666458,-0.0158265142219694,0.000888450005755746,0.0798484399533254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,0.00496435053986784,0.00283601682617534,-0.000594242439435818,0.0105229435191715,0.0800507415866406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.00778321346395943,0.00445198088590544,-0.0165090960003341,0.000942669072415231,0.0804318675347058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,24421,-0.00268727164035323,0.00153762966517342,-0.00570102578409313,0.000326482503386675,0.0805334905005002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,29640,-0.00840893469147931,0.00481651684191417,-0.0178493077016311,0.00103143831867246,0.0808467084703506
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C7,Complement component C7,24374,-0.00393456034785524,0.00225373657431297,-0.00835188403350866,0.000482763337798177,0.0808593173283477
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,0.0087946849956055,0.00504000873162317,-0.00108373211837592,0.0186731021095869,0.0810016851796171
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,-0.00998957021930736,0.00573136195340579,-0.0212230396479827,0.00124389920936798,0.0813521312697968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,24016,0.00571926496213858,0.00328404886041211,-0.000717470804269166,0.0121560007285463,0.081603778612899
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.00303590851938329,0.00174404620761863,-0.000382422047549227,0.0064542390863158,0.0817418708143578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,28931,-0.00585080102038978,0.00336229925829274,-0.0124409075666435,0.000739305525863981,0.0818487526460746
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,0.00886364142697479,0.00509500436006594,-0.00112256711875445,0.018849849972704,0.0819292293697815
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,-0.0106432408153676,0.00612115955749142,-0.0226407135480508,0.00135423191731555,0.0820893105148546
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,-0.00575438923141209,0.00331011235751604,-0.0122422094521435,0.00073343098931936,0.0821479692452856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,24229,-0.00767022424048258,0.00443349403772842,-0.0163598725544303,0.00101942407346513,0.0836317516052143
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,24793,-0.00968840156202183,0.00564030060140495,-0.0207433907407755,0.00136658761673187,0.0858619920591562
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,-0.0055761642292103,0.0032517914067998,-0.0119496753865379,0.000797346928117303,0.0863931279233213
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,28774,0.00775117901357143,0.00453673588798949,-0.00114082332688798,0.0166431813540308,0.0875476234349745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,24101,-0.00734883324248585,0.00430327381514575,-0.0157832499201715,0.00108558343519982,0.0876991901574711
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,-0.00253860072831609,0.00148783824663093,-0.00545476369171271,0.000377562235080527,0.0879769798672392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,29121,0.00675769265501038,0.00396201933477685,-0.00100786524115225,0.014523250551173,0.088089840455021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,24805,0.00722733863549857,0.00424144786084294,-0.00108589917175359,0.0155405764427507,0.0883975180613855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00416660351974437,0.00245121513941423,-0.000637778153507526,0.00897098519299627,0.0891772047589721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,24016,0.00363363699662253,0.00214015859611041,-0.000561073851753868,0.00782834784499892,0.0895517978548471
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,24229,0.00393571032032336,0.00231807845033608,-0.000607723442335352,0.00847914408298206,0.0895521155459234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,-0.00921625413625518,0.00544167470488253,-0.0198819365578249,0.00144942828531457,0.0903439752645765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,0.00618219297712034,0.00367666269226455,-0.00102406589971818,0.0133884518539589,0.0926847271439597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.00226219198394489,0.00134709190711041,-0.000378108153991503,0.00490249212188129,0.0931012623703627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,24381,-0.0080281732483848,0.00478658021278432,-0.0174098704654421,0.00135352396867246,0.093511267040986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,29313,0.00448527375402025,0.00267595368257672,-0.000759595463830125,0.00973014297187062,0.0937213878513024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,29218,-0.00383547848281151,0.00229465429746049,-0.00833300090583408,0.000662043940211047,0.094636783821892
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,29497,0.0027762087365768,0.00166722363535229,-0.000491549588713695,0.00604396706186729,0.0958897138219292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.00300083005562047,0.00180247107377082,-0.00653367336021128,0.00053201324897035,0.0959567884250074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,-0.0061951224198551,0.00372327035096824,-0.0134927323077529,0.00110248746804266,0.0961465094462678
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00648767845364313,0.00389964686578994,-0.00115562940330515,0.0141309863105914,0.0961938156004274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,-0.00821425243676869,0.00495050795563524,-0.0179172480298138,0.00148874315627639,0.0970730751682478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,0.010488979025605,0.00634414603223655,-0.0019455471975786,0.0229235052487887,0.0982763653920556
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,24101,0.0103816275962831,0.00632696289365165,-0.00201921967527412,0.0227824748678404,0.100840610759915
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,28931,0.0161481976506992,0.00984190645158139,-0.00314193899440028,0.0354383342957988,0.100858305600468
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,29674,0.00588258864411903,0.00358625398998168,-0.00114646917624507,0.0129116464644831,0.100950151585484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,24307,-0.00952759303004481,0.00582436335571116,-0.0209433452072387,0.00188815914714907,0.101890832068574
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,29786,-0.00876064384749248,0.00537371913995508,-0.0192931333618044,0.00177184566681947,0.103053814793003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,-0.00770291651356578,0.0047252900053705,-0.016964484924092,0.0015586518969604,0.103083493059282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,24195,-0.0058515883111976,0.00358985814023046,-0.0128877102660493,0.00118453364365409,0.103107483803017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,24793,0.00698086779625353,0.00428269105201807,-0.00141320666570189,0.0153749422582089,0.103110191181854
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,29349,0.00964066682051855,0.0059187622769536,-0.00196010724231051,0.0212414408833476,0.10335941850107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,0.00374176593777364,0.00229924981683376,-0.000764763703220519,0.0082482955787678,0.103665946328918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,24826,0.00268522882448897,0.00165531920007044,-0.000559196807649092,0.00592965445662702,0.104777113883913
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,24195,-0.0103326149149943,0.00637711020638897,-0.0228317509195167,0.00216652108952811,0.10518818635601
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,28626,0.00752445111976588,0.00464979877714941,-0.00158915448344696,0.0166380567229787,0.105623726765169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,24867,-0.00285345819301488,0.00177381032486309,-0.00633012642974654,0.000623210043716789,0.107703349699035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,24195,-0.00660151775277478,0.00413693682645323,-0.0147099139326231,0.00150687842707356,0.110557644734795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C5,Complement C5,24966,0.00167694218449937,0.00105180232597061,-0.000384590374403034,0.00373847474340177,0.110870086155096
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.00883438622152839,0.00554644657428372,-0.0197054215071245,0.00203664906406769,0.111217985704539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00543179378750035,0.00341347441707698,-0.00125861606997052,0.0121222036449712,0.111559684322673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,24845,-0.00763600260272085,0.00479912723065982,-0.0170422919748141,0.0017702867693724,0.11159458556869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,-0.0134227046000776,0.00844534540464353,-0.029975581593179,0.00313017239302368,0.111989944099826
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,-0.0131087481731276,0.0082519572784137,-0.0292825844388185,0.00306508809256321,0.112172221131599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,24445,-0.00338546776804424,0.00213257474238856,-0.00756531426312581,0.000794378727037333,0.112411818668124
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,24111,0.00379707978943165,0.00239186299615526,-0.000890971683032648,0.00848513126189596,0.112412824376568
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,-0.00395254299035672,0.00248990472113744,-0.0088327562437861,0.00092767026307266,0.112428954066979
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,-0.0063764930448131,0.00403166790765748,-0.0142785621438218,0.00152557605419556,0.113751449443978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,29279,-0.00657129227108807,0.00416981847551879,-0.0147441364831049,0.00160155194092875,0.115055495876922
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,24229,0.00384456546385727,0.00244075580181915,-0.000939315907708269,0.00862844683542281,0.115234041525755
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,24101,0.00809770614841372,0.00514898608991645,-0.00199430658782253,0.01818971888465,0.115806125655771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,29757,-0.00326222322735151,0.00207635574392224,-0.0073318804854391,0.000807434030736087,0.116163268474416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,29434,0.00606310787691328,0.00386187437232483,-0.00150616589284339,0.01363238164667,0.116427967205499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,0.0118885521943031,0.00757329339691973,-0.00295510286365959,0.0267322072522657,0.116472532314444
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,0.0036758960650174,0.00234165466617878,-0.000913747080693005,0.0082655392107278,0.116478099847345
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,28884,-0.004475422793127,0.00285552982934127,-0.0100722612586359,0.00112141567238189,0.11705956321098
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,29349,0.0045319570547061,0.00289851587480567,-0.00114913405991301,0.0102130481693252,0.117935485840813
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,-0.00261997577593169,0.00168216966607956,-0.00591702832144762,0.000677076769584244,0.119363067668153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,-0.0107006439778206,0.00688790060879444,-0.0242009291710577,0.00279964121541647,0.120306803767869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,29400,-0.00941193337304869,0.0060748676324786,-0.0213186739327067,0.00249480718660936,0.121314813724851
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,-0.00849670509145049,0.00549158454417812,-0.0192602107980396,0.00226680061513863,0.121822250484403
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,24111,0.00556983556949984,0.0036015383543268,-0.00148917960498068,0.0126288507439804,0.121993206113547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,-0.00752402658095947,0.00488090783765384,-0.017090605942761,0.00204255278084207,0.123202935309457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,29694,0.00318343954067344,0.00207027016306467,-0.000874289978933311,0.00724116906028019,0.124134402981372
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,24111,0.00539133326449456,0.0035068110857454,-0.00148201646356642,0.0122646829925555,0.124211174965676
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,24016,0.00647143676014823,0.00421124357075997,-0.00178260063854131,0.0147254741588378,0.124378880900433
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,29434,-0.00828707582084399,0.00540002305869319,-0.0188711210158826,0.00229696937419467,0.124883743241961
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,24951,0.00561612596819196,0.00366533709541448,-0.00156793473882042,0.0128001866752043,0.125479281187956
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,0.00903942364181496,0.00590280312938996,-0.00253007049178936,0.0206089177754193,0.125686963823555
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,24445,-0.00464200213088586,0.00303834990488287,-0.0105971679444563,0.00131316368268455,0.126574237037454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,24845,0.00280679386436224,0.00184042031171003,-0.000800429946589429,0.0064140176753139,0.12725111440764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,0.00534616570126536,0.00350587405559144,-0.00152534744769387,0.0122176788502246,0.127292859929704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.00472016837567535,0.00309649259305061,-0.00134895710670385,0.0107892938580546,0.127431655059587
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,24833,0.00499962043722363,0.0032820032907908,-0.00143310601272634,0.0114323468871736,0.127685373537165
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,29478,-0.00911845993394456,0.005988757433194,-0.0208564245030048,0.00261950463511568,0.127870466839916
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,28916,-0.00887978445357152,0.005844209158653,-0.0203344344045314,0.00257486549738836,0.128668775042199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.00431099073487743,0.00283754063815262,-0.00987257038565655,0.0012505889159017,0.12870763471529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,-0.00993429854005937,0.00654305167563826,-0.0227586798243104,0.00289008274419162,0.128952193260217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,24922,-0.00754995869625698,0.00497477820617486,-0.0173005239803597,0.00220060658784574,0.129116028130866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,-0.0093537990707988,0.00621121763187496,-0.0215277856292737,0.00282018748767612,0.132092034250941
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,24101,0.00985375509336744,0.0065464440256937,-0.00297727519699221,0.0226847853837271,0.132283910836825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,0.0073329948646101,0.00487496486771353,-0.00222193627610843,0.0168879260053286,0.132539149847495
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00454535732210199,0.00302331993369283,-0.00138034974793596,0.0104710643921399,0.132740299734965
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,24938,0.0053920667730118,0.00359061691603742,-0.00164554238242154,0.0124296759284451,0.133184584550007
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,24195,0.00349418018768527,0.0023305166356993,-0.00107363241828536,0.00806199279365589,0.13380480532225
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,0.00264426076139956,0.00176820505273186,-0.000821421141954893,0.00610994266475401,0.134810406059643
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.00568026754206273,0.00380303538095669,-0.00177368180461238,0.0131342168887378,0.135289219664601
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,-0.00629795622184635,0.00421784104165302,-0.0145649246634863,0.00196901221979357,0.135403339891794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,-0.00364974187231376,0.00244552836400787,-0.0084429774657692,0.00114349372114167,0.135601443846405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,29341,0.00743039291921035,0.00498548013397491,-0.00234114814338047,0.0172019339818012,0.136128090496126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,24229,-0.00554635108916114,0.00372355299255488,-0.0128445149545687,0.00175181277624642,0.1363603745287
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,-0.00909391300246806,0.00613622826584247,-0.0211209204035193,0.00293309439858317,0.138351960698463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,-0.00793211459677222,0.00535366022615756,-0.018425288640041,0.0025610594464966,0.13845322050285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,24647,-0.00450125448772221,0.00304405480716787,-0.0104676019097712,0.00146509293432681,0.139232363983096
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.00464281149678577,0.00314888721427272,-0.0108146304367603,0.00152900744318875,0.140376653185039
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,24445,0.0172450810915864,0.0117048242552219,-0.00569637444864841,0.0401865366318213,0.140674673643954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,29820,-0.00738725168116151,0.00501992240251426,-0.0172262995900895,0.00245179622776643,0.141143042456227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,-0.0075121078454624,0.0051087421776918,-0.0175252425137383,0.00250102682281354,0.141455026166412
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,29349,-0.00555086524451183,0.00378261525587288,-0.0129647911460227,0.00186306065699902,0.142259623913221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.00312432190386613,0.00213457666650128,-0.00730809217020863,0.00105944836247637,0.143294233641966
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,24867,-0.0077490980804896,0.00530489922978824,-0.0181467005708746,0.00264850440989534,0.144098435456476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,24922,-0.00301531689837646,0.00206527443929986,-0.00706325479940419,0.00103262100265126,0.144300527953005
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,24867,-0.00362216103806784,0.00248165627768945,-0.00848620734233916,0.00124188526620349,0.144419821890691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,-0.00786652863724429,0.00539455082904343,-0.0184398482621694,0.00270679098768084,0.144788470469447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,-0.00398422462052628,0.00273952572696926,-0.00935369504538603,0.00138524580433347,0.145862786641259
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,28722,-0.00363736026928505,0.00250560457230148,-0.00854834523099596,0.00127362469242585,0.146598841179944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00283151042306642,0.00195091243049089,-0.00099227794069572,0.00665529878682855,0.146687723647925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,0.0049125727964684,0.00338830123451224,-0.00172849762317559,0.0115536432161124,0.147107605993258
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,-0.00498475202675983,0.00343990984413303,-0.0117269753212606,0.00175747126774091,0.147324332859154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,-0.00506813499402055,0.00349750462058554,-0.0119232440503682,0.00178697406232711,0.147328452319614
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,29327,-0.005942905423971,0.00410141888801413,-0.0139816864444787,0.0020958755965367,0.14735172132898
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,-0.0111725065657543,0.00772546183856933,-0.0263144117693501,0.00396939863784163,0.148133761631804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,24195,0.0060436301045465,0.0041821542518619,-0.00215339222910283,0.0142406524381958,0.148442824816154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCT,Secretin,24195,-0.00470617983803399,0.00325689343805484,-0.0110896909766215,0.00167733130055349,0.148473532816743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,28797,-0.007602698087711,0.00526978455916447,-0.0179314758236734,0.00272607964825136,0.149116955615196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00548119888115712,0.00381348557518591,-0.00199323284620727,0.0129556306085215,0.150637983017445
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,-0.00328907952098364,0.00229506019537793,-0.00778739750392437,0.0012092384619571,0.151836542791808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,0.00318716033406185,0.00222501135679584,-0.001173861925258,0.0075481825933817,0.152033288245464
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,24867,-0.00371589911304862,0.00259766447954392,-0.00880732149295469,0.00137552326685746,0.152592754162971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,24016,0.00686331843478195,0.00481028747942845,-0.00256484502489782,0.0162914818944617,0.153650543334866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,-0.00453456457593711,0.00317963308395414,-0.0107666454204872,0.00169751626861301,0.153841878003406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.00538670340164399,0.00378190403833669,-0.00202582851349593,0.0127992353167839,0.154362033708655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,29320,-0.00412903956619022,0.0029025335033963,-0.00981800523284697,0.00155992610046653,0.154873240331304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,24229,0.00656769726188314,0.00461790167419509,-0.00248339001953924,0.0156187845433055,0.154973694791111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,0.00651486354194643,0.00458260525100404,-0.00246704275002148,0.0154967698339143,0.155140698355213
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,0.0070565542027991,0.00497087133948877,-0.00268635362259889,0.0167994620281971,0.15574247686661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESPL1,Separin,24016,0.00545189308055393,0.00385632014176562,-0.00210649439730669,0.0130102805584145,0.157446728581035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,29349,0.00289603400950046,0.0020518911885536,-0.00112567272006459,0.00691774073906551,0.158138057560424
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,24229,0.00675765644891438,0.00481502912449646,-0.00267980063509868,0.0161951135329274,0.160495278236874
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,-0.00560609134947876,0.0040044682163839,-0.0134548490535912,0.00224266635463369,0.161536372464586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,-0.00706699346728455,0.00505690930001887,-0.0169785356953215,0.00284454876075243,0.162276117980243
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,24149,-0.00658285610420298,0.00472381556599942,-0.0158415346135618,0.00267582240515588,0.163467460662483
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,0.00402659592069938,0.00289903220192191,-0.00165550719506756,0.00970869903646632,0.164862399934511
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,-0.00489985612554995,0.00353844045449277,-0.0118351994163558,0.00203548716525588,0.166141684181159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,24381,-0.00736016963840541,0.00532219494804429,-0.0177916717365722,0.00307133245976139,0.166702080561633
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,-0.00655541712245057,0.00474752527172311,-0.0158605666550279,0.00274973241012672,0.16735105227393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,0.00479414983354681,0.00347478148946334,-0.00201642188580134,0.011604721552895,0.167692388625967
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,24111,0.00568259427669061,0.0041189323029733,-0.00239051303713705,0.0137557015905183,0.167714017769157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,24195,-0.00485265271825956,0.00351927928118958,-0.0117504401093911,0.00204513467287203,0.167945482236795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,-0.00506536250399116,0.00367415109369775,-0.0122666986476388,0.00213597363965644,0.168015917730915
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,29453,0.00895741804009634,0.00650315113404328,-0.00378875818262849,0.0217035942628212,0.168400145721784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.00980724658379291,0.00712350471250551,-0.00415482265271789,0.0237693158203037,0.168603659661317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,24016,-0.00750892494110291,0.00545625371001696,-0.0182031822127361,0.00318533233053033,0.168770939743932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.00605570109534921,0.0044272126567262,-0.00262163571183415,0.0147330379025326,0.171374230049691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,24111,0.00407334296365755,0.00298042137773743,-0.00176828293670781,0.00991496886402291,0.171731996593085
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,-0.00519005864213146,0.00380787623133611,-0.0126534960555502,0.00227337877128731,0.172901214829868
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00431509016285245,0.00316683756589943,-0.0105220917920153,0.00189191146631044,0.173025600472536
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,24845,-0.00430295838213713,0.00315833460654912,-0.0104932942109734,0.00188737744669914,0.173079715055633
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,0.00418419497639229,0.00308192858933502,-0.00185638505870434,0.0102247750114889,0.174585914109754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,-0.00711308275422273,0.00525829178883869,-0.0174193346603466,0.00319316915190109,0.176152160530104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,0.00297384806450871,0.00220422702187317,-0.0013464368983627,0.00729413302738012,0.17729921225987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,24867,0.00724670910096206,0.00538032882688738,-0.00329873539973721,0.0177921536016613,0.178028063170039
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.00378417470954915,0.00281364867949053,-0.0017305767022523,0.0092989261213506,0.178658869895355
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,0.00721835934587703,0.0053697233106927,-0.00330629834308066,0.0177430170348347,0.17887366918859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,0.00606953790064058,0.00451766219048063,-0.00278507999270147,0.0149241557939826,0.179118574681589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,24229,0.00700330163351317,0.00521357502686292,-0.00321530541913815,0.0172219086861645,0.179193257952117
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,-0.00688473226147778,0.00512553941828888,-0.016930789521324,0.00316132499836842,0.179212656835502
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,-0.00354891191738449,0.00264281764885954,-0.00872883450914919,0.00163101067438021,0.179332634426965
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,-0.00338678420776712,0.0025243618992364,-0.00833453353027047,0.00156096511473622,0.179723423251571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,28931,-0.00464895588160716,0.00347135717192211,-0.0114528159385745,0.00215490417536018,0.180505377287808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,24922,-0.00255186541246159,0.00190713846303025,-0.00628985680000088,0.00118612597507769,0.180889141538436
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTN,Titin,24111,-0.00622364938405444,0.00467062736225603,-0.0153780790140763,0.00293078024596738,0.18270584005216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,-0.00407251194005804,0.00305704337698147,-0.0100643169589417,0.00191929307882564,0.182813564383141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,29434,-0.00367624855023351,0.00277390345040031,-0.0091130993130181,0.00176060221255109,0.185082641182909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.005481247412243,0.0041378981685204,-0.013591527822543,0.00262903299805698,0.185301381475467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,-0.00518716618026298,0.00391984697947116,-0.0128700662600265,0.00249573389950049,0.185745349509707
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,24229,0.00934217859354388,0.00707372980931402,-0.00452233183271159,0.0232066890197993,0.186618439535781
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,0.00336113076819544,0.0025461797523693,-0.0016293815464484,0.00835164308283927,0.186824764736128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,28916,0.00486752200857473,0.0036913819740913,-0.00236758666064422,0.0121026306777937,0.187307365554564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,0.00238369401442515,0.00180813393291519,-0.00116024849408862,0.00592763652293891,0.187407787659862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,-0.00222372502013501,0.00168984265173457,-0.00553581661753476,0.00108836657726474,0.188205742684393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,0.00267709428640452,0.00203933870692065,-0.00132000957915996,0.006674198151969,0.189287512188342
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,24381,0.0102107685504235,0.00777944457764271,-0.00503694282175616,0.0254584799226033,0.189353119335384
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,0.00310073215852493,0.00236588902068208,-0.00153641032201195,0.00773787463906181,0.190005764123031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,0.00321717439021801,0.00245569698886207,-0.00159599170795165,0.00803034048838766,0.190179212198169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.00443507952378184,0.00338811419226989,-0.00220562429306715,0.0110757833406308,0.190543029536976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,0.0027773207276461,0.00212559262219274,-0.00138884081185168,0.00694348226714388,0.191357693679303
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,24938,0.00398141144525425,0.00304806796066957,-0.0019928017576581,0.0099556246481666,0.191493810090529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,0.00571962347442958,0.00437883632808066,-0.00286289572860852,0.0143021426774677,0.191497823525284
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,28797,0.0149451017482838,0.011448682260801,-0.00749431548288612,0.0373845189794537,0.191767352833463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,24966,0.00230501951733544,0.00176973053129717,-0.00116365232400701,0.00577369135867788,0.192768059959089
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00521380508774158,0.00401388834526143,-0.00265341606897082,0.013081026244454,0.193976465004573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,29039,-0.00617679873055618,0.00475604906316978,-0.0154986548943689,0.00314505743325659,0.194048717526866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,29518,-0.00340803038136929,0.00262547773377575,-0.00855396673956976,0.00173790597683118,0.194276504731896
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,24111,0.00546988183684388,0.00422045136844528,-0.00280220284530887,0.0137419665189966,0.194973460603851
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,28797,0.0027883240488587,0.00215352890670706,-0.00143259260828714,0.00700924070600454,0.195410062037056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,29163,-0.00285519310967766,0.00220591754759067,-0.00717879150295538,0.00146840528360006,0.195560483344038
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,-0.00483150802216948,0.00373731927225666,-0.0121566537957925,0.00249363775145357,0.196099728161992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,29434,-0.0033073332155133,0.0025621994989981,-0.00832924423354958,0.00171457780252298,0.196776940318705
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,0.00299205537788813,0.00232599926441804,-0.00156690318037123,0.00755101393614749,0.1983324140968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.0105615891283093,0.00821348655188793,-0.0266600227700097,0.005536844513391,0.198493742896539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.00466354234987614,0.00363717218823223,-0.00246531513905902,0.0117923998388113,0.199786663481692
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,28443,-0.00318336847460533,0.00248668745981634,-0.00805727589584536,0.0016905389466347,0.20049780909937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,-0.00652329281352383,0.00510054450707078,-0.0165203600473826,0.00347377442033489,0.200929933252181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,24381,0.00746063818201093,0.00584030219834718,-0.00398635412674954,0.0189076304907714,0.201458967843419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.0126731009716852,0.00998534415701572,-0.032244375519436,0.0068981735760656,0.204392683340359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,28830,-0.00427220855068305,0.00337501537275125,-0.0108872386812755,0.00234282157990941,0.205582823394621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00255597867113767,0.00202224516151312,-0.00140762184542804,0.00651957918770338,0.206265269427029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,24445,-0.00255329391571713,0.00203095148071037,-0.00653395881790945,0.00142737098647518,0.208696500886548
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,-0.00304948773616088,0.00243492192055241,-0.00782193470044361,0.00172295922812184,0.210435542880419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,-0.00524783860151679,0.00419058140755446,-0.0134613781603235,0.00296570095728994,0.21047489109327
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,24845,0.00234666972383381,0.00187491684902092,-0.0013281673002472,0.00602150674791481,0.210722818132292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.00274636840241804,0.00219611601057396,-0.00155801897830691,0.007050755783143,0.211108199909202
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,24229,-0.0103910789859104,0.00832847442511391,-0.0267148888591337,0.00593273088731286,0.212168778864404
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,29443,0.00449271741739329,0.00360798485421019,-0.00257893289685867,0.0115643677316453,0.213062588263725
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,-0.00781138604754931,0.00628459633099448,-0.0201291948562985,0.00450642276119987,0.213901119922265
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,23970,0.00687841732374719,0.00554800667096806,-0.00399567575135021,0.0177525103988446,0.215061612363674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,0.00167221742849294,0.00134946215849726,-0.000972728402161686,0.00431716325914756,0.215292994853203
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,24016,0.00376378302660609,0.00305243439536085,-0.00221898838830119,0.00974655444151336,0.217571777930708
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.0073971629950258,0.0060038076807552,-0.0043703000592544,0.019164626049306,0.217931744436484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,28845,0.00375470444913325,0.00305304708070497,-0.00222926782904849,0.00973867672731498,0.21877380545282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,-0.0075079293983738,0.00610695941222408,-0.019477569846333,0.00446171104958539,0.218929823086576
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.00395953223888158,0.00323457143279395,-0.00238022776939457,0.0102992922471577,0.220915234991244
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,28916,0.00910049055606827,0.00743576034155298,-0.00547359971337557,0.0236745808255121,0.221006857875434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00201474305633418,0.00165439898112416,-0.00525736505933753,0.00122787894666917,0.223307875228534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.00503281288421747,0.00413693186954876,-0.00307557358009811,0.013141199348533,0.223784718847295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,-0.00369706007015187,0.00304725671287561,-0.00966968322738807,0.00227556308708433,0.22504917772859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,-0.00307556894981449,0.00254012736180606,-0.00805421857895437,0.00190308067932538,0.225986487237277
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,-0.00196762831270173,0.00163134063066687,-0.00516505594880881,0.00122979932340534,0.227772565114534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,28114,-0.002346546022983,0.00194734026485888,-0.00616333294210641,0.0014702408961404,0.228213250848719
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,28852,0.00609363446786227,0.00507670726017712,-0.00385671176208489,0.0160439806978094,0.230027911544389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,28916,-0.00404413528401851,0.00337197122246299,-0.010653198880046,0.00256492831200895,0.230406139404766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,-0.00961782941214246,0.00802037506513346,-0.025337764539804,0.00610210571551911,0.230471525825425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,29283,-0.00317688170651866,0.00265804140464463,-0.00838664285962213,0.00203287944658482,0.232019960957942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,-0.00600395228204405,0.00502653119281539,-0.0158559534199622,0.00384804885587412,0.232312643321243
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,28797,0.00716899548148772,0.00601280203053086,-0.00461609649835276,0.0189540874613282,0.233157921571109
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,0.00248759413096348,0.00209075577959805,-0.00161028719704869,0.00658547545897566,0.234134310452269
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,29420,-0.00783349475458361,0.00658389423112734,-0.0207379274475932,0.00507093793842598,0.234135965204039
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,-0.00514213325471553,0.00433053644074009,-0.0136299846785661,0.00334571816913504,0.235074430833632
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,0.0043245743440246,0.00364214858057394,-0.00281403687390032,0.0114631855619495,0.235093872522665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_DRA,,29322,0.00296988557275238,0.00250147221008431,-0.00193299995901288,0.00787277110451763,0.235136645808665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,29478,0.00234728490175936,0.00198399686728403,-0.00154134895811733,0.00623591876163606,0.23677542714882
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,-0.00532826314973542,0.00450749234404198,-0.0141629481440577,0.00350642184458686,0.237181362617397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,-0.0045892574013129,0.00390441244022135,-0.0122419057841467,0.00306339098152094,0.23984313466304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,28931,0.00530477868318042,0.00452099710755139,-0.00355637564762031,0.0141659330139811,0.240659227451164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,0.00592048588503035,0.00504588134589957,-0.00396944155293281,0.0158104133229935,0.240672869913806
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,24229,-0.00399521391985795,0.00343105805777939,-0.0107200877131055,0.00272965987338965,0.244262803997704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00278300489232309,0.00239193300069423,-0.0019051837890376,0.00747119357368377,0.244637610097688
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,28916,0.00490565791511195,0.00421923261743753,-0.0033640380150656,0.0131753538452895,0.244965059709435
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,24195,0.00478315824783006,0.00411473447806982,-0.00328172132918679,0.0128480378248469,0.245065660552482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,28916,-0.00292673053834907,0.00251898980077701,-0.007863950547872,0.00201048947117387,0.245299182349382
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2,Complement C2,29545,-0.00187425751856732,0.00161609481172846,-0.0050418033495551,0.00129328831242045,0.246162109783451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,-0.00391551601070173,0.00337699122930487,-0.0105344188201393,0.00270338679873582,0.246276314368805
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,0.00349625488832401,0.00301541921850569,-0.00241396677994715,0.00940647655659517,0.246280636654454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,-0.0192155608740904,0.0166042216025279,-0.051759835215045,0.0133287134668643,0.247173362229465
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.00537739804277325,0.00465919713816761,-0.00375462834803527,0.0145094244335818,0.248451228190183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",29725,0.0058393862102274,0.00506954336525273,-0.00409691878566795,0.0157756912061228,0.249389336092933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,-0.00840518616763749,0.00734099561406183,-0.0227935375711987,0.0059831652359237,0.252234696097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,29413,-0.0101298954081539,0.00885470961340631,-0.0274851262504302,0.00722533543412248,0.252627911515326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,-0.00558869226203435,0.00491351244442194,-0.0152191766531014,0.00404179212903266,0.255376673348655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00281770401599781,0.0024790261402043,-0.00204118721880262,0.00767659525079823,0.25570956536176
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,-0.00319352791667097,0.00281110874836162,-0.00870330106345975,0.0023162452301178,0.25595167234923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,-0.00481039308152349,0.00424175278661562,-0.0131242285432901,0.00350344238024313,0.256781521434177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,24793,0.00268703876941715,0.00238905797921086,-0.00199551486983613,0.00736959240867044,0.260715497324076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,-0.00253346684548956,0.00225526872324201,-0.0069537935430439,0.00188685985206478,0.261296050367148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,-0.0054934485026056,0.00489693807744237,-0.0150914471343927,0.00410455012918145,0.261953008513703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,24101,0.00270493752092769,0.00241188679306164,-0.00202236059347312,0.0074322356353285,0.262085128343173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,-0.00359540899752078,0.00320727576597453,-0.00988166949883085,0.0026908515037893,0.262290199234693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,0.00311993206451923,0.00279176988019768,-0.00235193690066822,0.00859180102970667,0.263771961801927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00473042150473511,0.004241719161111,-0.00358334805104245,0.0130441910605127,0.264770161621364
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.00280546630683622,0.00252082675070609,-0.00213535412454772,0.00774628673822017,0.265754119717675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,-0.00306475616160585,0.00275566671520532,-0.00846586292340829,0.00233635060019658,0.266076488475757
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,0.00590795434538514,0.00531672423570161,-0.00451282515659002,0.0163287338473603,0.266492523049895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,24229,0.00249428300554121,0.00224718860234871,-0.00191020665506226,0.00689877266614467,0.267028523611018
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,24016,0.00315539422908815,0.00284398073817287,-0.00241880801773068,0.00872959647590698,0.267226024218402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,24111,-0.0046290503620962,0.00417745633097529,-0.0128168647708078,0.00355876404661538,0.267828553672082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,0.00671460435064392,0.00606724731223796,-0.00517720038134248,0.0186064090826303,0.268435710316947
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,24229,0.0042063448436211,0.00382396333022628,-0.0032886232836224,0.0117013129708646,0.271344745641845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,24922,-0.00401337480173778,0.00365549702946036,-0.0111781489794801,0.00315139937600453,0.272258219868087
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,-0.00518066918944145,0.00472031995608408,-0.0144324963033663,0.00407115792448335,0.272421144339017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,24229,0.00288029728246397,0.0026274955011853,-0.00226959389985922,0.00803018846478717,0.272996047927385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,-0.00324316132554976,0.00295868923128316,-0.00904219221886476,0.00255586956776525,0.273024785127462
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,28931,0.00410021386725787,0.00374677563596825,-0.0032434663792399,0.0114438941137556,0.273818815913949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,-0.00281391227981186,0.00257791158969512,-0.00786661899561429,0.00223879443599057,0.275041251744731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,24229,-0.00309051494014953,0.00283702174594123,-0.00865107756219434,0.00247004768189529,0.27600958856349
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,0.0018918653513632,0.00174096407039722,-0.00152042422661536,0.00530415492934176,0.277190397920753
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,-0.00506298260596946,0.00466450001908651,-0.014205402643379,0.0040794374314401,0.277740878180263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,24229,-0.00293800093243358,0.00270999076409698,-0.00824958283006366,0.0023735809651965,0.278314906799765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,24101,0.00551765312440119,0.00509010774407816,-0.004458958053992,0.0154942643027944,0.278377710702213
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,24229,0.00309791883838484,0.00286111432644564,-0.00250986524144862,0.0087057029182183,0.278922845657266
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,-0.00362776915042736,0.00335095211635757,-0.0101956352984882,0.00294009699763348,0.278991272561929
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPL,Periplakin,24229,0.00245196146625337,0.00226996706550588,-0.00199717398213816,0.0069010969146449,0.280075057886594
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.00446799561489375,0.00413973439870796,-0.0125818750363613,0.00364588380657384,0.280466943230406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,29433,-0.00288384931467409,0.00267644949176305,-0.00812969031852966,0.00236199168918149,0.28126995868733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,24195,-0.00452322636651274,0.00419916248398139,-0.0127535848351163,0.00370713210209078,0.281413527250056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,-0.00311692673060615,0.00289779276536888,-0.00879660055072916,0.00256274708951686,0.282107206807278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,24195,0.00307859465358159,0.00289311353591891,-0.00259190787681948,0.00874909718398266,0.28728893201943
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,0.00398214311426365,0.00374491310877993,-0.00335788657894502,0.0113221728074723,0.287635116602292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,24845,-0.0068268935729876,0.0064308449970378,-0.0194313497671817,0.00577756262120648,0.288434098854363
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,24229,0.00220942352888757,0.00208594737112097,-0.00187903331850954,0.00629788037628468,0.289521873544313
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,-0.00635733429819175,0.0060128670389315,-0.0181425536944975,0.00542788509811398,0.29039064731123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00265674565240696,0.00252017989557752,-0.00228280694292497,0.00759629824773889,0.291806977548093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,-0.00367018352157957,0.00349185518293591,-0.010514219680134,0.00317385263697481,0.29323703774728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,28797,-0.00528720706119606,0.00503228411159616,-0.0151504839199245,0.00457606979753242,0.293424741509585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,29434,0.00467874106109458,0.00445476170556286,-0.00405259188180862,0.0134100740039978,0.293598650307418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,24445,0.0041274503898437,0.00394802438089012,-0.00361067739670093,0.0118655781763883,0.295826750392247
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,-0.00240062353274665,0.00230155929842132,-0.00691167975765244,0.00211043269215915,0.296937401505043
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,0.00368923409096996,0.00354031171562405,-0.00324977687165318,0.0106282450535931,0.297390413184681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,0.00341349845667259,0.00328061959832335,-0.00301651595604117,0.00984351286938635,0.298114455644281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,29725,0.00211777410142749,0.002037687870093,-0.00187609412395478,0.00611164232680977,0.298672529189219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.00639841935536833,0.006164937451366,-0.00568485804930904,0.0184816967600457,0.299337894980683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,24816,-0.00464309749888542,0.00447726181065451,-0.0134185306477683,0.00413233564999741,0.299727543591446
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,24867,0.00428689637956768,0.00414017854431203,-0.00382785356728391,0.0124016463264193,0.300474685922071
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,-0.0061443727276762,0.00594892556354204,-0.0178042668322186,0.0055155213768662,0.301682502586371
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,24754,0.00369986201550334,0.00359076114490713,-0.00333802982851465,0.0107377538595213,0.302839960609289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,0.00559351009365092,0.00543159234887918,-0.00505241091015227,0.0162394310974541,0.303109229468519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0060603118690202,0.00590224703667903,-0.0176287160609111,0.0055080923228707,0.304534108714854
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,0.00319808963000005,0.00311607977082552,-0.00290942672081797,0.00930560598081807,0.304751572364717
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,24111,0.00340547186378976,0.00333000749872636,-0.00312134283371392,0.00993228656129343,0.306477988099285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,28931,0.00291266508915804,0.00284958335404585,-0.00267251828477183,0.00849784846308791,0.306724529725689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,29114,0.00738360601506612,0.00722803928590005,-0.00678335098529797,0.0215505630154302,0.307015364532399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,0.00178954454593979,0.00175375268051188,-0.00164781070786349,0.00522689979974307,0.307543008383681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,29713,0.00149513481002292,0.00146827211002628,-0.00138267852562859,0.00437294814567443,0.308545864762895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,24195,-0.00584449058919256,0.00574638164269895,-0.0171073986088825,0.00541841743049738,0.30912879886313
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,0.00286834920565817,0.00283019368196372,-0.00267883041099073,0.00841552882230706,0.310838579533159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.0024144419531666,0.00238276900486859,-0.00708466920270904,0.00225578529637584,0.310928748090667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,0.00261052095830922,0.00259353871506352,-0.00247281492321527,0.00769385683983371,0.314162186969297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,24195,-0.00484601492900878,0.00482194023650238,-0.0142970177925534,0.00460498793453588,0.314910402237653
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,24938,0.00637132698622662,0.00634125633838646,-0.00605753543701084,0.0188001894094641,0.315030821590462
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.00261343274300955,0.00260136821635082,-0.00248524896103805,0.00771211444705715,0.315079567250606
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0102534511001748,0.0102210405364625,-0.00977978835129166,0.0302866905516413,0.315788170619985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,24016,-0.00510889012561942,0.00510015948195772,-0.0151052027102565,0.00488742245901772,0.316492886277533
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,29478,0.00278528679381487,0.00278415176264297,-0.00267165066096535,0.00824222424859509,0.317121472579683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,24111,0.00330554930039151,0.00330930486243065,-0.00318068822997256,0.00979178683075558,0.317870050091286
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,-0.00434678472416852,0.00436664370974348,-0.0129054063952657,0.0042118369469287,0.31952475132503
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,-0.00602847425434073,0.00605729711749945,-0.0179007766046397,0.00584382809595819,0.319628642017922
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,-0.00392287728840259,0.00394643673599596,-0.0116578932909547,0.0038121387141495,0.320218107005169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0059854230842456,0.00602944292316845,-0.0178031312136558,0.00583228504516457,0.320866265061925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,-0.00766197220749398,0.0077465754799608,-0.0228452601482171,0.00752131573322919,0.322632996783179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,0.0072859558710731,0.00736642160453283,-0.00715223047381124,0.0217241422159575,0.322635505917416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,24111,-0.00507884342850894,0.00513594304234034,-0.015145291791496,0.00498760493447813,0.322730635855703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,-0.00430119874444924,0.00435217967946331,-0.0128314709161973,0.00422907342729885,0.323020659526618
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,24016,-0.00501128519677425,0.00507169128047553,-0.0149518001065063,0.00492922971295778,0.323118749529386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,24381,-0.00647521049806346,0.00659033397610326,-0.0193922650912258,0.00644184409509892,0.325847844624463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00341828602642406,0.00348154326747396,-0.00340553877782489,0.010242110830673,0.326193382655376
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,24111,0.00444008425470352,0.00453833745353208,-0.00445505715421936,0.0133352256636264,0.327910873344553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,0.00425833024278842,0.00435335238736117,-0.00427424043643948,0.0127909009220163,0.327998760683408
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,-0.0071789675452406,0.00735373860744234,-0.0215922952158276,0.00723436012534638,0.328958170522052
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,-0.00487752190878615,0.00499974496815985,-0.0146770220463795,0.00492197822880715,0.329293444784006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,24016,0.00543449932027229,0.0055794338923285,-0.00550119110869157,0.0163701897492362,0.330054723392951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,24381,-0.00261493077944787,0.00269149334676836,-0.00789025773911385,0.00266039618021811,0.331282184506411
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,24111,0.00248542003160095,0.00256088313551534,-0.00253391091400913,0.00750475097721102,0.33179092906482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,29443,-0.00167180233485911,0.00172878821541202,-0.00506022723706666,0.00171662256734844,0.333533436484043
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,24229,0.00318974646760172,0.00332487357419827,-0.00332700573782689,0.00970649867303033,0.337387640118997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,-0.00190969287429712,0.00199520648378128,-0.00582029758250843,0.00200091183391419,0.338504235077152
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,28916,0.0047313218795018,0.00494544252508952,-0.00496174546967365,0.0144243892286773,0.33872496315751
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,-0.00754256870900724,0.00788592085569664,-0.0229989735861727,0.00791383616815818,0.338849156327684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,0.00369456887774667,0.00387352788729579,-0.00389754578135308,0.0112866835368464,0.340194758909719
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,28916,-0.00399152864173951,0.00419145201334869,-0.0122067745879029,0.00422371730442391,0.340951746342264
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,-0.00202167330787028,0.00213912799332537,-0.00621436417478801,0.00217101755904745,0.344621206786352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,24195,0.00311570117570296,0.00329747789125648,-0.00334735549115975,0.00957875784256567,0.344732639764274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.00366094083658309,0.00387511713378968,-0.00393428874564468,0.0112561704188109,0.3448058917171
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,29786,-0.00176765044290926,0.00187122470044069,-0.00543525085577301,0.00189994996995449,0.344845795202314
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,-0.0055304260909668,0.00586331013741417,-0.0170225139602986,0.00596166177836497,0.345574782297447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,24229,-0.00285016809394948,0.00302599276388513,-0.00878111391116434,0.00308077772326538,0.346255688377142
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,-0.00532151733018108,0.00565240144819837,-0.0164002241686499,0.00575718950828772,0.346476232312106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_A,,24867,0.00211208217136074,0.00227058108012899,-0.00233825674569209,0.00656242108841357,0.3522793922775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00236564178360027,0.00256940807841625,-0.00740168161729613,0.00267039805009559,0.357218816188085
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,-0.00211555759306201,0.00230559519678202,-0.00663452417875478,0.00240340899263075,0.358850077763891
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,24195,0.00436138907551358,0.00475565605138107,-0.00495969678519332,0.0136824749362205,0.359101931387793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,24229,0.00297066624315533,0.0032524715839475,-0.00340417806138176,0.00934551054769242,0.361064140223262
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,-0.00480826511138313,0.00527172933216003,-0.0151408546024168,0.00552432437965054,0.361731626494374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,24203,0.00440340536510735,0.00484296193166179,-0.00508880002094976,0.0138956107511645,0.363233531315334
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00258606293849576,0.00285405189281484,-0.00300787877142133,0.00818000464841285,0.364890652609731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,0.00277560575454979,0.00306871307532282,-0.00323907187308294,0.00879028338218251,0.365747187373642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,28797,0.00571339217027943,0.00632088289641598,-0.0066755383066959,0.0181023226472548,0.366060514428406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,-0.00542295020985333,0.00600813413366173,-0.0171988931118303,0.00635299269212366,0.366746388170363
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,24793,-0.00322245616557879,0.0035717467490792,-0.010223079793774,0.00377816746261643,0.366955501262448
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,-0.00287670310590756,0.00318937591658204,-0.00912787990240835,0.00337447369059324,0.367084865783931
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00417669857238435,0.0046608432105377,-0.0133119512650382,0.00495855412026955,0.370194906455988
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,29478,0.00472758907081187,0.00527962728903961,-0.00562048041570576,0.0150756585573295,0.370559280587937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,24805,0.0019097209362145,0.00213694726551586,-0.00227869570419659,0.00609813757662559,0.371508340162034
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.00309073732467924,0.00347198087175181,-0.0037143451839543,0.00989581983331278,0.373369050835795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,24111,0.00300893849437802,0.00340069570252675,-0.00365642508257442,0.00967430207133046,0.376272871988494
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,24195,-0.00299360670796792,0.0033861372797181,-0.0096304357762154,0.00364322236027955,0.376663339061867
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,24229,0.00184867818336916,0.00209733987278306,-0.00226210796728563,0.00595946433402395,0.378088741474751
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',24111,-0.00263159812385924,0.0029902779560675,-0.00849254291775154,0.00322934667003306,0.378840273966133
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,24111,0.00282277916366314,0.00320939026518499,-0.00346762575609945,0.00911318408342572,0.379118668101541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,29349,0.00455339067167393,0.00518522688241971,-0.0056096540178687,0.0147164353612166,0.379871221378579
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.00172691626544109,0.00197020461051596,-0.00558851730205238,0.0021346847711702,0.380756654616302
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,24240,0.00428789361465776,0.00490542046575395,-0.00532673049821999,0.0139025177275355,0.382065181936636
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,-0.00176766674844395,0.00202328963954646,-0.00573331444195501,0.0021979809450671,0.382310709713249
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,24445,-0.00514497120368887,0.00595079244695898,-0.0168085243997285,0.00651858199235073,0.387274606645376
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,-0.00594049060909846,0.00689574986311943,-0.0194561603408125,0.00757517912261561,0.388986831900718
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,24445,-0.00246078144848826,0.0028854390955134,-0.00811624207569452,0.003194679178718,0.393763401400325
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,0.00383381989728704,0.00449905769797696,-0.0049843331907478,0.0126519729853219,0.394145488817358
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,24195,-0.00355552826995365,0.00418527823278265,-0.0117586736062076,0.00464761706630033,0.395593678299499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,24195,-0.0044472156100504,0.00523591140322115,-0.0147096019603638,0.00581517074026304,0.395684960829207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,-0.00511773326945389,0.00605091183564366,-0.0169775204673155,0.00674205392840769,0.397682969361233
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,0.00152830435854101,0.00182155492602292,-0.0020419432964639,0.00509855201354593,0.401471573320331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,24445,0.00306666417760881,0.00366474037990007,-0.00411622696699533,0.010249555322213,0.402711736033839
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,29454,-0.00208033653894391,0.00248822557437583,-0.00695725866472053,0.00279658558683272,0.403121002525348
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.00321351872353143,0.00384418968412845,-0.00432109305736033,0.0107481305044232,0.40319460239505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,24229,-0.00293369428360418,0.00356134105579893,-0.00991392275297008,0.00404653418576171,0.410083418414615
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.00558422931754823,0.00678237935502072,-0.00770923421829237,0.0188776928533888,0.41031929772962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,-0.00320519796678191,0.0038929479739277,-0.0108353759956802,0.00442498006211638,0.410326039318738
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,24195,0.00396867024474239,0.00482059377795413,-0.0054796935600477,0.0134170340495325,0.410360229320937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,24229,-0.00260874938655774,0.00317503569214873,-0.00883181934316925,0.00361432057005378,0.411287564335907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,-0.00157303008783677,0.00191553296086609,-0.0053274746911343,0.00218141451546077,0.41154082232347
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,24793,0.00238264757505471,0.00290733850543873,-0.00331573589560519,0.00808103104571462,0.41249267171367
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,-0.00550334503795984,0.00674142635569816,-0.0187165406951282,0.00770985061920856,0.414309390456391
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,-0.00416927796278752,0.00511547898726287,-0.0141956167778227,0.0058570608522477,0.415060866204331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.00513686725812438,0.00630297732316475,-0.00721696829527853,0.0174907028115273,0.415085707174003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,0.00248520352938307,0.00305046096654475,-0.00349369996504465,0.00846410702381079,0.415253312205907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,24793,-0.0021873997491951,0.00268790324202158,-0.00745569010355739,0.00308089060516718,0.415770746237956
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,24867,0.00386555596128369,0.00477699320084358,-0.00549735071236973,0.0132284626349371,0.418406288869187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,24951,0.00158062978258161,0.00196770986005929,-0.0022760815431346,0.00543734110829783,0.421818278950163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,24016,0.00285659618326856,0.00356265642564933,-0.00412621041100412,0.00983940277754125,0.422667135550863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0016737651475715,0.00209360804502894,-0.00242970662068522,0.00577723691582822,0.42402777055478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,29579,-0.00841608245370823,0.0105438379136337,-0.0290820047644303,0.0122498398570138,0.424761342228177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,24101,0.00264528303538431,0.00331576145027935,-0.00385360940716321,0.00914417547793183,0.424999931100167
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,0.00224483411660117,0.00281466160769379,-0.00327190263447866,0.00776157086768099,0.425139411239519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,24229,-0.00346529297442311,0.00437072887619713,-0.0120319215717695,0.00510133562292326,0.427878243780116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,24381,0.00199002684829454,0.00251122089750735,-0.00293196611081986,0.00691201980740895,0.428103764154463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.00251754760012727,0.00318719064747013,-0.00372934606891418,0.00876444126916872,0.429596521669078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,24793,0.00200564078998987,0.00255619035201947,-0.00300449229996829,0.00701577387994803,0.432683277969419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,24195,0.00157764149681991,0.00201202658283194,-0.00236593060553068,0.00552121359917051,0.43298577615927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00126735753093372,0.00162107136661967,-0.00190994234764083,0.00444465740950827,0.43433833768604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,0.00462879346335402,0.00592999781920875,-0.00699400226229514,0.0162515891890032,0.435060433899673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,24101,-0.00398455804385909,0.00510639140468408,-0.0139930851970399,0.00602396910932171,0.435217275125077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,24229,0.00311716282835172,0.0040014759218025,-0.00472572997838118,0.0109600556350846,0.435985400988343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,24966,-0.00139795985768415,0.00179597374861232,-0.00491806840496429,0.00212214868959599,0.43634918715796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,24016,0.00365722097914615,0.00470008351477645,-0.00555494270981569,0.012869384668108,0.436506947282272
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,0.00382405758810681,0.0049172079139726,-0.00581366992327947,0.0134617850994931,0.436760123559241
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,0.0032963888486594,0.00424256911431919,-0.00501904661540622,0.011611824312725,0.437178545067643
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,28931,-0.00265727150136388,0.00342291941000944,-0.00936619354498238,0.00405165054225462,0.437568019493217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,29349,-0.00442224396515405,0.00570158228053822,-0.015597345235009,0.00675285730470087,0.437981430796972
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,-0.00199489606136194,0.00257244190050331,-0.00703688218634842,0.00304709006362455,0.438059284291408
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,0.0033716025166024,0.00434828321639826,-0.00515103258753819,0.011894237620743,0.438118594352406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,28931,0.00411383085560512,0.00530703861604691,-0.00628796483184681,0.0145156265430571,0.438248475825429
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,28797,0.00233938546138654,0.00302830815647389,-0.00359609852530229,0.00827486944807536,0.439821286124748
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,-0.00177638473929509,0.002302428057565,-0.0062891437321225,0.00273637425353231,0.440402323257742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,24195,-0.00337027702705701,0.00437086078193213,-0.011937164159644,0.00519661010552998,0.440667903527679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,-0.00277169098801718,0.00363058579029882,-0.00988763913700286,0.00434425716096851,0.4452156117522
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,-0.00341400755911255,0.00447419729761594,-0.0121834342624398,0.0053554191442147,0.44544483458165
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,-0.00188946913796469,0.00247997800706967,-0.00675022603182124,0.00297128775589186,0.446133202976976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,23902,0.00231856850448603,0.00304779939799881,-0.00365511831559163,0.00829225532456369,0.446822711331359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00135375502885333,0.00178280362528756,-0.00484805013441696,0.0021405400767103,0.447656093721629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00387868950082915,0.00512199191455085,-0.00616041465169051,0.0139177936533488,0.448900359379785
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,28719,0.00181397997527865,0.00240642966591369,-0.00290262216991218,0.00653058212046948,0.450972189511993
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,24016,0.00414559048903509,0.00552204397767097,-0.0066776157072,0.0149687966852702,0.452819644839747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,-0.00443308951522574,0.00591741972304539,-0.0160312321723947,0.00716505314194323,0.453768460846787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,0.00257897357460363,0.00345381212722107,-0.00419049819474966,0.00934844534395691,0.455249846762363
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.00263944619287546,0.00355188962192797,-0.00432225746610336,0.00960114985185429,0.457422104001193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,24016,0.00479655209723682,0.00648980803442001,-0.00792347165022639,0.0175165758447,0.459859587733362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,0.0020186090117163,0.00273463315791184,-0.00334127197779091,0.00737849000122352,0.460421470550677
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.00199560921380804,0.00270698239697821,-0.00331007628426926,0.00730129471188534,0.461002991721088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,24938,0.00454374833171045,0.00616353921205696,-0.00753678852392119,0.0166242851873421,0.461008933244501
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,28931,0.00331736956047694,0.00451414618499293,-0.00553035696210921,0.0121650960830631,0.462416675628564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,0.00306960222814499,0.00421900596129706,-0.00519964945599724,0.0113388539122872,0.466886778842548
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,-0.00267221220788833,0.00368979012481787,-0.00990420085253136,0.00455977643675469,0.468938880478283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,-0.00259207116935887,0.00359745907573575,-0.00964309095780094,0.00445894861908321,0.471205485999446
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,28774,-0.00306247247413839,0.00425210574365781,-0.0113965997317077,0.00527165478343092,0.471392382696848
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARTN,Artemin,28931,0.0022196712140754,0.00309917443257909,-0.00385471067377961,0.00829405310193042,0.473865183326706
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,24111,-0.00252356841632655,0.00354735529306755,-0.00947638479073895,0.00442924795808585,0.476846802256908
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,-0.00329008822240882,0.00463815664311629,-0.0123808752429168,0.0058006987980991,0.478112402386537
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,-0.00260374884731385,0.00367302900238469,-0.00980288569198784,0.00459538799736015,0.47840357745212
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,0.00156381226735502,0.00220924444501509,-0.00276630684487456,0.0058939313795846,0.479045622558299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTTG1,Securin,24445,0.00202811212298333,0.0028767972094533,-0.00361041040754515,0.00766663465351181,0.480823427108565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,-0.00188210519235913,0.0026779294239048,-0.00713084686321254,0.00336663647849429,0.482174028291697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,28334,0.00231385256045191,0.00331859592746788,-0.00419059545738513,0.00881830057828896,0.4856593260877
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,0.0019371561564928,0.00277862779966215,-0.00350895433084501,0.00738326664383061,0.485707592675434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.00580185270996121,0.00838933662631291,-0.0106412470776121,0.0222449524975345,0.489209930489031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,24111,0.004010192400545,0.00582080448366521,-0.00739858438743881,0.0154189691885288,0.490866863560765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,-0.0036042194844479,0.00523456267125069,-0.0138639623200993,0.00665552335120346,0.491117738510367
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,24793,0.00211306464507812,0.00308199680249121,-0.00392764908780465,0.00815377837796089,0.492962046142499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.00191949612067222,0.00280054224993414,-0.00356956668919868,0.00740855893054313,0.49309696147675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,0.00336306370818842,0.00492227906081033,-0.00628460325099984,0.0130107306673767,0.494466166800902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,24867,0.00177193717737316,0.00259485735993597,-0.00331398324810133,0.00685785760284765,0.494698539821468
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.00311772360128115,0.00457335240214673,-0.0120814943094887,0.00584604710692644,0.495425617304838
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,0.00259436826414582,0.00382130612347079,-0.00489539173785693,0.0100841282661486,0.497193714437577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.00107054556355907,0.00157910221881208,-0.00202449478531261,0.00416558591243074,0.497812414209399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,24101,0.00452463546118293,0.00671840518543777,-0.0086434387022751,0.017692709624641,0.500655630619859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,-0.0013895370018074,0.00206519149001861,-0.00543731232224388,0.00265823831862908,0.501057500849403
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,0.00287547965597364,0.00428414684311297,-0.00552144815652779,0.0112724074684751,0.502105468248741
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,0.00215775783322571,0.00321663938502074,-0.00414685536141493,0.00846237102786636,0.502346002897177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,0.00220357833497241,0.00328973025683645,-0.00424429296842703,0.00865144963837184,0.50296901324489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,28931,0.00222872463212414,0.00333570153409816,-0.00430925037470826,0.00876669963895654,0.504047839648838
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00267824002266603,0.004011847634545,-0.00518498134104217,0.0105414613863742,0.504406430672519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,24195,-0.00302245627102285,0.00453406775272768,-0.0119092290663691,0.00586431652432339,0.505027447372336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,29443,-0.00558065650378134,0.00837941809762722,-0.0220043159751307,0.010843002967568,0.50541906283258
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,29565,-0.00177624265565979,0.0026716355922809,-0.00701264841653035,0.00346016310521076,0.506150254453424
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,-0.0011429308489633,0.00172214844358782,-0.00451834179839544,0.00223248010046883,0.506909546000945
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.00845013755146394,0.0128375912357793,-0.0167115412706635,0.0336118163735914,0.510393020645332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,24101,0.00200242227779239,0.00305867403130747,-0.00399257882357025,0.00799742337915503,0.512686464060372
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,0.00233351468318936,0.0035678381608424,-0.00465944811206175,0.00932647747844047,0.513091227393315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.00414733464342257,0.0063503239744576,-0.00829930034651432,0.0165939696333595,0.513704141780782
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,23970,-0.00161010391350344,0.00246816791185632,-0.00644771302074183,0.00322750519373495,0.514183088155156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,-0.00127273245748381,0.00195248347911083,-0.00509960007654104,0.00255413516157343,0.514502110511831
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,0.00277877088500774,0.00426444777417886,-0.00557954675238283,0.0111370885223983,0.514656847191231
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,0.00409189484600413,0.00629708600226354,-0.00825039371843241,0.0164341834104407,0.515822621454392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00117492137414561,0.00181571354562159,-0.00473371992356393,0.0023838771752727,0.517582930264074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.00212539259953769,0.00329294948769081,-0.0043287883963363,0.00857957359541168,0.518648953031278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00248982890517685,0.00386597818702516,-0.0100671461517462,0.00508748834139246,0.519558235608354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,29725,0.00268393459898829,0.0041734134963166,-0.00549595585379224,0.0108638250517688,0.520162253000946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,-0.00292570111792992,0.00455812979280575,-0.0118596355118292,0.00600823327596934,0.520967324634468
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,0.00416369799145965,0.00650396717374645,-0.0085840776690834,0.0169114736520027,0.522062865345348
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,-0.00332662451206184,0.00522110370699718,-0.0135599877777763,0.00690673875365263,0.524032424134402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,24016,-0.00263323949183429,0.00414036477841567,-0.010748354457529,0.00548187547386043,0.524787603496635
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,-0.00451042265578932,0.00709337333364445,-0.0184134343897324,0.00939258907815379,0.524870899412436
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.00131520914848848,0.00207315241979241,-0.00274816959430463,0.0053785878912816,0.525824306572875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,24445,0.00196481578528078,0.00310642224281922,-0.00412377181064489,0.00805340338120644,0.527065346208847
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,0.00482670240573835,0.00768393340819272,-0.0102338070743194,0.0198872118857961,0.529908435181308
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,0.00429830631787831,0.0068527294008258,-0.00913304330774025,0.0177296559434969,0.530507838330937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.003404561455341,0.00543412995108324,-0.00724633324878215,0.0140554561594641,0.530983413764281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.00140964523781163,0.00226398405895642,-0.00302776351774295,0.00584705399336621,0.533527532841848
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.00201753935864884,0.00324567154172852,-0.00434397686313906,0.00837905558043675,0.534203779392078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,24111,-0.00478478676486905,0.00772133034910177,-0.0199185942491085,0.0103490207193704,0.535471549674753
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,24101,-0.00322526184458187,0.00520782711081654,-0.0134326029817823,0.00698207929261854,0.535717707261219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,24059,0.00365589958080408,0.00592814370826381,-0.00796326208739299,0.0152750612490011,0.537436973701054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,28797,-0.00438966010109901,0.00715802458982171,-0.0184193882971496,0.00964006809495154,0.539715753774318
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,0.00267983497691203,0.00437858294428491,-0.00590218759388639,0.0112618575477104,0.540521106871413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,29434,0.00209122050410174,0.00342016614379944,-0.00461230513774517,0.00879474614594865,0.540914191261188
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,-0.00256913600221782,0.00420791242247959,-0.0108166443502778,0.00567837234584219,0.541503875101641
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,28774,-0.00137304064632819,0.002255603958245,-0.00579402440448839,0.00304794311183202,0.542712091563268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,-0.00389239665737131,0.00643303209351415,-0.016501139560659,0.00871634624591641,0.545142138931575
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,0.00178104811840851,0.00294874146573287,-0.00399848515442792,0.00756058139124494,0.545847443125098
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,-0.00273201578615562,0.00453967721087615,-0.0116297831194729,0.00616575154716163,0.547306414740458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,-0.00156206408139404,0.00260004472817448,-0.00665815174861601,0.00353402358582793,0.547989790333279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,-0.00215668242224617,0.00360107180511328,-0.00921478316026819,0.00490141831577586,0.54924416940565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BSND,Barttin,24016,0.00140275917240473,0.00235659476030114,-0.0032161665577855,0.00602168490259496,0.551683078849353
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,24421,0.00158309389011128,0.00266204375500554,-0.00363451186969958,0.00680069964992215,0.55205544431334
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,-0.00203605235864557,0.00342483034006667,-0.00874871982517623,0.0046766151078851,0.552184981678589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,-0.00519871154155317,0.00877412793564108,-0.0223960022954097,0.0119985792123033,0.553518103000247
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,29590,0.00168306965125921,0.00284668162718782,-0.00389642633802893,0.00726256564054734,0.554364706846867
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,24101,0.00266080387329132,0.00450638725515925,-0.00617171514682081,0.0114933228934034,0.554893418902304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,0.00138676130611227,0.00235034425637507,-0.00321991343638287,0.00599343604860742,0.555179582265569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,0.00169841343653066,0.00288063438879474,-0.00394762996550702,0.00734445683856835,0.555466362098361
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,-0.000982100312813765,0.00166747525907536,-0.00425035182060147,0.00228615119497394,0.555883909159523
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,28931,-0.00158832724494134,0.00269816698795513,-0.00687673454133338,0.00370008005145071,0.556087939586278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,29523,0.0022498919101504,0.00382613959324714,-0.00524934169261399,0.00974912551291479,0.556515420608687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.00233706749183711,0.00398170259305531,-0.0054670695905513,0.0101412045742255,0.557240706196054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.00112749475156923,0.00194594310538931,-0.00494154323813228,0.00268655373499382,0.562319231171024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,24195,0.00261481250907512,0.00454708471030712,-0.00629747352312683,0.0115270985412771,0.565261129856595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.0023074396623512,0.00401834800177397,-0.00556852242112579,0.0101834017458282,0.565820279455857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,0.00190461308201881,0.00333031096352813,-0.00462279640649634,0.00843202257053395,0.567393381981065
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,0.00127631464566338,0.00223366474155812,-0.00310166824779053,0.00565429753911729,0.567734099810121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,29694,-0.00207075493116111,0.00362934345571871,-0.00918426810436977,0.00504275824204756,0.568302869903385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,28797,0.00317592874487941,0.00557293462274508,-0.00774702311570094,0.0140988806054598,0.568760524669801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,0.00195069639878462,0.0034366592264256,-0.00478515568500956,0.0086865484825788,0.57030230722969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,-0.00463215690061785,0.00816878807026739,-0.0206429815183419,0.0113786677171062,0.570680818779456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,24229,0.000861223037588706,0.00152122760954659,-0.00212038307712261,0.00384282915230002,0.571305987364294
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00212389234240143,0.00376012979712603,-0.00524596205996559,0.00949374674476845,0.572184144370977
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,24101,0.00302318424548222,0.00536478708913717,-0.00749179844922663,0.0135381669401911,0.573083626165283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,-0.00186551682610821,0.00331974526125048,-0.00837221753815915,0.00464118388594274,0.5741573517084
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.0020392993598864,0.00363393430165214,-0.0050832118713518,0.00916181059112459,0.57467846175237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,-0.00266770076440145,0.00475806872668326,-0.0119935154687006,0.00665811393989775,0.57502848372247
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.00345401011810682,0.00617505325475471,-0.00864909426121242,0.0155571144974261,0.575928672965288
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,-0.001576120617922,0.00281900015193422,-0.00710136091571306,0.00394911967986906,0.576093470022089
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,28916,-0.00181800686459615,0.00325801778761847,-0.00820372172832835,0.00456770799913604,0.576841802611959
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,28774,-0.00228777783650383,0.00413311527473103,-0.0103886837749767,0.00581312810196899,0.579909063879322
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,24229,0.00336027904606651,0.00607240340811653,-0.00854163163384189,0.0152621897259749,0.580015955870398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,24016,0.00205556875028808,0.0037226899178442,-0.00524090348868655,0.00935204098926272,0.580834992541007
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,24922,-0.00249789182788383,0.0045285607055294,-0.0113738708107214,0.00637808715495379,0.581236805716586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,24845,0.000863410796599194,0.0015658978004245,-0.00220574889223282,0.00393257048543121,0.581375513763068
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",24966,-0.000634731472480543,0.00115279581886289,-0.00289421127745182,0.00162474833249073,0.581911592242405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,28931,-0.00120065289223614,0.00218634878689052,-0.00548589651454156,0.00308459073006928,0.582900648320256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,-0.0014934476524742,0.00272493504546609,-0.00683432034158775,0.00384742503663935,0.583650804967431
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.00159598876927536,0.00293912005283056,-0.00416468653427253,0.00735666407282325,0.587123098741876
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,24445,0.00129590008031954,0.00238915578512154,-0.00338684525851869,0.00597864541915776,0.587541590066873
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,28774,0.00198247522936692,0.0036682925176594,-0.00520737810524551,0.00917232856397935,0.588900967324836
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,0.00275351234547882,0.00510778831456233,-0.00725775275106335,0.012764777442021,0.58983578103115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.00150351408644142,0.00279121992988344,-0.00396727697613011,0.00697430514901296,0.590127554732691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.00463879309383894,0.00865258277157198,-0.0123202691384421,0.02159785532612,0.591882124126731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,29461,0.00692905868986243,0.0129761212265657,-0.0185041389142064,0.0323622562939313,0.593355697818613
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,29645,-0.00181369210594044,0.00341149894836012,-0.00850023004472628,0.0048728458328454,0.594978771092832
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,0.00206725031199602,0.00392573082900466,-0.00562718211285312,0.00976168273684515,0.598483237210359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",24793,-0.00158365667010681,0.00300818209640155,-0.00747969357905385,0.00431238023884024,0.598580478916158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,-0.00171589453145425,0.00329643721624642,-0.00817691147529723,0.00474512241238873,0.602698992199074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,0.0015552191995818,0.0029880682948427,-0.0043013946583099,0.0074118330574735,0.602736316689275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,-0.00190669202351651,0.00367703374480309,-0.00911367816333057,0.00530029411629755,0.604085709114482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00620633054958274,0.0119698876437435,-0.02966731033132,0.0172546492321545,0.604117362303828
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,-0.00333849984917369,0.00651573046962059,-0.0161093315696301,0.00943233187128267,0.608392178700846
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,24421,0.00349181686935315,0.00685384991111082,-0.00994172895642405,0.0169253626951304,0.610428863499328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,24793,0.00133848859866413,0.00263309568676778,-0.00382237894740072,0.00649935614472898,0.611224577598948
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,28872,0.00197955645240832,0.00389622581328229,-0.00565704614162497,0.00961615904644162,0.611407956038954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,-0.00152473095676882,0.00301864147071785,-0.0074412682393758,0.00439180632583816,0.613488927955911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,-0.00102944024578077,0.002039183407156,-0.00502623972380653,0.00296735923224499,0.613683123523365
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,-0.00347301525906379,0.00691065673083059,-0.0170179024514917,0.0100718719333642,0.615277866237531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,-0.00197001772592767,0.00392126857778407,-0.00965570413838446,0.00571566868652911,0.615394857785933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,-0.00102423258649156,0.00204336411898167,-0.00502922625969564,0.00298076108671252,0.616201012533548
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,0.00126258804369999,0.00252004188491984,-0.0036766940507429,0.00620187013814287,0.61636254110237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,24016,0.00154205776842931,0.00308448653313041,-0.0045035358365063,0.00758765137336491,0.617122006986108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,0.00188323179276949,0.00377816195800291,-0.00552196564491622,0.00928842923045519,0.618170098329074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.00147130669762382,0.00297066469427229,-0.00435119610314987,0.0072938094983975,0.620407853335937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,24381,-0.00369353602129592,0.0075157331983815,-0.0184243730901237,0.0110373010475318,0.623119319811922
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,29566,0.000733138026348725,0.00151120798511265,-0.00222882962447207,0.00369510567716952,0.627585055104969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,0.00167346208679139,0.00348851894438991,-0.00516403504421284,0.00851095921779562,0.631441081284333
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,24922,0.00163261223536723,0.00341536958733274,-0.00506151215580494,0.0083267366265394,0.632640735172136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,-0.00129957210355003,0.00271900986518415,-0.00662883143931096,0.0040296872322109,0.632683819925326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.0016199059537151,0.00341583519129433,-0.00507513102122179,0.00831494292865199,0.635337188980204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,0.00274363073530376,0.00579726902772973,-0.00861901655904651,0.014106278029654,0.636030054610494
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00165376672146301,0.00350286710900056,-0.00851938625510411,0.0052118528121781,0.636846818360137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00179737630549037,0.00382791685438608,-0.00930009334008708,0.00570534072910634,0.638684936730129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,-0.00247927642825272,0.00541173560144075,-0.0130862782070766,0.00812772535057115,0.646862757086902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00220982176847211,0.00483121645673354,-0.00725936248672562,0.0116790060236698,0.647384198813148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,24229,0.00198354141704295,0.0043415800126936,-0.00652595540783651,0.0104930382419224,0.647767964402687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,28931,0.00286689613604418,0.00635681824929034,-0.00959246763256488,0.0153262599046532,0.651996206728673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.00166484994230727,0.00370151945775005,-0.00559012819488282,0.00891982807949738,0.652876789214754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.00152011862169981,0.00342883757863872,-0.00520040303243207,0.00824064027583169,0.657528441941773
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,24445,-0.00221236524692832,0.00499195303276906,-0.0119965931911557,0.00757186269729905,0.657634904012708
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.00243094597330915,0.00548586578314392,-0.00832135096165295,0.0131832429082712,0.657675792973283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,24445,0.00229265147721966,0.0051826349658451,-0.00786531305583674,0.0124506160102761,0.658224109360223
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.00208471016236818,0.00471660433115039,-0.00715983432668658,0.0113292546514229,0.658496971203144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.000893214977938044,0.00202465699435379,-0.00307511273099539,0.00486154268687148,0.659094922926732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,23913,0.00105735093785722,0.00240510914443453,-0.00365666298523447,0.0057713648609489,0.660211251223458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,29694,0.00197990316384362,0.00452690818962689,-0.00689283688782509,0.0108526432155123,0.661851132220831
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,28931,0.00188071342242406,0.00432186186344234,-0.00659013582992293,0.0103515626747711,0.663447524619009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,-0.00205383393595001,0.00473482463507445,-0.0113340902206959,0.00722642234879591,0.664457845150729
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,-0.000967623422474395,0.00223271360032326,-0.00534374207910799,0.0034084952341592,0.66473935466424
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,24793,-0.00133750905003513,0.00310623407316093,-0.00742572783343055,0.0047507097333603,0.666771260640102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.00158500214991447,0.0037548603651551,-0.00894452846561846,0.00577452416578952,0.672941049100571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00185016505056947,0.00440642532280538,-0.00678642858212908,0.010486758683268,0.67457767535562
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,24195,-0.00121713300680057,0.00290588537846826,-0.00691266834859836,0.00447840233499721,0.675328747347654
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,29683,0.00175136211489871,0.00418162011665027,-0.00644461331373581,0.00994733754353323,0.675347926229587
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,0.00158402961394522,0.00378313559427357,-0.00583091615083097,0.00899897537872141,0.675433169986014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,-0.00102642714093448,0.00245630253217228,-0.00584078010399215,0.00378792582212319,0.676041697866935
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,24381,-0.00333906315973277,0.0080371507235857,-0.0190918785779607,0.0124137522584952,0.677813537685747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,28774,0.00160089113821968,0.00385500272534547,-0.00595491420345745,0.0091566964798968,0.677942771420762
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,-0.00249187451301444,0.00603878802460261,-0.0143278990412356,0.00934415001520668,0.679870521915176
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00139824457926842,0.0034046462620041,-0.00807135125279646,0.00527486209425963,0.681305566005668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00163702258445919,0.00399177748588518,-0.00618686128787576,0.00946090645679414,0.68173723836623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,29434,-0.00184114875923022,0.00451301610035523,-0.0106866603159265,0.00700436279746603,0.683302966575263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.00115055714508849,0.00282515629287083,-0.00438674918893833,0.00668786347911531,0.68382422740265
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,24867,-0.00125694942479397,0.00308998762477956,-0.0073133251693619,0.00479942631977396,0.68417206780596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,24229,0.00134430708846054,0.00331085438478802,-0.00514496750572399,0.00783358168264506,0.684723949618221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,24229,-0.000609068167804581,0.0015067974028484,-0.00356239107738744,0.00234425474177828,0.686059142992001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,29349,-0.0024018833246196,0.00595155584586226,-0.0140669327825096,0.00926316613327044,0.686530169966697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,24195,-0.000989421843759098,0.00245186707007772,-0.00579508130111144,0.00381623761359324,0.686555960936444
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,28931,-0.00170702228219961,0.00426433929178709,-0.0100651272941023,0.00665108272970309,0.688937270604644
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00129866728974644,0.00325233645315766,-0.00507591215844258,0.00767324673793545,0.689672923492344
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NENF,Neudesin,24793,-0.00302667400424175,0.00762751736776117,-0.0179766080450536,0.0119232600365701,0.691511105692713
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,29661,-0.00117013894439009,0.00296986195442439,-0.00699106837506191,0.00465079048628172,0.693580558112074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,-0.00107807502272953,0.00274248027890933,-0.00645333636939181,0.00429718632393276,0.694246845599599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,-0.00074934076249687,0.0019091809560602,-0.00449133543637487,0.00299265391138113,0.694697108228903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,0.00154637394446705,0.00394503570114808,-0.00618589602978319,0.00927864391871729,0.6950766732017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,0.002290414868677,0.00588717094840907,-0.00924844019020478,0.0138292699275588,0.69724121511684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.00154506979402897,0.00398376023121986,-0.00626310025916196,0.00935323984721989,0.698135770321175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,0.00131315471227524,0.00340941859857043,-0.00536930574092281,0.00799561516547329,0.700125974026934
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0016448681702178,0.0043239613250588,-0.00683009602689745,0.0101198323673331,0.703646043609611
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,24101,0.0012901286445655,0.00343108733924486,-0.00543480254035442,0.00801505982948543,0.706911582801649
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00199384680518145,0.00531276511090928,-0.00841917281220074,0.0124068664225636,0.707445319535484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.00115367551114046,0.00309596770422634,-0.00491442118914317,0.00722177221142409,0.709421076443334
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.00216781529688309,0.00583422464417186,-0.00926726500569376,0.0136028955994599,0.710217248632389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,0.001024287758733,0.00275936819313849,-0.00438407389981845,0.00643264941728445,0.710489060416368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,24229,0.00158184257916067,0.00426243989835715,-0.00677253962161935,0.00993622477994069,0.710557362997038
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,-0.000997936503735684,0.00269607301658375,-0.00628223961623984,0.00428636660876847,0.711278061685737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.00264967238931052,0.00719313367266593,-0.0114488696091147,0.0167482143877357,0.712607041499163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,0.00222618165418649,0.00606935003596923,-0.00966974441631319,0.0141221077246862,0.713778316386076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,29343,-0.00273219470779147,0.00752136748182607,-0.0174740749721706,0.0120096855565876,0.716415001192289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,0.00063930144440377,0.0017614159612651,-0.00281307383967583,0.00409167672848337,0.71664721246257
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,24229,-0.000661240742698747,0.0018328485685494,-0.00425362393705557,0.00293114245165807,0.718272920967535
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.000947201887420575,0.00262651587127959,-0.00609517299512858,0.00420076922028743,0.718378791663046
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,-0.00121056662511389,0.00335855200311217,-0.00779332855121374,0.00537219530098596,0.718519019893345
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,-0.00174114856514097,0.00484103957542008,-0.0112295861329643,0.00774728900268239,0.719101385189357
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,-0.000853338360163775,0.00240124457261022,-0.00555977772247981,0.00385310100215226,0.722312494510851
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,24805,0.000862791557337954,0.00248441060203394,-0.00400665322264857,0.00573223633732448,0.728382276703601
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,-0.0026074959247682,0.0075209722105421,-0.0173486014574307,0.0121336096078943,0.728822250342876
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,-0.00116840533472228,0.0033885371678455,-0.00780993818369945,0.0054731275142549,0.730239281841095
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,-0.00218969205657255,0.00635139005494507,-0.0146384165642649,0.0102590324511198,0.730279359615396
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,0.000755081664588475,0.00220627292858682,-0.00356921327544168,0.00507937660461863,0.732170458675423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,24195,0.00153396341251555,0.00464508596573328,-0.00757040508032169,0.0106383319053528,0.741226329156524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,0.00191043680398011,0.00583600219036833,-0.00952812748914181,0.013349001097102,0.743403239556474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,24016,-0.00164188785851561,0.00502444468078131,-0.011489799432847,0.00820602371581575,0.743837163081882
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,-0.00185361851521467,0.00570382073118284,-0.013033107148333,0.00932587011790369,0.745199732909668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,-0.00130589926587812,0.0040206778686259,-0.00918642788838489,0.00657462935662865,0.74533793423525
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,29414,-0.00201616033614279,0.00628455006759289,-0.0143338784686248,0.0103015577963393,0.748354993303849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,-0.00183901804358945,0.00586028281781765,-0.013325172366512,0.00964713627933314,0.753667274035475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,24867,-0.000984517538878218,0.00313853912065295,-0.00713605421535799,0.00516701913760156,0.753761742425031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,29478,-0.000743648745149998,0.00237091061700776,-0.00539063355448521,0.00390333606418521,0.753785053832854
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,29166,-0.00152208095850949,0.00486182247207417,-0.0110512530037749,0.00800709108675589,0.754231252198878
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,0.00173007816325895,0.00553159880749177,-0.00911185549942491,0.0125720118259428,0.754463572415344
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,0.000818048331662665,0.00261679694728018,-0.0043108736850065,0.00594697034833183,0.754576354327092
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,24636,-0.00214079000075006,0.0068863968757893,-0.0156381278772971,0.011356547875797,0.755900338631264
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,-0.0022153713348766,0.00716762683938726,-0.0162639199400756,0.0118331772703224,0.75726320474588
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,0.00197750634568345,0.00642720948388494,-0.010619824242731,0.0145748369340979,0.758330554073861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.00163594770109451,0.00534550612650162,-0.00884124430684866,0.0121131397090377,0.759575542262912
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,27585,0.00103008511987317,0.00339299523993591,-0.00562018555040121,0.00768035579014755,0.761441282987149
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,-0.000774353371864515,0.00255387461548438,-0.00577994761821391,0.00423124087448488,0.761734036834525
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.00129503820693911,0.00429057649970962,-0.00711449173249174,0.00970456814636997,0.762781866859038
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,24229,-0.000895832141269663,0.00298697278105235,-0.00675029879213227,0.00495863450959294,0.764246047957563
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,-0.000982359069714529,0.00328010423625247,-0.00741136337276937,0.00544664523334031,0.764568553727704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,24240,0.00177929151867784,0.00596745073089374,-0.00991691191387389,0.0134754949512296,0.765578950052405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,28774,-0.00139274740559346,0.00467514467860223,-0.0105560309756538,0.00777053616446691,0.765778079877864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,24195,-0.00119559115295457,0.00401421862826654,-0.00906345966435699,0.00667227735844785,0.765828550374997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,-0.000459167591367646,0.00154674056115549,-0.00349077909123241,0.00257244390849712,0.766574798425236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,0.000937827585763214,0.00316231895942019,-0.00526031757470035,0.00713597274622678,0.766802492998302
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00068397690012935,0.00231325200610887,-0.00384999703184404,0.00521795083210274,0.767478396847806
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,-0.00198514420877115,0.00682717363565237,-0.0153664045346498,0.0113961161171075,0.771228956917861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,0.000804569098008163,0.00277095508188769,-0.0046265028624917,0.00623564105850803,0.77154443109663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,-0.000544181961248104,0.00188966536651664,-0.00424792607962072,0.00315956215712452,0.773365681141164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,24445,-0.00119999903552252,0.00418160822481322,-0.00939595115615644,0.0069959530851114,0.774137189461999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,0.00105610818531677,0.00370242807273261,-0.00620065083723914,0.00831286720787268,0.775457018512993
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,28774,-0.000941413752973804,0.00333174778221129,-0.00747163940610793,0.00558881190016033,0.777517307567161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,28797,0.000769788657669085,0.00272983933834158,-0.00458069644548042,0.00612027376081858,0.777952850861351
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,-0.00123243043954176,0.00440787526042746,-0.00987186594997958,0.00740700507089606,0.779788815268841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,-0.00100654520888099,0.00363691051506741,-0.0081348898184131,0.00612179940065112,0.781968003139514
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,29349,-0.00359874851403455,0.0130933526392263,-0.029261719686918,0.0220642226588489,0.783431039035921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,-0.0006192572555057,0.0022659468993036,-0.00506051317814076,0.00382199866712936,0.784633353030263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,-0.000589534572241596,0.00216680690311275,-0.00483647610234258,0.00365740695785939,0.785566464187918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEB,Nebulin,24111,-0.000705343075377612,0.0026369815278366,-0.00587382686993735,0.00446314071918213,0.789100949599567
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,28916,-0.000970707438498135,0.00364138375941231,-0.00810781960694626,0.00616640472994999,0.789797131790136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,-0.00078459257014373,0.00297181594518567,-0.00660935182270764,0.00504016668242018,0.791773159787881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPGN,Epigen,24793,0.000872963495712033,0.00333063223058933,-0.00565507567624306,0.00740100266766713,0.793245417197123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,-0.000880821031730868,0.00338102568149297,-0.0075076313674571,0.00574598930399536,0.794465778075968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.00216063532977447,0.00831832701307394,-0.0141432856158505,0.0184645562753994,0.795063086320567
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,-0.000942150636486775,0.00363433300924759,-0.00806544333461204,0.00618114206163849,0.795454864875978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,29163,-0.00135164957377728,0.00523251416201389,-0.0116073773313245,0.00890407818376993,0.796163764682577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,29566,0.00141565094624345,0.00548560455308238,-0.00933613397779802,0.0121674358702849,0.79635735709588
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,29218,-0.000764902271827693,0.00296921602338874,-0.00658456567766963,0.00505476113401424,0.796709068133629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.0020165762374184,0.00788318309802891,-0.0134344626347183,0.0174676151095551,0.798101775854289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.000530975895968121,0.00210092298691091,-0.00358683315837726,0.00464878495031351,0.800475064352639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.00212712550008482,0.00853372985872235,-0.014598985023011,0.0188532360231806,0.803160724256299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,24111,-0.00155572748908141,0.00628137593389643,-0.0138672243195184,0.0107557693413556,0.804389501254737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.000595935252313135,0.00242117440247724,-0.00414956657654226,0.00534143708116853,0.805579589845615
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,28774,0.000804197109508262,0.00328448433737671,-0.00563339219175008,0.00724178641076661,0.806576417994431
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,0.000638278193378022,0.00263467432276816,-0.00452568347924757,0.00580223986600361,0.808580182804282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,29381,-0.000683933711492211,0.00283843345545054,-0.00624726328417527,0.00487939586119085,0.809591954937955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,29594,0.00097285863678452,0.00404066495024385,-0.00694684466569342,0.00889256193926246,0.809737403239208
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,24111,-0.000795028768320821,0.00332808991384089,-0.00731808499944897,0.00572802746280733,0.811197252464793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,-0.000771365430191083,0.00325935100530622,-0.00715969340059128,0.00561696254020911,0.812920813924134
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.000377671761712891,0.00161247884714663,-0.0027827867786945,0.00353813030212028,0.814817265184804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,-0.00104614655709782,0.00463156229760593,-0.0101240086604054,0.0080317155462098,0.82130151119982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,24445,0.000835935419598879,0.00372284956991216,-0.00646084973742895,0.00813272057662671,0.822337607357695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,29694,-0.000464334868509679,0.00207995266923443,-0.00454104210020917,0.00361237236318981,0.823347925430645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,-0.000541415324076332,0.00243798608297092,-0.00531986804669933,0.00423703739854667,0.824257177215745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,-0.000585981391130937,0.00266389777075782,-0.00580722102181626,0.00463525823955438,0.825895219968977
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,0.000557648175227549,0.00253719985351042,-0.00441526353765288,0.00553055988810798,0.826037428114388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,-0.000679169281921658,0.00315236688431507,-0.0068578083751792,0.00549946981133589,0.82942028282004
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,0.00187182536836121,0.0087152430320549,-0.0152100509744664,0.0189537017111888,0.829943733202919
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,0.000727334033046781,0.00340521956085041,-0.00594689630622002,0.00740156437231358,0.830865253383597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,0.000469802319218379,0.00221762154429877,-0.0038767359076072,0.00481634054604396,0.832226141321024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,28745,0.000820113582483448,0.00389851571439077,-0.00682097721772246,0.00846120438268935,0.833383833872216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.000831269520610432,0.003964531449347,-0.00860175116133055,0.00693921212010969,0.833921528331208
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.000591258119993948,0.00283646002636817,-0.00496820353168766,0.00615071977167556,0.834879915407775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,24016,-0.000589722975670123,0.00284943717894065,-0.0061746198463938,0.00499517389505356,0.836041905609702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.000721538911775895,0.00349040821794798,-0.00611966119540215,0.00756273901895394,0.836229898361917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,-0.000630101639646874,0.00305341117684897,-0.00661478754627086,0.00535458426697711,0.836511523041572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,28757,-0.00154074672382762,0.00759759950183504,-0.0164320417474243,0.0133505482997691,0.839297572667848
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,-0.00074769275438685,0.00368731583906394,-0.00797483179895218,0.00647944629017848,0.839313266448256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.000909716941862216,0.00448738999459892,-0.00970500133127609,0.00788556744755166,0.839349787735163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.000683212392234503,0.00339955534481609,-0.00597991608360504,0.00734634086807404,0.840722856323929
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,24101,0.000882298668843345,0.00440246775188833,-0.00774653812485779,0.00951113546254448,0.84116161229553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,24793,-0.000733082953907336,0.00366277827816314,-0.00791212837910709,0.00644596247129242,0.84136963518682
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.00365615017618886,0.018332614457583,-0.0395880745130515,0.0322757741606738,0.84192478903443
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.000973629922835226,0.00492219683147874,-0.0086738758668631,0.0106211357125335,0.843199818657959
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,24445,0.000823488646132644,0.00417588385587766,-0.00736124371138756,0.00900822100365285,0.84367185598989
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,0.000663355294226792,0.00336842185821691,-0.00593875154787834,0.00726546213633193,0.843881204360676
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,29373,0.000907680724646161,0.00461633008260983,-0.00814032623726911,0.00995568768656143,0.844123244120948
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,-0.000822039106303176,0.00423678040171995,-0.00912612869367427,0.00748205048106792,0.846158305804379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,0.000654856502041008,0.0033821541682148,-0.00597416566766001,0.00728387867174202,0.846473914860783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,-0.000769253827457735,0.00398489098332013,-0.0085796401547652,0.00704113249984973,0.846927217009631
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,-0.000607284006959005,0.00317440273056644,-0.00682911335886923,0.00561454534495122,0.848286745154129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,28931,0.00079307536191025,0.00414896799056835,-0.00733890189960371,0.00892505262342421,0.848409392788289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,29395,-0.000519995630474521,0.00278706101007673,-0.0059826352102249,0.00494264394927586,0.851995235854531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.000584712569914253,0.00313651801111356,-0.00556286273186833,0.00673228787169683,0.852115996722395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,24966,-0.000251816037923835,0.00135761253059007,-0.00291273659788037,0.0024091045220327,0.852850569314132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.000690468093125793,0.00373375371134539,-0.00662768918111118,0.00800862536736277,0.853288638125916
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,29725,0.000795191454819624,0.00435356383330546,-0.00773779365845907,0.00932817656809832,0.855071549252566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,24016,-0.000783401686842308,0.00441978167982619,-0.00944617377930164,0.00787937040561703,0.859314338994534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,-0.000469522219134915,0.00266148727713697,-0.00568603728232337,0.00474699284405354,0.859970556609059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,28931,-0.000595349544629155,0.00337489072053391,-0.00721013535687562,0.00601943626761731,0.859976558962138
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,29434,0.000635548245779556,0.00360387431723887,-0.00642804541600863,0.00769914190756775,0.86001910494979
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,24845,-0.00118043321837629,0.00671040965652485,-0.014332836145165,0.0119719697084124,0.860365491563658
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,-0.000652945283605452,0.0037129840069593,-0.00793039393724567,0.00662450337003477,0.860409637983832
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,28674,0.000544816376862118,0.00310788757225938,-0.00554664326476626,0.0066362760184905,0.860844218430927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,-0.00118939998766718,0.00698200451554775,-0.0148741288381408,0.0124953288628064,0.864734555669846
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,29478,0.000794028791346871,0.00467538818770063,-0.00836973205654636,0.0099577896392401,0.865143718012172
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,24229,-0.000466021365577919,0.00276779785610235,-0.00589090516353853,0.00495886243238269,0.86629155601524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,-0.000504768317522914,0.00303440308196893,-0.00645219835818201,0.00544266172313618,0.867884098465882
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,24101,0.00127472514274474,0.00770335801805142,-0.013823856572636,0.0163733068581255,0.868570290971112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,-0.000457221421868226,0.00278388563155503,-0.00591363725971608,0.00499919441597963,0.869544662427778
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,-0.000630828980559127,0.00386920031336453,-0.00821446159475361,0.00695280363363535,0.870489391463715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,-0.000600599132819131,0.00374558523554925,-0.00794194619449566,0.0067407479288574,0.872607642876164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,0.000736852185978982,0.00460482646620515,-0.00828860768778312,0.00976231205974108,0.872868720032845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,24867,-0.00174176336450768,0.0110046444569705,-0.0233108665001699,0.0198273397711545,0.874241159217528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,24938,-0.000596418518022999,0.00377311887709557,-0.00799173151713031,0.00679889448108431,0.87440258276183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,28706,-0.00082448055394343,0.00524046856641572,-0.0110957989441182,0.00944683783623138,0.874986240893709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.000916170846107999,0.00583557758764857,-0.0105215612256832,0.0123539029178992,0.875247953689539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,0.000559612789956868,0.00356502175957579,-0.00642782985881169,0.00754705543872542,0.875267298576338
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.000425083403273609,0.00271582721312785,-0.00489793793445697,0.00574810474100419,0.87562381073486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,24805,-0.000366634790939429,0.00234771167628679,-0.00496814967646153,0.00423488009458267,0.875902759497777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,-0.000444538930478439,0.00289981960599769,-0.0061281853582339,0.00523910749727703,0.878163908534962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.000469969534490392,0.00311656217006705,-0.00563849231884102,0.0065784313878218,0.88013674902351
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,24195,0.000322429132136709,0.00217406049930048,-0.00393872944649224,0.00458358771076566,0.882101458662569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,24229,0.00034061316828324,0.00231521587273283,-0.00419720994227311,0.00487843627883959,0.883039002909108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,-0.000675364874015407,0.00460136077731245,-0.0096940319975478,0.00834330224951699,0.883310820873944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.000618587829624125,0.0043268534961798,-0.00786204502288828,0.00909922068213653,0.886319128046857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,28797,0.00136556744011983,0.00958804050665813,-0.0174269919529301,0.0201581268331698,0.886746073664575
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,0.00048282489270139,0.00339606125126892,-0.0061734551597857,0.00713910494518848,0.886945324296533
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,28774,-0.000370894857796656,0.0026856122072865,-0.00563469478407819,0.00489290506848488,0.890158876646807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,-0.000519977915851728,0.00377408709937684,-0.00791718863063033,0.00687723279892687,0.890418752638596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.000887409039164289,0.00655428672199931,-0.0119589929359544,0.0137338110142829,0.892301541158604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,29786,-0.000212948530408234,0.00162896448706731,-0.00340571892506015,0.00297982186424368,0.895992695073693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,24805,0.00232502960409025,0.0180008099102513,-0.0329565578200024,0.0376066170281829,0.89723011633787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,-0.000233791498083601,0.00184421039652295,-0.00384844387526858,0.00338086087910138,0.899123057881418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,24101,0.000461224458031948,0.0036699658508792,-0.00673190860969128,0.00765435752575518,0.899989917427209
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,24101,-0.000502931526554553,0.00400320500529878,-0.00834921333694017,0.00734335028383106,0.900024106711544
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,24016,-0.000460516605836104,0.00368940912029919,-0.00769175848162251,0.0067707252699503,0.900666120441909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,24229,-0.000254991092723202,0.00205347182331769,-0.00427979586642587,0.00376981368097947,0.901177272924973
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,24445,0.000506311181062124,0.00412788924914788,-0.00758435174726771,0.00859697410939196,0.902380363532579
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,-0.000280571175277025,0.00234961859539231,-0.00488582362224596,0.00432468127169191,0.90495041900571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,24016,0.000345161049797226,0.00292317472756323,-0.0053842614162267,0.00607458351582116,0.906007270104108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,24229,0.000221998488580028,0.00189222408879546,-0.00348676072545907,0.00393075770261913,0.906606294601099
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,24111,0.000326347948112178,0.00278517921562964,-0.00513260331452191,0.00578529921074627,0.906723897978081
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,24381,-0.000359983388551392,0.00307352480570926,-0.00638409200774154,0.00566412523063876,0.906762790392216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,-0.000493715717513541,0.00430221912029395,-0.00892606519328968,0.0079386337582626,0.908637586623536
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,28931,-0.000412248308104727,0.00362262471292668,-0.00751259274544101,0.00668809612923156,0.909398525664016
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.000509087464678981,0.00486924581989541,-0.00903463434231601,0.010052809271674,0.916732465107571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,29725,0.000407307378171478,0.00413740798228874,-0.00770201226711446,0.00851662702345742,0.921579559613905
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,29392,-0.000509546723181707,0.00545802265580023,-0.0112072711285502,0.0101881776821868,0.925620280960771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,28774,0.000369677252779913,0.00398701607450963,-0.00744487425325896,0.00818422875881879,0.926126429936175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.000454765304857357,0.00518264555974282,-0.0106127506019533,0.00970321999223858,0.930077924311992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,24111,-0.000203714669232612,0.00232803525828737,-0.00476666377547586,0.00435923443701064,0.930270857493721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,-0.000344721846821872,0.00443743385722896,-0.00904209220699063,0.00835264851334689,0.938079310133707
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,-0.000183319848912447,0.00241365571574567,-0.00491408505177397,0.00454744535394907,0.939458506445212
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,24101,0.000195824659365976,0.0026119191512343,-0.00492353687705326,0.00531518619578521,0.940236437700974
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,0.000213365093223649,0.00288809612320167,-0.00544730330825161,0.00587403349469891,0.94110853779517
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,28774,-0.000152133624176934,0.00207338083740388,-0.00421596006548853,0.00391169281713467,0.941508487980088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,24195,0.000239934954592671,0.00335820020343139,-0.00634213744413286,0.0068220073533182,0.943042210414779
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,24240,0.00014708630046313,0.0020655788173642,-0.0039014481815707,0.00419562078249696,0.943232584970142
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.000292873264617034,0.0042317665951648,-0.00800138926190598,0.00858713579114005,0.944824315502126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.000315809320194702,0.00457830892842806,-0.0092892948199137,0.00865767617952429,0.945006534040331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,24016,0.000279804061743765,0.0042030232596229,-0.00795812152711712,0.00851772965060465,0.946922916261575
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,24195,-0.000104003599454184,0.00158892854294692,-0.00321830354363014,0.00301029634472177,0.947812134211864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,24445,-0.000104515051100072,0.00160001522581039,-0.00324054489368843,0.00303151479148828,0.947918729749266
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,-0.000117756613586957,0.00184415503857237,-0.0037323004891888,0.00349678726201489,0.949087038785381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,0.000170153191964349,0.00279094857318031,-0.00530010601146905,0.00564041239539775,0.951386722288809
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,28916,-0.000112267722432984,0.00190192148054191,-0.00384003382429513,0.00361549837942916,0.952929753115333
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,0.000166010588488009,0.00286175504586822,-0.0054430293014137,0.00577505047838971,0.953741092802972
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,29434,-0.000241726181194815,0.0041781889568279,-0.00843097653657749,0.00794752417418786,0.953865081422658
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,0.000193024325305511,0.00342452518295186,-0.00651904503328013,0.00690509368389115,0.955051280159975
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,24240,-6.70610509008286e-05,0.00125027125511358,-0.00251759271092345,0.0023834706091218,0.957224659132349
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,28797,-0.00027494794483264,0.00514209447568347,-0.0103534531171722,0.00980355722750696,0.957357780318294
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,0.000222592469987871,0.00417263836960339,-0.00795577873443478,0.00840096367441052,0.957456881419759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,24111,0.000187287859546558,0.00353539168946008,-0.0067420798517952,0.00711665557088831,0.957752156719705
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.000245106486277415,0.00495483503081005,-0.00946637017411029,0.00995658314666512,0.9605466331238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,28931,-0.000108364880176721,0.0022159192731852,-0.00445156665561971,0.00423483689526627,0.960997014941569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,7.61567820666395e-05,0.00177331030994985,-0.00339953142543507,0.00355184498956835,0.96574484296139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,0.000160845976218452,0.00377706527669825,-0.00724220196611011,0.00756389391854701,0.966032779454978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,0.000104671383737589,0.00258307524824432,-0.00495815610282128,0.00516749887029646,0.967677291816714
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,0.000317826273150688,0.00822831492893571,-0.0158096709875633,0.0164453235338647,0.969188952870573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,28847,0.000233407354216252,0.00617293128783081,-0.0118655379699321,0.0123323526783646,0.969838293493722
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.000200161523137788,0.00531957701795204,-0.0106265324783238,0.0102262094320482,0.969985113792937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.000357251541872666,0.00955827892682174,-0.0190914782384433,0.0183769751546979,0.970185398688458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.000223159253821342,0.00604413472683215,-0.0116233448107697,0.0120696633184123,0.970547801805285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,28931,-0.000141223377547088,0.00385316473469966,-0.00769342625755843,0.00741097950246425,0.970763317133633
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,29208,-0.000114125392925571,0.00315168753757428,-0.00629143296657115,0.00606318218072001,0.971114454803082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,29443,0.000108136339872512,0.00304695422285319,-0.00586389393691975,0.00608016661666477,0.971689278040934
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,-0.000103306209053415,0.00291543436553737,-0.00581755756550666,0.00561094514739983,0.971733772014419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00010740047452333,0.00307746367903174,-0.00613922928542555,0.00592442833637889,0.972160550189163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,29313,0.000160841923861421,0.00481512799012076,-0.00927680893677527,0.00959849278449812,0.973353079943457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.0001350803017277,0.00412593809356496,-0.00795175836165962,0.00822191896511502,0.973882760540486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,24016,0.000264032304994941,0.00811350328955142,-0.0156384341425258,0.0161664987525157,0.974039829678163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.000253390071165602,0.00825619459137649,-0.0159287513279323,0.0164355314702635,0.975516252882627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,29434,-6.69528291006301e-05,0.0024023923723878,-0.00477564187898071,0.00464173622077945,0.977766637668788
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.000137761742989095,0.00607905654414013,-0.0117771890835256,0.0120527125695037,0.981920311006665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,-0.000141054840202003,0.00680929647736028,-0.0134872759358282,0.0132051662554242,0.98347313913895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,2.57224395351511e-05,0.00129651754431931,-0.0025154519473307,0.002566896826401,0.984171455690276
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,28931,3.54078456974129e-05,0.00197942039637939,-0.0038442561312062,0.00391507182260102,0.985728336129204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,6.69473572990699e-05,0.00386695356184916,-0.00751228162392528,0.00764617633852342,0.986187303613904
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,28931,4.31249715079468e-05,0.00301651299214023,-0.00586924049308691,0.0059554904361028,0.988593690970794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,2.32542191541645e-05,0.00210688851986357,-0.00410624727977843,0.00415275571808676,0.991193829517924
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,-4.50633279252297e-05,0.0043857079329806,-0.0086410508765672,0.00855092422071674,0.991801931740175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,3.18017838416599e-05,0.00327577430370096,-0.00638871585141222,0.00645231941909554,0.992254200250577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,29216,-3.1828909942888e-05,0.00358088769424533,-0.00705036879066373,0.00698671097077795,0.992908114921362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-3.53175872649496e-05,0.00583575973879339,-0.0114734066753,0.0114027715007701,0.995171341292982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,-1.23219191630448e-05,0.00237523274993312,-0.00466777810903196,0.00464313427070587,0.99586089408684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,-1.43849397313115e-05,0.00392105610857893,-0.00769965491254601,0.00767088503308339,0.997072886441901
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,6.10379514136818e-06,0.00173180550327795,-0.00338823499128342,0.00340044258156616,0.997187869217339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,29293,5.43679101467531e-06,0.00387974335767357,-0.00759886019002552,0.00760973377205486,0.998881912345284
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,-3.67814150107342e-07,0.00339266318871311,-0.00664998766402779,0.00664925203572758,0.999913498415661
